directorate, medical & health services, (e.s.i. scheme) · 2020-01-29 · 3/71 eligibility...
TRANSCRIPT
1/71
DIRECTORATE, MEDICAL & HEALTH SERVICES, (E.S.I. SCHEME)
LAXMINAGAR, AJMER ROAD, JAIPUR-302006
Tel/Fax 0141-2223572,www.health.rajasthan.gov.in/esi E-Mail [email protected],[email protected]
Ref. No. F434/ESI/Store/LabEmp/2017/5540 Dated:01/11/2017
E- Tender Document
For
“E- Tender forAnalysis of Drugs, Cotton, Gauzes, Bandage & Other items”
For The
Office of the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme
Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur & attached ESIS Institutions in Rajasthan ( for
the period of two years from the date of award. )
( Non-transferable )
Price of Tender Document Rs. 2000/-
Last date & time of submission of Technical & Financial Bids is 11.12.17 at 1:30 pm
Date & time of online opening of Technical Bid is 11.12.17 at 3:00 pm
Visit Us At
http://sppp.raj.nic.in, www.dipronline.org,
http://eproc.rajasthan.gov.in, www.health.rajasthan.gov.in/esi
Our Address: DIRECTORATE, MEDICAL & HEALTH SERVICES, (E.S.I. SCHEME)
LAXMINAGAR, AJMER ROAD, JAIPUR-302006
2/71
DIRECTORATE, MEDICAL & HEALTH SERVICES, (E.S.I. SCHEME)
LAXMINAGAR, AJMER ROAD, JAIPUR-302006
Tel/Fax 0141-2223572,www.health.rajasthan.gov.in/esi E-Mail [email protected],[email protected]
Ref.No.F434/ESI/Store/LabEmp/2017/ 5540 Dated:01/11/2017
E-bids in two separate bids (Technical & Financial) for the Empanelment of
Analytic Testing Laboratories For The Test and Analysis of drugs, cotton,
bandage, gauze & other items.
Brief Details of E-Tender
Estimated Cost : Rs 50 lacs
EMD (Bid Security)Rs 100000/-
RISL processing fees Rs 1000/-
Cost of the Tender Document Rs 2000/-
Performance Security 5% of contract value
Services Required:- The service of analysis of drugs, cotton, gauze,
bandages & other items are required in the office of the Director cum Ex-
officio Dy. Secretary, Medical & Health Services, ESI Scheme, Laxmi
Nagar, Ajmer Road, Jaipur abbreviated as DMHS ESIS in this Document
& attached ESIS Institutions in Rajasthan.
Period of services will be for 2 years from the date of award.
Schedule of Tender
Description of Tender Process Date & Time
Pre-bid conference(ESI Directorate Meeting
Hall)
16.11.2017 at 1.30 p.m.
Date & time for downloading Tender
Document
07.11.2017 at 6.00 p.m.
Last date & time for submission of online
bids
11.12.2017 at 1.30 p.m.
Last date of physical submission of EMD,
Tender Document fees, Processing fees
11.12.2017 at 1.30 p.m.
Date & time for on-line opening of
Technical Bid
11.12.2017at 3.00 p.m.
Date & time for opening of Financial Bid(For
technically qualified bidders )
Will be intimated later on
Bid validity period/validity of bid offer for
acceptance by DM&HS ESI
70 days from the date of opening of the
Technical Bid
3/71
Eligibility Criteria for Empanelment
(1) Drugs Testing Laboratories should have valid approval for carrying out test
on drugs under the Drugs and Cosmetics Act, 1940 and rules there under, with
three years standing in drugs, cotton, gauzes, bandages & other item. The
Laboratory shall be entitled for empanelment for the categories of items for
which Laboratory is having approval. Tender is invited from approved Drugs
Testing Laboratories situated in India.
(2) The Laboratory should be GLP compliant under the provision of Drugs and
Cosmetics Act, 1940 and rules there under and should hold schedule L-1
certificate or should have NABL accreditation with proper scope of accreditation
to undertake testing of drugs, cotton, gauzes, bandages & other items.
(3) The Laboratory should have an average annual turnover of not less than Rs.
50 Lacs for past preceding three years (2013-14, 2014-15, 2015-16 OR 2014-15,
2015-16, 2016-17).Relaxation will be given to Government undertaking/PSU on
producing the certificate issued by the competent authority. The certificate
should be scanned & uploaded online at the time of submission of tender
documents in Technical Bid.
(4) The Laboratory should have undertaken test and analysis of drugs, cotton,
gauzes, bandages & other items and supplies of similar nature of at least three
government institutions/corporation/ reputed manufacturers of drugs, cotton,
gauzes, bandages & other items.
(5) The Laboratory should not stand banned / debarred or blacklisted by any
State or Central Government Organizations or its central procurement agencies
on the due date of bid submission.
(6) The Laboratory and its responsible persons should not have been convicted
under the provisions of applicable laws with regard to the activities and conduct
of the Laboratory.
(7) The Laboratory should have all necessary instruments/ equipments/ machines
for testing of drugs, cotton, gauzes, bandages & other items. as per standards laid
down in Drugs & Cosmetics Act/Pharmacopoeia/ Bureau of Indian Standards
and other standards as applicable/ desired.
(8) The Bidder should submit test parameters for individual item given in
Annexure-IX as per per standards laid down in Drugs & Cosmetics
4/71
Act/Pharmacopoeia/ Bureau of Indian Standards and other standards as
applicable/ desired and should have facilities of testing for the same.
General Conditions
(1) The details of the drugs, cotton, gauzes, bandages & other items to be
analyzed has been given in Annexure-IX.
(2) The Bidder should fill the names of test and the procedure to be performed
for each item given in annexure-IX as per standards laid down in Drugs &
Cosmetic Act/ Pharmacopoeia /Bureau of Indian Standards and other standards
as applicable/ desired when submitting Technical Bid. However, the rates for the
complete analysis of each item should be submitted in BoQ in Financial Bid.
Wherever tests are prescribed and their names and methodology for testing are
not stated, such Laboratory will not be considered responsive for testing for such
item.
(3) The rates quoted should be exclusive of taxes. The rates quoted should not be
higher than quoted elsewhere in any other government institution or rate
prevalent in market, otherwise necessary action will be taken to recover the
difference amount.
(4) The rates quoted and accepted will be binding on the Bidder for the stipulated
period and on no account any revision will be entertained till the completion of
the bid period.
(5) Analytical Laboratory, which also has its manufacturing activity, if
empanelled by Director cum Ex-officio Dy. Secretary, Medical & Health
Services E.S.I. Scheme, Rajasthan, Jaipur [DMHS(ESIS)] then samples of its
own manufacturing unit shall not be sent to its Empanelled Laboratory for
testing.
(6) The Laboratory will not be permitted to outsource any test from other
Laboratory.
(7) DMHS(ESIS) shall have the right to cause the Laboratory to be inspected by
the members of its Technical Committee before opening of Financial Bid and
subsequently as and when considered appropriate and based on the findings, the
Bidder may be disqualified or de-empanelled, as the case may be.
5/71
(8)The successful Bidder will have to collect the samples from Office of the
Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme
Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur & attached ESIS Institutions in
Rajasthan at his/her own cost & the cost of transport of items will not be
paid separately. At present there are 78 ESIS Instiutions under this office in
Rajasthan. The number of ESIS Institutions may be increased or decreased
at any time.
(9)The department reserves the right to amend or withdraw any of the terms
and conditions contained in the Tender Document or to reject all tenders
without assigning any reason. The decision of the Director cum Ex-officio
Dy. Secretary, Medical & Health Services, ESI Scheme Rajasthan, Laxmi
Nagar, Ajmer Road, Jaipur in this regard shall be final & binding on all.
Special Instruction Before Participating in Tender
(1)Read Tender Document carefully :The Bidder should go through the detail
mentioned in Tender Document completely before submitting the bids.
(2)Compliance with code of integrity: Any person participating in empanelment
process shall:-
(a) not offer any bribe, reward or gift or any material benefit either directly or
indirectly in exchange for an unfair advantage in procurement process or to
otherwise influence the procurement process;
(b) not misrepresent, omit, mislead or attempt to mislead so as to obtain a
financial or other benefit or avoid an obligation;
© not indulge in any collusion, bid rigging or any-competitive behavior to impair
the transparency, fairness and progress of the procurement process;
(d) not misuse any information shared between the Procuring Entity and the
bidders with an intent to gain unfair advantage in the procurement process;
(e) not indulge in any coercion including impairing or harming or threatening to
do the same, directly or indirectly, to any part or to its property to influence the
procurement process;
(f) not obstruct any investigation or audit of a procurement process;
(g) disclose Conflict of Interest, if any; and
6/71
(h) disclose any previous transgressions with any entity in India or any other
country during the last three years or any debarment by any other Procuring
Entity.
(3)No Conflict of Interest: The Bidder participating in a bidding process must
not have a Conflict of Interest. A Conflict of Interest is considered to be a
situation in which a party has interests that could improperly influence that
party’s performance of official duties or responsibilities, contractual obligations,
or compliance with applicable laws and regulations. A Bidder may be considered
to be in Conflict of Interest with one or more parties in bidding process if
including but not limited to :
(a) have controlling partners/shareholders in common; or
(b) receive or have received any direct or indirect subsidy from any of them; or
(c) have the same legal representative for purposes of the bid; or
(d) have a relationship with each other, directly or through common third parties,
that puts them in a position to have access to information about or influence on
the bid of another Bidder, or influence the decisions of the Procuring Entity
regarding the bidding process; or
(e) the Bidder participates in more than one bid in a bidding process,
participation by a Bidder in more than one bid will result in the disqualification
of all bids in which the Bidder is involved. However, this does not limit the
inclusion of the same subcontractor, not otherwise participating as a Bidder, in
more than one bid; or
(f) the Bidder or any of its affiliates participated as a consultant in the
preparation of the design or technical specification of the goods , works or
services that are the subject of the bid; or
(g) Bidder or any of its affiliates has been hired (or is proposed to be hired by
the Procuring Entity as engineer-incharge/ consultant for the contract.
7/71
Procedure to Be Followed :
(1) Deposit Bid Security (EMD), Tender Document fees and RISL (Rajcom Info
Service Limited)Processing fees. The last date to deposit these fees is 11.12.2017
at 1.30 pm.
(a) The Bid Security (EMD) of Rs 100,000/- shall be taken as DD for an amount
of Rs. 100,000/- (Rupees one lac only) from Nationalized Scheduled Bank
drawn in favor of Director Cum Ex-Officio Dy. Secretary, Medical & Health
Department, ESI Scheme, Rajasthan Jaipur, payable at Jaipur , has to be
submitted offline (and scanned copy of DD to be uploaded online at the time of
submission of tender documents in Technical Bid) towards EMD fees, failing
which tender will be rejected. Bidders are requested to write their name & full
address at the back of the bank draft submitted.
Government undertaking/PSU are exempted for bid security on producing the
certificate issued by the competent authority. The certificate should be sent
offline & copy of the same should be scanned & uploaded online at the time of
submission of tender documents in Technical Bid.
The Bid Security will be forfeited if the Bidder withdraws its bid after expiry of
last date & time fixed for receiving bids or in the case of successful Bidder, if
the Bidder fails within specified time to sign the contract agreement or/& fails
to furnish the Security Deposit (Performance Security).
(b) The Tender Document fees of Rs 2000/-(non-refundable) shall be taken as
DD for an amount of Rs.2000/- (Rupees two thousand only) from Nationalized
Scheduled Bank drawn in favor of Director Cum Ex-Officio Medical & Health
Department ESI Scheme, Rajasthan Jaipur, payable at Jaipur , has to be
submitted offline (and scanned copy of DD to be uploaded online at the time of
submission of tender documents in Technical Bid) towards Tender Document
fees, failing which tender will be rejected. Bidders are requested to write their
name & full address at the back of the bank draft submitted.
(c) Rajcom Info Service Limited (RISL) Processing fees of Rs 1000/-(non-
refundable) shall be taken as DD for an amount of Rs.1000/- (Rupees one
thousand only) from Nationalized Scheduled Bank drawn in favor of MD
Rajcom Info Service Limited payable at Jaipur , has to be submitted offline (and
scanned copy of DD to be uploaded online at the time of submission of tender
8/71
documents in Technical Bid) towards RISL Processing fees, failing which tender
will be rejected. Bidders are requested to write their name & full address at the
back of the bank draft submitted.
(d) The aforesaid DDs toward EMD, Tender Document fees & RISL Processing
fees should be submitted offline to the tender inviting authority i.e. Director Cum
Ex-Officio Dy. Secretary, Medical & Health, ESI Scheme, Rajasthan, Jaipur,
Laxmi Nagar, Ajmer Road, Jaipur 302006 on or before 11.12.17 at 1.30 pm &
the scanned copies to be uploaded online on or before 11.12.17 at 1.30 pm with
Technical Bid, failing which tender will be rejected. Bidders are requested to
write their name & full address at the back of each of the aforesaid bank drafts
before submitting offline. The aforesaid DDs should bear the date after the date
of notice inviting tender (NIT).
(e) The aforesaid DDs should be submitted offline in the duly sealed water proof
envelope. The envelope should super-scribed as:
“E-Tender for Empanelment of Analytic Testing Laboratories For the
Test & Analysis of Drugs, Cotton, Gauzes, Bandages. Don’t open before
11.12.17”
(f ) The address to send the sealed envelope is DIRECTORATE, MEDICAL & HEALTH SERVICES,
(E.S.I. SCHEME) LAXMI NAGAR, AJMER ROAD, JAIPUR-302006 and last date to receive the
sealed envelope is 11.12.2017 on 1.30 PM. If the envelope is sent by registeredpost/courier it should be recieved on or before 11.12.2017 on 1.30 PM in the office of DIRECTORATE, MEDICAL & HEALTH SERVICES, (E.S.I. SCHEME) LAXMI NAGAR, AJMER
ROAD, JAIPUR-302006. Therefore bidders must post this envelope timely & this office shall not be responsible for delay.
(2)Submission of bids :
(a) In order to submit the Bids, the aspirating Bidders have to get themselves
registered online on the e-procurement portal (http://eproc.rajasthan.gov.in.)
with valid Digital Signature Certificate (DSC).The online registration of the
Bidder will be free of cost and one time activity only.The registration should be
in the name of Bidder, whearas DSC holder may be either Bidder himself /
herself or his/her duly authorized person.
(b)Signature of Bidder : individuals signing tender or other document
connected with contract specifying :-
(i) Whether signing as a “Sole Proprietor” of the firm or his attorney.
9/71
(ii) Whether signing as a “Registered Active Partner” of the firm or his attorney.
(iii) Whether signing for the firm “Per procuration”
(iv) In the case of companies firm registered under the Indian Partnership Act the capacity in
which signing ex secretary, manager, partner etc or their attorney and produce copy of
documents, empowering him to do so, it called upon to do so.
(v) In case of unregistered firm all the members or all attorneys duly authorized by all of
them or the manager of the firm should sign the tender and subsequent documents.
(c) E- Bids in two separate bids ( Technical & Financial Bid ) will be received
till 1:30pm on 11.12.2017 by the Director cum Ex-officio Dy. Secretary,
Medical& Health, Services ESI Scheme, Rajasthan, Jaipur for the empanelment
of Analytical Laboratory for the test and analysis of drugs, cotton, gauge,
bandage for the period of two years from the date of award.
(d)The bid along with necessary documents should be uploaded in the
eproc.rajasthan.gov.in portal as per guideline mentioned in the portal. Tenders
have to be submitted only online at http//eproc.rajasthan.gov. in two bids system
i.e. Technical Bid & Financial Bid in the prescribed Performa. All the
documents in support of eligibility criteria etc. are also to be scanned &
uploaded along with tender documents. Tender sent by any other mode will not
be accepted.
(e)The bids shall be valid for a period of 70 days from the date of opening of
Technical Bid .
(f) The Bidder must furnish the following in Technical Bid in the same order
as given below. Any additional document if necessary should be annexed in
the last.
(i)The bidders shall submit / upload scanned copy of DDs towards EMD,Tender Document fees, RISEL Processing fees in Technical Bid. (ii) Documentary evidence for the constitution of the company/concern. (iii) Attested photocopy of analytical approval duly renewed up to date, issued by the State Licensing Authority. (iv) Compliance of Schedule L-1 of Drugs & Cosmetics Rules, 1945 (GPL certificate)/Copy of NABL accreditation with proper scope for testing of drugs, cotton, gauzes, bandages & other items. (v) Non- Conviction Certificate by the State Licensing Authority/ competent authority.
(vi) Attested copy of certificate of registration for GST.
(vii) A copy of PAN issued by Income Tax Department.
10/71
(viii) Copies of the Balance sheet and Profit and Loss Account for three years i.e. 2013-14, 2014-15, 2015-16, or, 2014-15, 2015-16, 2016-17, duly certified by the practicing Chartered Accountant. (ix) Annual turnover statement for 3 years i.e. 2013-14, 2014-15, 2015-16, or 2014-15, 2015-16, 2016-17, certified by the practicing Chartered Accountant. (Annexure-I) (x) Documentary evidence of having analyzed of drugs, cotton, gauzes, bandages & other items for the last three years with a statement in the Performa as given in Annexure-II. (xi) The list of qualified personnel employed in the Laboratory with proof of their qualifications and relevant approvals. (Annexure-III) (xii) The list of sophisticated instruments available in the Laboratory. (Annexure-IV)
(xiii) Micro Biological facilities available in the Laboratory. (Annexure-V)
(xiv) List of Reference sample along with their date of procurement and quantities, wherever required . (Annexure-VI) (xv) A declaration in the Performa given in Annexure-VII duly signed and Notarized.
(xvi) Details of Laboratory in Annexure – VIII.
(xvii) List of drugs , cotton, gauzes, bandages & other items proposed to be testing is in Annexure-IX Bidders are allowed the option to quote for any one item or more items as mentioned in bid. The Bidder has to mention names of test and the procedure to be performed for each item given in Annexure-IX as per standards laid down in Drugs & Cosmetic Act / Pharmacopoeia / Bureau of Indian Standards and other standard as applicable/ desired.
(g) The Financial Bid will also be known as Price Bid/Document and every
Bidder will be required to submit its price in excel format attached to the Price
Bid Document (BoQ). BoQ template must not be modified / replaced by the
Bidder and the same should be uploaded after filling the relevant columns, else
the Bidder is liable to be rejected for this bid. Bidders are allowed to enter the
Bidder name and values only The Bidder should quote rate for the complete tests
as applicable to the item. The rate for sterility test for sterile products should also
be quoted separately at last entry of BoQ.
Opening & Evaluation of Technaical & Financial Bids
(1) The Technical Bid will be opened on 11.12.2017 at 3.00 pm. There after the
bidders found eligible as stated above on the basis of the examination on
Technical Bid, the Financial Bid will be opened on the date intimated and after
scrutiny thereof, including inspection of the laboratory, if required, the
acceptable rates for analysis will be decided and communicated.
11/71
(2) Provided that a Financial Bid is substantially responsive, the Procuring
Entity will correct arithmetical errors during evaluation of Financial Bids on the
following basis:
(i) If there is a discrepancy between the unit price and the total price that is
obtained by multiplying the unit price and quantity, the unit price shall prevail
and the total price shall be corrected, unless in the opinion of the Procuring
Entity there is an obvious misplacement of the decimal point in the unit price, in
which case the total price as quoted shall govern and the unit price shall be
corrected.
(ii) If there is an error in a total corresponding to the addition or subtraction of
subtotals, the subtotals shall prevail and the total shall be corrected; and
(iii) If there is a discrepancy between words and figures, the amount in words
shall prevail, unless the amount expressed in words is related to an arithmetic
error, in which case the amount in figures shall prevail subject to clause (i) and
(ii) above. If the Bidder that submitted the lowest evaluated bid does not accept
the correction of errors, its bid shall be disqualified and its Bid Security shall be
forfeited or its Bid Securing Declaration shall be executed.
Acceptance of Bid
(1) The Bid Evaluation Committee formed by the Director cum Ex-officio Dy.
Secretary, Medical & Health, Services ESI Scheme, Rajasthan, Jaipur will
evaluate the bid with reference to various criteria.
(2) The Director cum Ex-officio Dy. Secretary, Medical & Health, Services ESI
Scheme, Rajasthan, Jaipur reserves the right to accept or reject any bid for any
one or more of the items bidded for, without assigning any reason.
(3)The acceptance of Bid on the basis of BoQ submitted on line by the Bidder
will be provisional and successful Bidder must submit duly stamped and signed
copy of BoQ &/or duly stamped and signed copy of revised rates if any as a
result of Negotiation to the tender inviting authority to proceed for agreement
and deposition of Performance Security.
Agreement & Performance Security
(1) The agreement with Empanelled Laboratories will remain valid up to 2 years
from the date of award. This may be further extended for a further period of upto
one year with mutual consent.
12/71
(2) All bidders who are empanelled will have to execute an agreement on a non-
judicial stamp paper of value Rs. 1000/- (Stamp duty to be paid by the Bidder),
in favor of the Director cum Ex-officio Dy. Secretary, Medical & Health,
Services ESI Scheme, Rajasthan, Jaipur within 15 days from the date of receipt
of the intimation to them informing that their bids have been accepted, the form
of agreement will be issued by Director cum Ex-officio Dy. Secretary, Medical
& Health, Services ESI Scheme, Rajasthan, Jaipur.
(3) The Bidder shall not, at any time, assign, sub-let or make over the contract or
the benefit therefore or any part there of to any person or persons whatsoever.
(4) All notices or communication relating to, or arising out of this agreement or
any of the terms thereof shall be considered duly served on or given to the
Bidder if delivered to him or left at the premises, places of business or abode.
(5) The successful Bidders shall be required to deposit Performance Security @
5% of contract value in the form of demand draft at the time of execution of the
agreement. Performance Security will be refunded three month after expiry of
rate contract subject to successful completion of services.
(6) Term & condition of Agreement :
1 (a) On empanelment and entrustment of the job, the Analytical Laboratory should furnish the test reports
within;
(i)10 days from the receipt of the sample in case of (non-sterile products)
(ii) 21 days from the receipt of the sample of drugs, cotton, gauzes, bandages & other items requiring test for
sterility.
(b) All the tests prescribed under Drugs & Cosmetics Act/BIS etc. (as the case may be) should be carried out for
each and every sample. The results obtained in the test should be mentioned in numerical value (wherever
possible). However this condition will not apply when only specific testing is called for/desired on any particular
sample.
(c) “COMPLIES” or “PASSES” in the result column of the report of is treated as incomplete report, if the result
has some numerical value.
(d) Every test report must have remarks either as “Standard Quality or “Not of Standard Quality”. Any
ambiguity/cutting in reports will not be accepted (clear mention of “standard quality or not of standard quality”
should be stated in bold letters and crossing/cutting of one of these will not be accepted).
(e) Reports should be in A4 size (8.27” X 11.69”) paper of good quality.
(f) Report should be issued on form 39 and should have serial number, name of drug sample, code number,
manufacturing date, expiry date , description of tests, protocol of test specified & applied, findings & results
obtained and should be signed by person-in-charge of testing. In the case of products not falling in
Pharmacopoeia Drugs & Cosmetics Act 1940 and rules 1945, BIS etc, the method of analysis must be appended
13/71
to the report, especially if the sample is declared as “Not of Standard Quality”. In case of Not of Standard Quality
Report the final results and reason for failure should be highlighted by pink/red highlighters.
(g) Reports should be attached along with spectra / chromatography data sheets, if applicable and it will be
considered incomplete if spectra of chromatograms are not attached,
2. All test reports of each batch of sample should be submitted to the ESIS Institute from where the samples were
collected in triplicate. In case of failure of a sample, the result should be communicated immediately to the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer
Road, Jaipur as well as to the ESIS Institute from where the sample was collected through phone / e-mail and the
report should be sent along with protocol.
3. If in any circumstance (like break down of instrument, non-availability of reference standard etc,) the
Analytical Laboratory is unable to undertake analysis for a sample it should be reported within 24 hours of
receipt of such a sample by phone or e-mail and the sample , the such sample should be returned to ESIS Institute
from where it was collected after taken necessary telephonic or mail consent, In case of inability of Laboratory to
undertake the testing, a penalty of 25% of testing charges applicable for the product / products will be recovered.
4. If standard test procedure of any product is required the same should be demanded within 48 hours from date
of receipt of sample. Period lapsed / taken in providing standard testing procedure will be condoned from
prescribed time limit for that sample.
5. If any sample is received in a damaged condition by the Laboratory, the sample should not be analyzed and the
information should be sent immediately to the ESIS Institute from where it was collected by telephone & e-mail.
6. The Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi
Nagar, Ajmer Road, Jaipur or his authorized representative (s) has/have the right to inspect the Laboratories of
the Bidders who have submitted bids, before taking any decision regarding empanelment. Similarly, the Director
cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer
Road, Jaipur or his authorized representatives may also inspect any empanelled Laboratory, at any point of time
during the continuance of the bid and terminate/cancel its empanelment or any orders issued to the Laboratory,
not to entrust any further testing job to the Laboratory based on facts brought out during such inspections.
7. The successful Laboratory shall have to make own arrangement for collection of sample, from Office of the
Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer
Road, Jaipur & attached ESIS Institutions in Rajasthan. If more than one samples are received of the same batch
number of any item from same or different ESIS Institutions it should be informed to Manager Central Medical
Store , Directorate Medical & Health Services ESI Scheme Laxmi Nagar Ajmer Road Jaipur and prior
permission to test the sample of same batch number must be taken in written from this office otherwise testing
charges wii not be paid to the Empennelled Laboratory.If pemission is not provided sample should be returned to
the ESIS Institute/ Central Medical Store from where the sample of same batch number was received.
8. It will be sole discretion of DMHS(ESIS) to allot the samples to any Empanelled Laboratory in case when
there are more than one Laboratory approved for item.
PAYMENT PROVISIONS
1. No advance payment towards any analysis will be made to the empanelled Bidder,
2. No payment will be made for the incomplete analysis or incomplete report. Deliberate o mission of any critical
test will be viewed seriously and shall invite action against the Laboratory as deemed fit by DMHS(ESIS).
3. Payments towards the analysis of drugs, cotton, gauzes, bandages & other items will be made as per approved
rate plus tax on it will be along with Tax at the prevailing rate as applicable at the time of payment.
4. The bills should submitted in triplet to the ESIS Institute from where the samples were received by the name
of the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi Nagar,
Ajmer Road, Jaipur
14/71
5. The original bill should be submitted only once otherwise strict action will be taken against such Laboratory.
The bill should be sent along with the Testing Report to avoid delay in payment.
6. Fall Clause Certificate (i.e. the rates of testing charged in the bill is not higher than the rates charged in any
other contract or rates prevalent in market) should be given on the body of bill.
7.No extra payement will be made towards collection of samples or transport expenditure to and from the
Empenelled Laboratory .
8.If any error is found in the procedure of testing laid down by the Bidder in technical bid &/or in the testing
report of item, as the case may be then Bidder will be bound to perform the test by correct/standard procedure &
in such cases payement will be made at rates for correct/standard procedure of testing or rates agreed in this
agreement,whichever is less, and the decision of Director cum Ex-officio Dy. Secretary, Medical & Health,
Services ESI Scheme, Rajasthan, Jaipur shall be final and binding to the respective Bidder/Empenelled
Laboratory .
10.If in any case standard procedure to be followed is other than the standard procedure submitted in technical
bid then no extra payement will be made and the decision of Director cum Ex-officio Dy. Secretary, Medical &
Health, Services ESI Scheme, Rajasthan, Jaipur shall be final and binding to the respective Bidder/Empenelled
Laboratory .
11.Tender Inviting Authority can send the demand to repeat the testing of the send sample(s) of item(s) for
which no extra payement will be made to Bidder/Empenelled Laboratory .The Empenned Laboratory should keep
/retain the part of send samples for a period of not less than 3 months from the date of reporting of result of
testing of the send samples of items or as per the guideline decided by the competent authority.
PENALTIES
1. If the successful Bidder fails to execute the agreement and payment of Performance Security within the time
specified or withdraws the bid after intimation of the acceptance of the bid has been sent to or owing to any other
reasons, he is unable to undertake the contract, the empanelment will be cancelled and the Bid Security (EMD)
deposited by the Bidder shall stand forfeited in favor of the Director cum Ex-officio Dy. Secretary, Medical &
Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur. Such Bidder(s) will also be liable for
all damages sustained by the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme
Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur due to breach of bid/tender conditions. Such damages shall be
assessed by the Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan,
Laxmi Nagar, Ajmer Road, Jaipur whose decision shall be final.
2. Non performance of any bid or empanelment conditions will disqualify a Laboratory to participate in the bid
for the period as decided by DMHS(ESIS).
3. If it is revealed that the Analytical Laboratory is involved in any form of fraud and collusion with the suppliers
of Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi
Nagar, Ajmer Road, Jaipur, the Analytical Laboratory will be black listed for a period considered suitable. The
Bidders shall also be liable for action under criminal law and the matter will be notified to the concerned Director
of Drugs Control for suitable action against them under Drugs & Cosmetics Act & Rules.
4. The Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi
Nagar, Ajmer Road, Jaipur will be at liberty to terminate without assigning any reasons, the empanelment of
any Laboratory either wholly or in part at one month notice. The Bidder will not be entitled for any compensation
whatsoever in respect of such termination.
5. In all matters pertaining to the bid, the decision of the Director cum Ex-officio Dy. Secretary, Medical &
Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur shall be final and binding.
15/71
6. (i) If the Laboratory requires an extension in time for submission of test report, on account of occurrence of
any hindrance he shall apply in writing for extension on occurrence of hindrance but not after the stipulated date
of furnishing the test report.
(ii) The Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan, Laxmi
Nagar, Ajmer Road, Jaipur may extend the testing period with or without liquidated damages in case they are
satisfied that the delay in the submission of test reports is on account of any hindrances, he shall apply in writing
for extension on occurrence of hindrance but not after the stipulated date of submission of report, reasons shall be
recorded.
(iii) Extension in testing period:- In case of extension in the testing period with liquidated damages the recovery
shall be made on the basis of following percentages of testing charges which the Bidder has failed to submit:-
(a) Delay up to one fourth period of the prescribed testing period; 2.5%
(b) Delay exceeding one fourth but not exceeding half of the prescribed testing period; 5%
(c) Delay exceeding half but not exceeding three fourth of the prescribed testing period; 7.5%
(d) Delay exceeding three fourth of the prescribed testing period; 10%
Note :- Fraction of a day in reckoning period of delay in furnish the test report shall be eliminated if it is less than
half a day. The maximum amount of liquidated damages shall be 10%
(iv) If, at any time during the continuance of this Agreement, the Laboratory has, in the opinion of the Procuring
Entity, delayed in submitting any test report, by the reasons of any riots, mutinies, wars, fire, storm, earthquakes,
tempest or other exceptional cause, on a specific request made by the Laboratory, the time for submitting test
report as may be extended by the DMHS(ESIS) purely at his discretion for such period as may be considered
reasonable. No further representation from the Laboratory will be entertained on this account.
Grievance Redressal During Empanelment Process:
The designation and address of the First Appellate Authority is Deputy Secretary, Labour & Employment, Govt.
of Rajasthan.
The designation and address of the Second Appellate Authority is Secretary, Labour & Employment, Govt. of
Rajasthan.
(1) Filling an appeal
If any Bidder or prospective Bidder is aggrieved that any decision, action or omission of the Procuring Entity is
in contravention to the provision of the Act or the Rule of the Guidelines issued there under, he may file an
appeal to First Appellate Authority, as specified in the Tender Document within a period of ten days from the
date of such decision or action, omission, as the case may be, clearly giving the specific ground or grounds on
which he feels aggrieved; provided that after the declaration of a Bidder as successful the appeal may be filed
only by a Bidder who has participated in procurement proceedings, Provided further that in case a Procuring
Entity evaluates the Technical Bids before the opening of the Financial Bids, an appeal related to the matter of
Financial Bids may be filed only by a Bidder whose Technical Bid is found to be acceptable.
(2) The officer to whom an appeal is filed under Para (1) shall deal with the appeal as expeditiously as possible
and shall endeavor to dispose it of within thirty days from the date of the appeal
(3) If the officer designated under Para (1) fails to dispose of the appeal filed with in the period specified in Para
(2), or if the Bidder or prospective Bidder or the Procuring Entity is aggrieved by the order passed by the First
Appellate Authority, the Bidder or prospective Bidder or the Procuring Entity, as the case may be, may file a
second appeal to Second Appellate Authority specified in the Tender Document in this behalf within fifteen days
17/71
Annexure-I
ANNUAL TURN OVER STATEMENT
The Annual Turnover (for drugs, cotton, bandage, gauze & other items
testing services) of M/s._________________________for the past three years
given below and certified that the statement is true and correct.
S.No. Years Turnover in Lacs (Rs)
1 2013-14
2 2014-15
3 2015-16
Total Rs. Lacs
4 2014-15
5 2015-16
6 2016-17
Total Rs. Lacs
Average turnover per annual Rs. Lacs
18/71
Annexure-II
PERFORMA FOR PERFORMANCE STATEMENT
(for a period of last 3 years)
Name of the Laboratory:____________________________________
Address:__________________________________________________
_______________________________________________________
S.No. Types of Sample Analysis
No. of Sample Analysis during
1 Drugs & Medicines 2013-14
2014-15
2015-16
2
Cotton, Gauzes & Bandages
2013-14
2014-15
2015-16
3 Others (Specify) 2013-14
2014-15
2015-16
Signature :
Date :
Name of the Lab :
Office Seal :
19/71
Annexure-III
PERSONNEL IN QC DEPARTMENT
Name of the Technical Staff approved by State Licensing Authority
along with the Designation. Highest Qualification, Experience
(Experience relevant to analysis of drugs, cottons, gauzes, bandages &
other items)
Signature :
Date :
Name of the Lab :
Office Seal :
20/71
Annexure-IV
LIST OF SOPHISTICATED EQUIPMENT/INSTRUMENT/APPARATUS
AVAILABLE IN THE LABORATORY
S.No. Name of the Equipments/Instruments/Apparatus
Make & Description
Date of Installation
Date of Last
Validation
Approved for testing of drugs
from State Licensing Authority
Since
Signature :
Date :
Name of the Lab :
Office Seal :
21/71
Annexure-V
FACILITIES IN THE MICROBIOLOGICAL SECTION
I. LIST OF STOCK CULTURES AVAILABLE
II. LIST OF EQUIPMENT/APPARATUS AVAILABLE WITH ADTE OF
INSTALLATION, make and approval from Licensing Authority to
permit microbiological testing in the Laboratory
Signature :
Date :
Name of the Lab :
Office Seal :
22/71
Annexure-VI
LIST OF REFERENCES SAMPLES ALONG WITH THEIR DATE OF
PROCUREMENT AND QUANTITIES, If required for any item.
Signature :
Date :
Name of the Lab :
Office Seal :
23/71
Affidavit
(On Non Judicial Stamp of Rs.100/-) Annexure-VII
DECLARATION FORM
1. I (Name of the Bidder) S/O__________________, Age__________, Resident
of_____________, am proprietor/Partner/Director having our office
at_________________________________and the approved drug testing Laboratory
(Name)……………………………………………………………………. Situated at (Address)
__________________________________do here by declare that I have carefully
read all the conditions of bid of Director cum Ex-officio Dy. Secretary, Medical &
Health Services ESI Scheme Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur for the bids
floated for empanelment of approved drugs testing Laboratories for analysis of drugs
, cotton, gauzes, bandages & other items for the period of two years from the date
of award and shall abide by all the conditions set forth there in.
2. I further declare that I posses valid approval for testing of all the drugs , cotton,
gauzes, bandages & other items for which Price Bid have been submitted by me/us
in cover B and permission on form 37 have obtained for testing of these items from
States Licensing Authority where ever applicable.
3. That the approval to test drugs , cotton, gauzes, bandages & other items have been
obtained on Form 37 bearing No.____________which is valid/renewed up to
_____________
4. That the Bidder firm is a proprietorship/Partnership/Pvt. Ltd./Ltd. firm and following
are the other partners/directors:-
S.No. Name of Partner/Director Age Present & Permanent Address
5. That ourLaboratory/Firm/Company does not stand blacklisted/debarred or banned on
any ground either by Bid Inviting Authority or Govt. or Rajasthan on the date of bid
submission.
Our Laboratory/Firm/Company also does not stand blacklisted, debarred or banned
on the ground or wrong reporting of test results or on the ground of submission of fake of
forged documents or false information/facts, by any State or Central government or by its
central drug procurement agencies, on the date of bid submission for supply of
drugs/medicines in India.
(Affidavit page 1)
24/71
6. That I/We have carefully read all the conditions of bid in ref.
No.________________________ Dated: _______________ for the empanelment of
analytical testing Laboratories for the test and analysis of drugs , cotton, gauzes,
bandages & other items for the period of two years from the date of award for
Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme
Rajasthan, Laxmi Nagar, Ajmer Road, Jaipur and accept all conditions of bid,
including a amendments if any.
7. I/We hereby declare under Section 7 of Rajasthan Transparency in Public
Procurement Act, 2012. That :
a. I/We posses the necessary professional, technical, financial and managerial
resources and competence required by the Tender Document issued by the
Procuring Entity;
b. I/We have fulfilled my/our obligation to pay such of the taxes payable to the
Union and the State Government or any local authority as specified in the
Tender Document;
c. I/We are not insolvent, in receivership, bankrupt or being wound up. Not have
my/our affairs administered by a court or a judicial officer, not have my/our
business activities suspended and not the subject of legal proceedings for any
of the foregoing reasons;
d. I/We do not have, and our directors and officers not have, been convicted of any criminal offence related to my/our professional conduct or the making of false statements or misrepresentations as to my/our qualifications to enter into a procurement contract within a period of three years preceding the . commencement of this procurement process, or not have been otherwise . disqualified pursuant to debarment proceedings;
e. I/We do not have a Conflict of Interest as specified in the Act, Rules and the
Tender Document, which materially affects fair competition;
8. Our complete address for communication with Phone No. :-
……………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………
9. E-mail address:-……………………………………………………………………………………………
(Affidavit Page-2)
25/71
10. Bank detail for e-Baking :-
Name of account holder………………………………………………………………………………………….
Full name of Bank with Branch………………………………………………………………………………..
A/c no. with all digits………………………………………………………………………………………………
IFSC code………………………………………………………………………………………………………………..
(Deponent)
Signature :
Date :
Name of the Lab :
Office Seal :
Verification
I………………………………………………….S/o……………………………………….(Designation)………………….P
rop./Partner/Director of Lab M/s……………………………………….Address……………………………….
Affirm oath that the contents/information from para 1 to 10 as mentioned above are true &
correct to the best of my knowledge and nothing is hidden. I also declare on oath, that if any
information furnished by me as above is found wrong, false, forged or fabricated; the
Director cum Ex-officio Dy. Secretary, Medical & Health Services ESI Scheme Rajasthan,
Laxmi Nagar, Ajmer Road, Jaipur will be at liberty to cancel the bid and forfeiting the earnest
money deposit and or performance security, for which I shall be solely responsible and the
laboratory/firm may be Debarred/Banned/Prosecuted for the same.
(Name of Deponent & Signature)
ATTESTED BY NOTARY PUBLIC
(Affidavit Page-3)
26/71
Annexure-VIII
DETAILS OF LABORATORY
1. Name of the Laboratory & Full Address :
Phone No. (Landline) :
Fax :
Email :
2. Other Branches & their Address (if any) :
3. Whether the firm has it own manufacturing unit? :
If yes give details or address, license number etc. :
4. Date of Start testing or drugs , cotton, :
gauzes, bandages & other items
5. Approval No. & Date :
6. Approval Issues by :
7. Valid up to :
8. Schedule L-1 certificate its no. and date or issue :
9. (i) NABL Accreditation no. & date :
(ii) Scope of Accreditation :
(iii) Its validity :
10. Name of the authorized Signatory of Laboratory :
11. Specimen Signature of the authorized :
Signatory of Laboratory
12. Names & Specimen Signatures of the :
Approved technical Staff who are a authorized to
sign the test reports
(1) (Name) (Specimen Signature)
(2) (Name) (Specimen Signature)
27/71
List of drugs, cotton, gauzes, bandages & other items Annexure-IX
S.No. Item code
NAME OF ITEM Pack Name of test & procedure as per standards laid down in drugs & cosmetics Act/Pharmacopoeia/ Bureau of Indian Standards and other standards as applicable/ desired.
Remark
1 2 Antacid gel Each 10ml. to contain : Mag Hyd 185mg., Dimethicone 50mg., Sodium Car methyl cellulose 100mg., Dried Al Hyd gel 830mg.
170ml
2 5 Omeprazole Cap Each cap. to contain : Omeprazole 20mg IP 10 Caps 3 6 Tab. Bisacodyl Each tab to contain: Bisacodyl 5mg, IP 10 Tab 4 8 Tab. Metoclopramide- Each tab. to contain: Metoclopramide HCL
10mg, IP 10 Tab
5 10 Inj. Metoclopramide 5mg, IP-Metoclopramide HCL Eqv.to Metoclopramide 5 mg.
2ml amp
6 13 Syp. Promethazine- Each tab. to contain: Promethazine 5mg., IP 100ml Bott. 7 14 Promethazine Inj. Each ml. to contain : Promethazine 25mg. 2ml amp 8 16 Antispasmodic Drops/suspenson Each ml. to contain :
Dicyclomine hcl 10mg. Activated dimethicone 40mg 1ml bottle
9 18 Dicyclomine & Paracetamol Tab. Each tab to contain: Dicyclomine 20mg Paracetamol 325 mg
10 Tabs
10 19 Dicyclomine Inj. Each 2ml. to contain : Dicyclomine 10mg. 2ml amp 11 20 Tab. Furazolidone Each tab. to contain : Furazolidone100mg, IP 10 tab. 12 21 Susp. Furazolidone Each 5ml. to contain : Furazolidone 25mg, IP 60ml bot 13 24 Metronidazole Each 5ml to contain Metronidazole 200 mg 100ml bottle 14 25 Susp. Metronidazole Each 5ml. to contain : Metronidazole
200mg, IP 60ml bot
15 26 Norfloxacin & Tinidazole Each tab. to contain : Norfloxacin400+Tinidazole 600 Tab
10 Tabs
16 27 Cap. Digestive- Each cap. to contain: Fungal Diastase (1:2000) 20mg, Lactic acid Bacillus 150million Spores
10 Cap
17 29 Etophylline & Theophylline Inj. Each ml. to contain :Etophylline84.7+Theophylline25.3
2 ml. Amp
18 31 Syp. salbutamol Each 5ml. to contain : salbutamol sulphate eqv.to Salbutamol 2 mg, IP
100ml bott.
19 33 Syp. BRONCHODILATOR - Each 5ml. Each tab. to contain: contain : Theopyllin ethanoate of Piperazine 80mg, Eph. Hcl. 12mg. Guaiphenesin 50 mg. Alcohol 0.55ml. Absolute alcohol contenl 10.44mg
200ml Bott.
20 36 Syp. Bromhexine Each 5ml. to contain : Bromhexine Hcl. 4mg. 100ml bott. 21 48 Iso-sorbide Dinitrate Each tab. to contain : Iso-sorbide Dinitrate
10mg, IP 10 tab
22 53 Amlodipine Tab Each tab. to contain : Amlodipine 5mg IP 10 Tabs 23 54 Tab. Methyldopa Each Tab. to contain : Methyldopa 250mg, IP 10 tab
28/71
24 57 Inj. Dopamine Each ml. to contain : Dopamine HCl 40mg, IP 5 ml amp 25 58 Frusemide Inj. Each tab. to contain : Frusemide 10 mg. IP
2ml Amp
26 59 Tab. Triamterine & Benzthiazide Each tab. to contain : Triamterine 50mg, Benzthiazide 25mg
10 tab
27 60 Tab. Frusemide Each tab to contain: frusemide 40mg, IP 10 tab. 28 63 Inj. Isoxsuprine Each ml to contain: Isoxsuprine 5mg, IP 2ml amp 29 69 Ethamsylate Inj. Each ml. containing : Ethamsylate 125mg. 2ml amp 30 71 Inj. Heparin Sodium- Each ml to contain: Heparin Sodium 5000IU 5ml vial 31 73 Acetyl salicylic Acid Tab. (soluble) Each tab to contain: Acetyl
salicylic acid 100mg+calcium carbonate 30mg+anhydrous citric acid 10mg.
14 tab.
32 75 Tab. Flunarizine- Each tab to contain: Flunarizine 10mg 10 Tab 33 79 Nimesulide Tab Each tab to contain : Nimesulide 100mg 10 Tabs 34 80 Tab. Asprin Each tab. to contain : Asprin 300mg, IP 10 tab 35 81 Paracetamol Tab Each tab to contain : Paracetamol 500mg, IP 10 Tabs 36 84 Diclofenac Sod Tab, Each tab. to contain: Diclofenac Sod 50mg,
IP 10 Tabs
37 85 Diclofenac sodium Inj. Each ml. to contain : Diclofenac sodium 25 mg., IP
3ml. Amp
38 86 Pentazocine Inj. Each tab to contain :Pentazocine (as lactate) 30 mg. IP
1ml. Amp
39 87 Ibuprofen & PCM Tab. Each tab to contain : Ibuprofen 400mg, Paracetmol 325mg. IP
10 Tabs
40 90 Inj. Each ml. to contain: Hyaluronidase IP 1500 units. IP 2ml. Vial 41 92 Tab. Diazepam - Each tab to contain: Diazepam 5mg, IP 10 tab 42 93 Inj. Diazepam Each ml to contain : Diazepam 5mg, IP 2ml amp 43 95 Tab. Trifluperazine- Each tab. to contain: Trifluperazine 5mg, 10 Tab 44 96 Tab. Imipramine Each tab. to contain: Imipramine 25mg, IP 10 Tab. 45 97 Cap. Fluoxetine Each cap. to contain : Fluoxetine 20mg, IP 10 cap 46 98 Tab. Phenytoin Sodium- Each tab. to contain: Phenytoin Sodium
100mg, IP 100 Tab.
47 99 Tab. Carbamazepine Each tab. to contain : Carbamazepine 200mg, IP
10 tab
48 103 Tab. Trihexyphenidyl Each tab. to contain : Trihexyphenidyl Hydrochloride 2mg, IP
10 tab
49 104 Nalidixic Acid Tab. - Each tab to contain: Nalidixic Acid 500mg, IP
10 tab
50 105 Nalidixic Acid Susp Each 5ml to contain: Nalidixic Acid Susp.300mg IP
30ml bottle
51 107 Liq. Disodium Hydrogen Citrate Each 5ml. to Contain : Disodium Hydrogen Citrate 1.25gm/5ml
100ml bottle
52 111 Inj. Methyl Ergometrine Maleate Each ml. to contain : Methyl Ergometrine Maleate 0.2mg, IP
1ml amp
53 112 Inj. Oxytocin Each ml. to contain : Synthetic Oxytocin 5 IU IP 1ml amp 54 114 Inj. Valethamate Each ml. to contain : Valethamate Bromide 8mg 1ml amp 55 119 Tab. Povidone Vaginal Each tab. to contain Povidone Iodine
200mg 10 tab
56 121 Tab. Pheniramine Maleate- Each tab. Carboprost contain: Pheniramine Maleate 25mg, IP
10 Tab.
29/71
57 122 Syp. Pheniramine Each 5ml. to contain : Pheniramine Maleate 15mg
100ml bottle
58 123 Syp. Pheniramine Each 5ml. to contain : Pheniramine Maleate 22.75mg
2ml amp
59 124 Tab. Cyproheptadine Each ml. to contain : Cyproheptadine 4mg, IP
10 tab
60 128 Tab. Norethisterone - Each tab to contain: Norethisterone 5mg, IP
10 tab
61 133 Dexamethasone Inj.Each ml. to contain: Dexamethasone Sodium Phosphate 4 mg., IP
1 vial
62 134 Tab. Prednisolone Each tab. to contain : Prednisolone 5mg, IP 10 tab 63 135 Tab. Thyroxine Sodium Each tab. to contain : Thyroxine Sodium
100mcg, IP 100 tab
64 136 Tab. Carbimazole- Each tab. to contain: Carbimazole 5mg, IP 100 Tab. 65 137 Tab. Acarbose Each tab. to contain : Acarbose 50mg, IP 10 tab 66 138 Glibenclamide Each Tab. to contain: Glibenclamide 5mg IP 10 tab 67 139 Metformin tab. Each Tab. to contain: Metformin HCL Tab 500mg
IP 10 Tabs
68 140 Glipizide Each Tab. to contain: Glipizide 5mg IP 10 Tabs 69 145 Sodium Benzyl Penicillin Inj. Each vial to contain : Sodium
Benzyl Penicillin 5Lac, (300mg.) IP 1 Vial
70 146 Sodium Benzyl Penicillin Inj. Each vial to contain : Sodium Benzyl Penicillin 10Lac, (600mg.) IP
1 Vial
71 147 Benzathine Penicillin Inj. Each vial to contain : Sodium Benzathine Penicillin 6Lac, (450mg.) IP
1 Vial
72 148 Benzathine Penicillin Inj. Each vial to contain : Sodium Benzathine Penicillin 12Lac, (900mg.) IP
1 Vial
73 149 Benzathine Penicillin Inj. Each vial to contain : Benzathine Penicillin 24Lac, (1.8gms.) IP
1 Vial
74 151 Inj. Streptomycine Each vial to contain : Streptomycine Sulphate 0.75gm, IP per vial
1 vial
75 155 Pot. Phenoxymethyl Penicilline Tab.Each vial to contain : Pot. Phenoxymethyl Penicilline 125 mg. IP
10 Tabs
76 156 Pot. Phenoxymethyl Penicillin Tab. Each vial to contain : Pot. Phenoxymethyl Penicillin 250 mg. IP
10 Tabs
77 161 Dry Syp. Ampicillin, Each 5ml to contain: Ampicillin IP 125mg/5ml 30ml. Bottle 78 164 Amoxycillin & Cloxacillin Cap. Each cap to contain :
Amoxycillin250, Cloxacillin250 Cap. 10 Caps
79 165 Cloxacillin Dry Syp. Each 5ml. to contain: Cloxacillin, 125mg. IP 40ml. Bottle 80 167 Inj. Cloxacillin sodium, Each vial to contain: Cloxacillin sodium IP
250mg 1 Vial
81 168 Syp. Cephalexin, Each 5ml to contain: Cephalexin IP 125mg- 30ml
30ml bottle
82 170 Gentamycin Inj Each ml to contain : Gentamycin Sulphate eqv. to Gentamycin, 40mg
2ml Vial
83 171 Erythromycin Tab. Each tab to contain : Erythromycin Stearate eqv to erythromycin, 250mg IP
10 Tabs
84 172 Susp. Erythromycin Oral Each 5ml. to contain : Erythromycin 125mg Each 5ml to contain
30ml bottle
30/71
85 173 Cotrimoxazole Susp. Each 5ml to contain : Trimethoprim 40mg. Sulphamethoxazole 200mg. IP
60 ml Bott.
86 174 Cotrimoxazole Tab. Each tab. to contain : Trimethoprim 80mg. Sulphamethoxazole 400mg. IP
10 Tabs
87 175 Tetracycline Cap.Each cap to contain : Tetracycline 250mg IP 10 Caps 88 176 Norfloxacin Tab. Each tab to contain : Norfloxacin 400mg IP 10 Tabs 89 178 Inj Ciprofloxacin, IP Each 100ml to contain Ciprofloxacin 200mg 100ml Vial 90 179 Doxycycline Cap/Tab. Each Cap/Tab. to contain: Doxycycline
HCL 100mg 10 Cap/Tab
91 183 Dry Syp. Amoxycillin & Clavulanic acid Each 5ml. to contain : Amoxycillin 200mg, Clavulanic acid 28.5 mg, IP
30ml bottle
92 191 Pyrazinamide Kid Tabs. Each Tab. to contain: Pyrazinamide 300mg. IP
10 tab
93 192 Dapsone Tabs. Each Tab. to contain: Dapsone 100mg. IP 10 tab 94 194 Tab. Griseofulvin - Each tab to contain: Griseofulvin IP 125mg 10 tab 95 195 Chloroquine Tab. Each tab. to contain : Chloroquine Phosphate
250mg IP 10 Tab
96 196 Syp. Chloroquine Each 5ml. to contain : Chloroquine Phosphate- 50mg.
60ml bottle
97 197 Inj. Chloroquine, Each ml to contain: eqv. Chloroquine phosphate eqv. to Chloroquine base 40mg. IP
5 ml. amp
98 198 Anti malarial Tab. Each Tab. to contain: Pyrimethamine 25mg. Sulphadoxine 500mg., IP
2 tab.
99 199 Tab. Quinine Each tab. to contain : Quinine Sulphate, IP 300mg 10 tab 100 200 Inj. Quinine, Each ml. to contain : Quinine IP 300mg/ml- 2ml 2ml amp 101 201 Tab. Diethyl Carbamazine- Each tab. to contain: Diethyl
Carbamazine Citrate IP 100mg 10 Tab.
102 202 Syp. Diethyl Carbamazine Each ml. to contain : Diethyl Carbamazine Citrate 120mg
100ml
103 204 Tab. Mebendazole- Each tab to contain: Mebendazole 100mg, IP
6 tab.
104 206 Piperazine Citrate Syp. Each 5ml to contain: Piperazine Citrate IP eqv to 0.75gm of piperazine hydrate IP
60ml bottle
105 210 ED. Chloramphenicol- Each vial to contain: Chloramphenicol IP 0.5% w/v
5ml vial
106 211 Chlor. Opth. Oint Each caps to contains: Chlormphenicol IP 1% inpliable gelatin caps with elongated tip IP
100 cap
107 212 Eye/Ear Drop- Gentamycin, Each vial to contain : Gentamycin, IP 0.3% w/v
5ml vial
108 213 Eye/Ear Drop- Ciprofloxacin Each vial to contain : Ciprofloxacin 0.3%, IP w/v
5ml vial
109 218 Norfloxacin Eye/Ear drops Containing: Norfloxacin 0.3% w/v 5ml vial 110 219 Nasal Drop. Oxymetazoline, Each vial to contain :
Oxymetazoline, IP 0.05% w/v 10ml vial
111 220 Nasal Drop. Xylometazoline, Each vial to contain : Xylometazoline, IP 0.1%
10ml vial
112 221 Cream Miconazole IP- Each tube to contain: Miconazole Nitrate 2%
15gm tube
113 223 Clotrimazole 1% w/v Ointment, IP 15gm Al Tube
31/71
114 224 Benzyl Benzoate Application- Each bottle to contain: Benzyl Benzoate 25%, IP
1Ltr Bottle
115 225 Povidone Iodine 5% w/v Ointment, IP 15gm Al Tube
116 226 Povidone Iodine Solution, IP 7.5% 500ml 500ml bottle 117 227 Framycetin Skin Cream. Each tube to contain : Framycetin
Sulphate 1% 30gm tube
118 229 Flucinolone Oint.., IP Containing: Flucinolone Acetonide IP 0.025% w/w
15gm tube
119 230 Betamethasone+Chinoform Ointment Containing: Betamethasone Valerate IP 0.12%, Chinoform 3% in cream base.
15gm tube
120 233 Cream Containing: Precipitated Sulpur 5% w/w, Benzyl Peroxide 10% w/w
20gm tube
121 234 Elastic Adhesive Bandage Roll Elastic Adhesive Bandage Roll size 8cm x 4mt
10 rolls pkt
122 235 Handloom Cotton Gauze- Handloom Cotton Gauze Absorbent FII (ISI marked) Size 18m x 60cm
One thaan
123 236 Handloom Cotton Bandage Cloth -Handloom Cotton Bandage Cloth FII (ISI marked) Size 20m x 100cm
One thaan
124 237 Cotton Wool Absorbent, Cotton Wool Absorbent 500 gm. 500gm pkt. 125 240 White Soft Paraffin, Each to contain : White Soft Paraffin, IP
500gm 500gm
126 250 Topical Lignocaine, Containing: Lignocaine 4% w/v 30ml vial 127 251 Inj. Lignocaine Each vial to contain : Lignocaine HCl IP 2% w/v 30ml vial 128 257 Inj. Vecuronium, Each amp to contain : Vecuronium, IP 4mg 1Amp./vial 129 258 Inj. Atracurium - Each ml to contain: Atracurium besylate IP
10mg. 2.5ml
130 260 Alfa calcidol Cap.Each cap. to contain: Alfa calcidol 0.25mcg. 10 cap. 131 262 Polyvitamin Tab. Each tab. to contain : NFI- III Prophylactic 10 Tab 132 265 Inj. Vitamin- Each 2ml to contain : Thiamine 10mg. Riboflavin
4mg. Nicotinamide 40mg. Cyanocobalamine 8mcg. Pyridoxine 4mg. D-Panthenol 6mg. Benzyl Alcohol 0.9%
2ml amp
133 267 Ferrous Sulphate tab. Each tab. to contain: Ferrous Sulphate 200mg.
10 Tab
134 268 Cap. Ferrous Sulphate 150mg (in S.R. form), Folic acid 0.5mg 10 Cap 135 272 Liq. Potassium Chloride- Each 15ml to contain: Potassium
Chloride USP 1.5gm. 200ml bottle
136 273 Dextrose Inj. Containing: Dextrose anhydrous 25% w/v 25ml. Amp. 137 277 Sterile water for Injection, Each amp to contain: Sterile water IP-
5ml 5ml Amp
138 279 Containing : Inj. (for IV infusion) Sodium Chloride IP 0.9% w/v 500ml 139 280 Sodium Chloride & Dextrose Inj., IP (for I.V. Infusion) Containing:
Dextrose anhydrous 5%w/v, Sodium chloride 0.9%w/v 500ml
140 282 Chick Embryo Cell Rabies Vaccine: Each dose to Contain: 2.5 IU inactivated rabies antigen
1dose Pack
141 285 Cap. Cyclosporine Each cap. to contain: Cyclosporine 50mg 50 cap 142 286 5-Fluorouracil Inj., Each vial to contain: Fluorouracil IP 250mg. 1 Vial 143 287 Cap. Hydroxy Each cap. to contain : Hydroxy Urea 500mg 10 cap 144 288 Inj. Cytosine Arabinoside- Each vial to contain: Cytosine
Arabinoside 100mg 1 Vial
32/71
145 289 Tab. Tamoxifen- Each tab to contain: Tamoxifen IP 10mg 10 tab 146 290 Inj. Etoposide, Each vial to contain : Etoposide, IP 100mg 1 vial 147 291 Cyclophosphamide Tab. Each tab to contain: Cyclophosphamide
IP 50mg 10 tab
148 292 Inj. Bleomycin Each vial to contain: Bleomycin IP 15mg 1 vial 149 293 Inj. Vincristine .- Each vial to contain: Vincristine 1mg I.P.
1 Vial
150 301 Cough Linctus Each 5ml. to contain : Codeine phosphate 10mg, chlor - pheniramine maleate 4mg.
100ml bottle
151 302 Levofloxacin Tab.Each tab to contain : Levofloxacin 500mg 10 Tabs 152 303 Inj. Cefpirome Each vial to contain : Cefpirome 1gm 1 vial 153 305 Calcium & Vit. D3 Tabs., BP / USP Each Tab. to contain:
Calcium Carbonate IP 1250mg eqv to elemental calcium 500mg from an organic source, vitamin D3 –IP 250 IU
15 tab
154 307 Tab. Cephalexin Dispersible Each tab. to contain : Cephalexin 125mg IP
10 tab
155 317 Essential Phospholipid Cap. Each cap. to contain : Lecithine 350mg Eqv.to 175mg of Essential Phospholipid
10 Cap
156 318 Tab. Naproxen Each tab. to contain : Naproxen IP 250mg 10 tab 157 321 Ribavirin Syp. Each 5ml. to contain: Ribavirin 50mg. 30ml bottle 158 322 Tab. Haemostatic- Each tab to contain: Micronized purified
flavonoid fraction of Rutaceae 500mg. 10 tab.
159 326 Inj. Nitroglycerine- Each ml to contain: Nitroglycerine 5mg 5ml amp 160 327 Dobutamine Injection Each vial/amp to contain: Dobutamine Hcl
eqv. To Dobutamine IP 250mg 1 vial/ amp
161 332 Inj. Vancomycin, Each tab to contain: Vancomycin, HCL Eqv. to Vancomycin, IP 500mg
1 Vial
162 334 Tab. Lamivudine, Each tab. to contain : Lamivudine, IP 150mg 10 tab 163 343 Thyroxine tab. Each tab to contain: Thyroxine Sodium IP 50
mcg 100 Tabs. Bot.
164 345 Antacid Tab. Each tab to contain -Dried Aluminium Hydroxide Gel 250mg+ Mg. Hydroxide 250mg + Methyl Polysiloxane 50mg
10 Tab
165 358 Haemorrhoidal Cream Containing : Beclomethasone dipropionate 0.025%,phenylepherine hydrochloride 0.1%, Lignocaine hydrochloride 2.5%.
20gm tube
166 359 Ipratropium Inhaler Each metered dose to contain : Ipratropium bromide 20mcg
200 doses
167 362 INHALER Budesonide Each Metered Dose to contain : Budesonide 100mcg.
200 doses
168 363 Tab. Theophyllin CR- Each CR tab to contain: Theophyllin Anhydrous 400mg
10 Tab
169 365 Tab. Losartan Hydrochlorthiazide Each tab. to contain : Losartan Potassium 50mg, Hydrochlorthiazide 12.5mg, IP
10 tab
170 367 Cap. Fenofibrate- Each cap. to contain: Fenofibrate IP (Micronised) 200mg
7 cap
171 371 Analgesic Gel- Each gm to contain : Nimesulide 10mg, Methyl Salicylate 100mg, Menthol 50mg, Capaicin 0.25mg.in cream base
30 mg tube
172 377 Tab. Methyl Ergometrine, Each tab. to contain Methyl Ergometrine, IP 0.125mg
10 tab
33/71
173 379 Syp. Norfloxacin Each 30ml. to contain Norfloxacin 400mg 30ml bottle 174 381 Mesalazine tab. Each Tab. to contain : Mesalazine (5-
aminosalicylicacid) 400 mg.
10 tab
175 382 Ethionamide tab. Each Tab. to contain: Ethionamide IP 250mg 10 tab 176 383 Cap./tab. Cycloserine, Each Cap./Tab. to contain : Cycloserine,
IP 250mg 10 tab/cap
177 385 Tab. Nevirapine Each to tab. to contain: Nevirapine 200mg 10 tab. 178 386 Indinavir Cap. Each cap to contain : Indinavir 400 mg 30 cap 179 387 TAB. ONDANSETRON - Each tab. to contain : Ondansetron
4mg., IP 10 tab
180 388 Inj. Ondansetron Each ml to contain: Ondansetron IP 2mg 4ml 181 390 Cap. Rifampicin, Each cap. to contain : Rifampicin, IP 600mg 3 cap 182 391 Pyrazinamide Tab. Each tab to contain: Pyrazinamide IP 1000mg 10 tab 183 392 Saline Nasal Drops Containing : Sodium Chloride 0.65%,
Benzalkonium Chloride 0.001%, Phenyl Mercuric acetate 0.002% 15ml
184 394 Lotion. Clotrimazole Each ml. to contain : Clotrimazole 10mg 15ml bottle 185 395 Clotri, Beclomethasone Dipropionate Containing: Clotrimazole IP
10mg, Beclomethasone Dipropionate IP 0.25mg 10gm tube
186 396 Ointment Containing: Silver Sulphadiazine 1 % Chlorhexidine Gluconate 0.2% Aloevera 15 % Allatoin 0.1 % Vitamin E 0.2%
15gm tube
187 398 Xylocaine Inj. Containing: Xylocaine 1% 30ml vial 188 399 Vitamin E Drop Each ml. to contain: Tocopheryl Acetate IP
50mg. 15ml
189 402 Inj. Doxorubicin- Each vial to contain: Doxorubicin IP 10mg 5ml vial 190 403 Tab. Methotrexate Each tab. to contain : Methotrexate IP 2.5mg 10 tab 191 405 Desferrioxamine Inj. Each vial to contain: IP Desferrioxamine
500mg 1 vial
192 406 Tab. Azathioprine Each tab. to contain : Azathioprine IP 50mg 10 tab 193 407 Vitamin Tabs. Each Tab. to contain: Thiamine Mononitrate IP
10mg, Pyridoxine Hcl. IP 3mg, Cyanocobalamine IP 15mcg, Riboflavine IP 5mg, Nicotinamide IP 50mg, calcium pantothenate IP 5mg
10 tab
194 411 Calamine Lotion Containing: Calamine 15%, Zinc Oxide 5% 100ml 195 415 Laxative Liq- Each 5ml. to contain : Liquid Parafin 1.25ml, Milk of
Magnesia 3.75ml, Sod.Picosulphate 3.33mg 110ml bot.
196 417 Drop Enzyme- Each ml to contain: Alpha-Amylase (Bacterial 1:800) 20mg, Papain 10mg, Dill Oil 2mg, Anise Oil 2mg, Caraway Oil 2mg (Drop CDS)-15ml
15ml. Phial
197 418 Enzyme Syrup Each 15ml to contain: lodised peptone 29 mg., Mag. Chl 20 mg., Mag. Sulph 4mg., Zn. Sulph. 6 mg., Sod. Metavandate 0.66 mg., Pyridoxine HCL 0.75mg., cyanocobalamin 0.5mcg., Nicotinamide 10mg. Alcohol 0.95 ml.
300ml
198 421 Inh. IPRATROPIUM+SALBUTAMOL INHALER - Each Metered dose to contain : Ipratropium I.P. 20 mcg. Salbutamol I.P. 100mcg
200 doses
199 422 Tab. Amiodarone- Each tab. to contain: Amiodarone HCl IP 100mg
10 Tab
200 425 Tab. Indapamide Prolonged Release- Each Prolonged Release tab. to contain: Indapamide 1.5mg
10 tab.
34/71
201 426 Inj. Neostigmine Each ml. to contain : Neostigmine IP 0.5mg/ml 1ml Amp 202 427 Tab. Sulphasalazine- Each tab. to contain: Sulphasalazine
500mg 10 Tab
203 429 Tab. Clopidogrel- Each tab. to contain: Clopidogrel IP 75mg 10 tab. 204 439 Artifical Tears Drop. Each vial to contain : ED- Polyvinyl Alcohol
1.4%, Povidone 0.6%, Benzalkonium Chloride 0.01%- 10ml
10ml vial
205 440 Anti Fungal ear drops Containing: Chloramphenicol IP 5%, Lignocaine HCL IP 2%, Beclomethasone Dipropionate 0.025%, clotrimazole IP 1%, Propylene glycol IP q.s.
5ml vial
206 447 Rocuronium Inj. Each ml to contain: Rocuronium 10mg 5ml vial 207 448 Cream Permethrin 5%- Each tube to contain: Permethrin 5%. 30gm 208 450 Cap. VITAMIN Each cap. to contain : Thiamine 10mg, Riboflavin
8mg, Pyridoxine 3mg, Vit. B12 5mcg, Niacinamide 50mg, Calcium Pantothenate 15mg, Folic acid 1mg, Ascorbic Acid 125mg
10 cap
209 451 Syp. Calcuim Each 5ml to contain: (Vit. D3 200IU, Vit. B12 2.5mcg, Calcium 82mg )
200ml bottle
210 454 Starch Inj. Each 100ml to contain: Hydroxyethyl Starch 6gms., Sodium chloride 0.9gm.
500ml bottle
211 455 Haemo Dialysis Fluid Containing: Haemo Dialysis Fluid 5Ltr. 212 458 Inj. Fludarabine Each vial to contain : Fludarabine 50mg 1 vial 213 460 Tab. Flutamide Each tab. to contain : Flutamide 250mg 10 tab 214 462 Isoflurane USP- Each 100ml to contain: Isoflurane 100ml 215 464 Inj. Erythropoietin- Each pack to contain: Recombinant Human
Erythropoietin 10000Units 1 pack
216 467 Methylprednisolone Sod. Succinate Inj. Each vial to contain: Methylprednisolone Sod. Succinate 40 mg.,
1ml vial
217 471 Tab. Tianeptine Each tab. to contain Tianeptine Sod. 12.5mg 10 tab 218 476 Inj. Haloperidol Each ml to contain: Haloperidol IP 5mg. 1 amp 219 478 Syp. Lactulose Each 15ml to contain: Lactulose 10gm 100ml bot. 220 479 Tab. Prednisolone Each tab. to Contain: Prednisolone IP 10mg 10 tab 221 480 Oint. Mupirocin- Each tube to contain: Mupirocin IP 2% 5gm tube 222 481 Resp. Soln. Ipratropium Each ml to contain: Ipratropium Bromide
250mcg 15ml bottle
223 482 ED Cipro+Dexa - Each vial to contain : Ciprofloxacin 0.3%, Dexamethasone 0.1%, Benzalkonium Chloride 0.01%
5ml vial
224 484 Povidone Iodine Dressing - containing : Povidone Iodine 10% Sterile Dressing
box of 20 dressings
225 485 Tibolone tab.Each Tab. to contain: Tibolone 2.5mg 28 tab 226 490 Tab. Mycophenolate Mofetil Each tab. to contain: Mycophenolate
Mofetil 500mg 10 tab
227 492 Endoscopic Cleaning Soln. Containing: Proteolytic Enzymes, Presoak Plus Cleaner
1ltr. Bottle
228 496 vit. B Complex Syp. Each 5 ml. to contain: Vit. A 2500 IU, Cholecalciferol 200 IU, Thiamine 2mg., Riboflavine 1mg., Pyridoxine 1mg., Nicotinaminde 15mg., Ascorbic acid 50 mg., D-Panthenol 2.5mg., Cyanocobalamin 1mcg., Citrus Bioflavonoid Compound 5mg.
200ml
35/71
229 500 Haematinic Syp. Each 15ml to contain: Ferric Ammonium citrate IP 160mg, Vit. B12 -7.5mcg, Folic acid IP 0.5mg, Alcohol (95%) 0.87ml
200ml
230 501 Syp. Vit. B Complex + Vit. C SYP- Each 5ml. to contain : Thiamine 2mg. Riboflavin 2.54mg Pyridoxine 2mg Niacinamide 20mg D- Panthenol 6mg, Ascorbic acid 75mg.
20ml bottle
231 502 Magnesium Sulfate Inj. Each ml to contain: Magnesium Sulfate IP 50%
1ml
232 503 PAS Granules Each gm to contain: Sodium Aminosalicylate 800mg.
100gm jar
233 504 Cap./tab. Imatinib- Each Cap./tab. to contain: Imatinib Mesylate IP 100mg
10/12cap/tab
234 505 Dry Syp. Cefuroxime- Each 5ml to contain: Cefuroxime 125mg 30ml bottle 235 507 Prothionamide tab. Each tab to contain : Prothionamide 250mg. 10 tab 236 510 Oint. Metronidazole + Povidone Iodine Each tube to contain:
Metronidazole 1% + Povidone Iodine 5% 15gm tube
237 512 Tab. Itopride- Each tab. to contain: Itopride HCl 50mg 10 Tab 238 516 Syp. Etophylline & Theophylline - Each 5ml to contain:
Etophylline 46.5mg, Theophylline 14mg 100ml bott.
239 517 Dicyclomine + Diclofenac sodium Each 2ml. to contain : Dicyclomine 20mg., Diclofenac sodium 50mg.
2ml Amp
240 518 Syp. COUGH SEDATIVE - Each 5ml to contain: Chlorpheniramine Meleate 2.5mg, Guaiphenesin 100mg, Noscapine 15mg, Sod. Citrate 60mg
100ml bott.
241 519 Fluocinolone Oint. Containing: Fluocinolone Acetonide 0.1% + Methyl Paraben 0.15% + Propyl Paraben 0.05%
15gm tube
242 521 Tab. Tranexamic Acid Each tab. to contain: Tranexamic Acid IP 500mg
10 Tab
243 522 Inj. Tranexamic acid- Each 5ml to contain: Tranexamic Acid 500mg BP
1 amp.
244 526 Goserelin Inj.Each PFS to contain: Goserelin 3.6mg. 1 PFS 245 533 Ear Drops Containing : 4-Carboxymethylamino-4, Aminodiphenyl
sulphone 0.84%, dihydroxymethyl carbamide 0.42% Dibucaine 1.1%
5ml vial
246 534 Pre & Probiotic Cap.- Each to cap. to contain: Streptococcus faecalis 30 million, Clostridium butyricum 2 million Bacillus mesentericus 1 million, lactic acid bacillus spoiogenes 50 million
10 cap
247 536 Inj. Pantoprazole- Each ml to contain: Pantoprazole 40mg vial 248 540 Tab. Sulbutiamine Each tab. to contain: Sulbutiamine 200mg 10 tab 249 542 Vaccine Vero Cell Culture Rabies- Each dose to contain: Purified
Vero cell culture Human Rabies Vaccine 1 dose pack
250 543 Inj. Sodium Hyaluronate (INTRA ARTICULAR) - Each PFS to contain: Sodium Hyaluronate 25mg Sodium Chloride, sodium phosphate Dihasic Monobasic qs
1 PFS
251 545 Inj. Erythropoietin Each vial to contain: Erythropoietin 20000 Units
1 vial
252 550 Flutcasone + Salmetrol Rotacaps- Each Rotacap to contain: Flutcasone 250mcg. + Salmetrol 50 mcg. , IP
30 Cap
36/71
253 551 Ear Drop. - Clotrimazole 1% + Lignocaine HCl 2%- 10ml 10ml vial 254 553 Tab. Flavoxate- Each tab. to contain: Flavoxate Hydrochloride IP
200mg 10 Tab.
255 559 Coal Tar + Salicylic Acid- Each bottle to contain: Coal Tar Topical sol. 4.25% + Salicylic Acid I.P. Sol 2%
60ml bottle
256 560 Each Tab. to contain: Dried Aluminium Hydroxide gel 240mg, Mag. Hydroxide 100mg,Mag.Carbonate 60mg, Activated Dimethicone 25mg.
10 Tab.
257 562 ED Tropicamide- Each vial to contian: Tropicamide 0.8% + Phenyl Ephrine HCl 5%
5ml vial
258 564 Prednisolone Eye drops containing : Prednisolone Acetate IP 1% 5ml 259 565 Betamethasone Eye drops Containing: Betamethasone Sodium
Phosphate 0.1% 5ml
260 569 Inj. Methylprednisolone Acetate- Each vial to contain: Methylprednisolone Acetate 40mg
1 vial
261 573 Tab. Piribedil- Each tab. to contain: Piribedil 50mg 10 Tab. 262 577 Each tab. to contain: Ursodesoxycholic acid 150mg., IP 10 Tab.
263 579 Povidone Iodine Mouth Wash Each bottle to contain: Povidone Iodine 1%
50ml bottle
264 580 Coagulant solution Each ml. to contain: Aqueous solution of Haemocoagulase Isolated from Bothrops atrox or Bothrops Jararaca 0.2CU, Chlorhexadine Gluconate soln. 0.1% (as preservative), Water for injection q.s.
10ml bottle
265 581 Inj. Lignocain HCl 21.3mg+Sod. Chloride 6mg water for inj.to make 1ml.
50ml bottle
266 582 Ambroxol+Salbutamol+Theophylline Each Tab. to contain : Ambroxol 30mg., salbutamol 2mg., theophylline (anhydrous) 100mg.
10 tab
267 588 Lignocaine with Adrenaline Inj. Each ml. to contain: Inj. Lignocaine IP 21.3mg., Adrenaline IP 0.005mg.
30ml
268 589 Mecobalamin + Lactic Acid Bacillus, Each Tab. to contain: Mecobalamin IP 500mcg., Lactic Acid Bacillus Spores 40 million, Alpha Lipoic Acid 100mg., Folic Acid IP 1.5mg., Vit. B1 IP 10mg., Vit. B6 IP 3mg.
10 tab
269 590 Ritodrine Tab.Each tab. to contain: Ritodrine 10mg. 10 tab 270 592 Beclomethasone Inhaler- Each metered dose to contain:
Beclomethasone Inhaler Dipropionate 200mcg. 200 doses
271 595 Calcium (Absorable) Cap. - Each cap. to contain: Elemental calcium 150mg (in the form of Calcium Hydroxide and Calcium Oxide and pretreated with heated algae)
15 cap
272 597 Inj. Amiodarone- Each ml to contain: Amiodarone IP 50mg 3ml 3ml 273 599 Tab. Doxylamine Succinate + Pyridoxin- Each tab. to contain:
Doxylamine Succinate 10 mg. + Pyridoxin 10 mg. 10 Tab
274 600 Inj. Infliximab- Each vial to contain: Infliximab 100mg 1 Vial 275 601 Inj. Vitamin K -Each ml to contain: Phytomenadione BP 10mg 1ml 276 602 Inj. Ofloxacin- Each 100ml to contain: Ofloxacin IP 200mg/ 100 Ml bottl. 277 713 Cream.- Each tube to contain: Desonide 0.05% 10gm tube 278 1002 Antacid Gel- Each 5ml to contain: Oxetacain 10mg, Al. Hydroxide
291mg, Mg.Hydroxide 98mg 200ml Bott.
37/71
279 1007 Ranitidine Inj., Each ml to contain : Ranitidine HCl eqv. to Ranitidine 25mg
2ml Amp
280 1010 Laxative Liquid- Each 15ml to contain: Milk of Magnesia 11.25ml, Liquid Paraffin 3.75ml
170ml
281 1013 Domperidon Tab., Each tab. to contain : Domperidon 10 mg 10 Tabs 282 1014 Domperidone Susp. Each ml. to contain : Domperidone 1mg. 30ml bottle 283 1019 Tab. Drotaverine Hydrochloride- Each tab. to contain: Drotaverine
Hydrochloride IP 80mg 10 tab
284 1020 Tab. Metronidazole + Diloxanide- Each tab. to contain: Metronidazole 200mg + Diloxanide 250mg
10 Tab
285 1028 Enzyme Syp.- Each 10ml to contain: Fungal Diastase (1:2000) 40mg, (Aspergillus Oryzae Enzyme)Cinnamon Oil 0.25mg, Caraway Oil 0.5mg, Cardamom Oil 0.5mg, In Glycerol sorbitol base in 10ml
200ml bottle
286 1029 Enzyme Cap.- Each tab. to contain: Pepsin (1:3000) 12.5mg, Fungal Diastase (1:2000) 18.75mg
10 cap
287 1032 Tab. Etophylline & Theophylline Each tab. to contain: Etophylline 77mg & Theophylline 23mg
10 tab
288 1033 Tab. Etophylline & Theophylline, Each tab. to contain: Etophylline 231mg & Theophylline 69mg
10 tab
289 1035 Syp. Terbutaline Sulphate- Each 5ml to contain: Terbutaline Sulphate IP 1.5mg.
100ml Bott.
290 1038 Theophylline CR Cap Each CR Cap to Contain: Theophylline anhydrous 200 mg
10 cap
291 1039 Inh. Salbutamol Each Metered dose to contain : Salbutamol 100mcg IP
200 doses
292 1041 Inh. Salbutamol + Beclmethasone Each Metered to contain : Salbutamol 100mcg.+ Beclmethasone 50mcg.
200 doses
293 1042 Adrenaline Inj. Each ml. to contain: acid tartrate eqv. To Adrenaline IP 1 mg.
1ml amp
294 1044 Beclomethasone Rotacaps Each cap to contain : Beclomethasone 100mcg.
30 cap
295 1045 Salmeterol Rotacap Each Rotacap to contain : Salmeterol IP 50mcg
30 cap
296 1046 Bronchodilator Syp. Each 10ml. to Contain : Bromhexine hcl 8mg. Terbutaline sulphates 4mg., Guaphanesin 200 mg.
100ml bottle
297 1047 Paediatric Cough Syp. Each 5ml to contain: Promethazine HCl 1.5mg, Pholcodine 1.5mg (as citrate)
60ml bottle
298 1050 Pediatric Cough Linctus Syp. Each ml to contain: Noscapine 1.83mg, Citric acid 5.8mg, Sod.Citrate 0.67mg, Amm. Chloride 7mg
50ml bottle
299 1052 Tab. Digoxin Each tab. to contain : Digoxin IP 0.25mg 10 tab 300 1055 Tab. Bisoprolol Fumerate- Each tab. to contain: Bisoprolol
Fumerate 5mg 10 Tab
301 1057 Tab. Verapamil Each tab. to contain: Verapamil HCl IP 40mg 10 tab. 302 1062 Diltiazem Inj. Each ml. to contain : Diltiazem Hcl IP 5mg. 5ml vial 303 1063 Tab. Trimetazidine- Each tab. to contain: Trimetazidine HCl HCl
20mg 10 Tab
304 1070 Tab. Frusemide + Spironolactone Each tab. to contain : Frusemide 20mg, Spironolactone 50mg
10 tab
38/71
305 1071 Tab. Acetazolamide Each tab. to contain : Acetazolamide IP 250mg
10 tab
306 1072 Tab. Cinnarizine Each tab. to contain : Cinnarizine IP 25mg 10 tab 307 1073 Pentoxyfylline Tab.
Each tab. to contain: Pentoxyfylline 400 mg. 10 tab
308 1074 Tab. Isoxsuprine Each tab. to contain : Isoxsuprine HCl IP 10mg 10 Tab 309 1077 Cap. Haemostatic- Each cap. to contain: Citrous Bioflavonoid
compound 150mg. Ascorbic Acid 75 mg. Menadione (vit. K) 0.66mg. Ferrous Gluconate 67mg. Tribasic Calcium phosp. 144.43mg.
10 cap.
310 1078 Haemo-coagulant Inj. Each ml. to contain: Aqueous solution of Haemocoagulase (one IU/CU/NIH unit) Isolated from venom of Bothrops, Jararaca or Bothrops Atrox containing Sodium Chloride 0.9%
1ml amp
311 1080 Oint. Heparin Each gm to contain: Heparin Sod. 50IU, Benzyl Nicotinate 2mg/3mg
15gm tube
312 1083 Cap. Tramadol Each cap. to contain: Tramadol HCL IP 50mg. 10 cap. 313 1084 Buprenorphine Inj., Each ml. To contain: 0.3mg Buprenorphine 2ml 314 1086 Soluble Aspirin tab. Each Tab. to contain : Acetyl salicylic acid
350 mg., Cal. Carbonate 105 mg., anhydrous citric acid 35 mg. 10 tab
315 1092 Susp. Ibuprofen Each 5ml. to contain : Ibuprofen BP 100mg 60 ml bottle 316 1093 Ibuprofen & Paracetamol oral Susp. Each 5ml to contain:
Ibuprofen 100mg + Paracetamol 162.5mg 60ml bottle
317 1094 Tab./Cap. Piroxicam Each tab./cap. to contain : Piroxicam IP 20mg
10 tab/cap
318 1096 Inj. Paracetamol Each ml to contain: Paracetamol 150mg 2ml amp 319 1098 Tab. Allopurinol Each tab. to contain : Allopurinol IP 100mg 10 tab 320 1099 Cap. Indomethacin- Each cap. to contain: Indomethacin IP 25mg 10 Cap 321 1100 Cap. Indomethacin SR Each SR cap. to contain: Indomethacin
75mg 10 cap.
322 1105 Tizanidine Tab. Each tab to contain: Tizanidine IP 2mg 10 tab 323 1106 Each ml. to contain: Glycopyrrolate USP 0.2mg. 1ml vial 324 1107 Tab. Serratiopeptidase Each tab. to contain: Serratiopeptidase IP
5mg (10000 units of Serratiopeptidase) 10 tab
325 1108 Each Tab. to contain : Trypsin and chymotrypsin 1lakh units. 10 tab 326 1110 Analgesic Oint- Each tube to contain: Methyl Salicylate 4% w/w,
Mephensin 5% w/w lodine 0.5% w/w 20 gm Tube
327 1112 Analgesic Gel- Eac tube to contain : Diclofenac Diethylamine Salt 1.16%, (eqv.to Diclofenac sodium 1%) Linolenic acid 3%, Methyl Salicylate 10%, Menthol 5%
30gm tube
328 1116 Nitrazepam Tab., IP Each Tab. to contain: Nitrazepam IP 5mg 10 tab 329 1117 Buspirone Tab. Each Tab. to contain Buspirone Hcl IP/USP 5mg 10 tab 330 1124 Tab. Nimodipine- Each tab. to contain: Nimodipine 30mg 10 Tab. 331 1125 Syp. Sodium Valproate Each 5ml. to contain : Sodium Valproate
I.P. 200mg 100ml bot.
332 1126 Syp. Carbamazepin Each 5ml. to contain : Carbamazepin IP 100mg
100ml bot.
333 1128 Carbamazepin Tab. Each tab. to contain: Carbamazepin 400 mg.,
10 tab
334 1130 Inj. Phenytoin - Each tab to contain: Phenytoin Sod50mg. 2ml.amp
39/71
335 1131 Sodium Valproate Each Tab. to contain:Sodium Valproate IP 200mg
10 tab
336 1132 Levodopa & Carbidopa Each tab. to contain: Levodopa 250 mg., Carbidopa 25mg.,
10 tab
337 1134 Phenazopyridine Tab. Each tab. to contain: Phenazopyridine 200 mg.,
10 tab
338 1135 Tab. Isoxsuprine SR - Each SR tab. to contain: Isoxsuprine Hcl 40mg
10 tab
339 1137 Inj. Carboprost- Each ml to contain: Carboprost 0.25mg 1ml. Amp 340 1138 Dinoprostone Gel. Containing : Dinoprostone 0.5mg
1 PFS
341 1143 Cetrizine Tab. Each tab. to contain: Cetrizine Hydrochloride 10mg
10 Tabs
342 1145 Tab. Fexofenadine- Each tab. to contain: Fexofenadine IP 120mg 10 Tab. 343 1146 Tab. Allylestrenol Each tab. to contain : Allylestrenol IP 5mg 10 tab 344 1149 Tab. Medroxy Progesterone- Each tab. to contain: Medroxy
Progesterone Acetate IP 10mg 10 Tab.
345 1150 Ethinyloestradiol tab. Each Tab. to contain: Ethinyloestradiol IP 0.05mg
10 Tab.
346 1156 Tab. Clomiphene Citrate Each tab. to contain: Clomiphene Citrate IP 50mg
10 tab
347 1158 Inj. Menotrophin- Each Inj. to contain: FSH 75 IU & LH-75 IU 1ml. Amp/vial
348 1159 Inj. Betamethasone Each ml. to contain : Betamethasone IP 4mg
1ml amp
349 1160 Tab. Dexamethasone Each tab. to contain: Dexamethasone IP 0.5mg
10 tab
350 1161 Inj. Nandrolone Each ml. to contain : Nandrolone Phenyl Propionate 25mg
1ml amp
351 1162 Nandrolone Decanoate Inj. Containing : Nandrolone Decanoate 25 mg
1 amp
352 1164 Hydrocortisone Sod. Succinate Each vial to contain : Hydrocortisone Sod. Succinate eqv. to Hydrocortisone IP 100mg/vial
1 vial
353 1167 Human Insulin (Soluble)- Each vial to contain: Human Insulin (Soluble) 40 units/ml, IP -10ml
10 Ml.
354 1170 Human Insulin (NPH)- Each vial to contain: Human Insulin (NPH100%) 40 units/ml-IP 10ml
10 Ml.
355 1171 Human Insulin Mixed (25%+75%) Containing : Human Insulin 25% soluble + 75% NPH 40units/ml,
10 Ml.
356 1172 Inj. Human Insulin Mixed (50% + 50%) Human Insulin 50% soluble + 50% NPH 40 units/ml
10ml
357 1173 Inj. Human Insulin Biphasic (30% + 70%) - Each vial to contain: Human Insulin Biphasic 30% Soluble + 70% NPH 40 units/ml
10ml vial
358 1174 Gliclazide Tab. Containing Gliclazide 80mg., IP 10 tab 359 1178 Amoxycillin dry. Syrup, Each 5ml to contain : Amoxycillin
Trihydrate eqv to Amoxycillin 125 mg.
60 ml Bott.
360 1181 Inj. Chloramphenicol Each vial to contain : Chloramphenicol Sodium Succinate eqv. to Chloramphenicol IP 1gm
1 vial
40/71
361 1184 Ceftazidime Inj., Each vial to contain : Ceftazidime 250mg 1 Vial 362 1185 Ceftazidime Inj., Each vial to contain : Ceftazidime 1gm. 1 Vial 363 1186 Ceftriaxone Inj., Each vial to contain : Ceftriaxone Sod. Eqv.
Anhydrous Ceftriaxone 250mg. 1 Vial
364 1187 Ceftriaxone Sod Inj eqv. to anhydrous Ceftraxone IP 1gm. 1 Vial 365 1189 Amikacin Inj., Each 2ml. to contain : Amikacin 500mg (As
Amikacin Sulphate) 2ml. Vial
366 1191 Amoxycillin & Cloxacillin Dry Syrp. Each 5ml. to contain: Amoxycillin IP 125mg. Cloxacillin IP 125mg.
30 Ml. bottl.
367 1193 Cefadroxil Cap/Tab. Each Cap/Tab. to contain , Cefadroxil 500mg
10 Tab/Cap
368 1194 Syp Cefadroxil- Each 5ml to contain: Cefadroxil IP 125mg/5ml 30 Ml. bottl. 369 1197 Rifampicin Syp. Each 5 ml. to contain: Rifampicin IP 100 mg. 100ml bottle 370 1204 Tab. Griseofulvin, Each tab. to contain: Griseofulvin IP 250mg 10 tab 371 1205 Fluconazole Tab./Cap., Each Tab./Cap. to contain : Fluconazole
150mg 10 Tab/Cap
372 1208 Syp Albendazole Each 5ml to contain : Albendazole 200mg., 10ml Bott. 373 1209 Syp Albendazole Each 5ml to contain : Albendazole 400mg., 10 Tab 374 1211 Antibiotic Eye Ointment Each gram to contain: Polymyxin B
Sulphate 5000 IU Neomycin sulphate 3400 IU Zinc Bacitracin 400 IU Hydrocortisone 10 mg. in white sterilized petroleum jelly base
5gm tube
375 1212 Flurbiprofen Eye Drops Containing: Flurbiprofen 0.03% w/v IP 5ml vial 376 1213 Atropine Eye Oint.Containing: Atropine sulphate IP 1% 5gm tube 377 1219 Eye drop Containing: Dexamethasone Sod. Phosphate IP 0.1%,
Neomycin Sulphate IP 0.5%, Benzalkonium Chloride IP in Isotonic Soln. 0.02%
3ml
378 1223 Cyclopentolate Eye Drops. Containing: Cyclopentolate IP/USP 1%
5ml vial
379 1226 Eye Drops Containing : Hydroxypropyl Methyl Cellulose IP 0.7%, Borax IP 0.19%, Boric Acid IP 0.19%, Sod. Chloride IP 0.45%, Pot. Chloride IP 0.37%, Benzalkonium Chloride IP 0.01%
5ml vial
380 1227 Methyl Cellulose ocular Solu. Contianing: Hydroxy Propyl Methyl Cellulose IP 2% w/v
2ml PFS
381 1228 Acyclovir Eye Ointment Containing: Acyclovir IP 3% 5gm tube 382 1234 Wax Softner Ear Drops Containing: Para Dichlorobenzene 2%
w/v, Benzocaine IP 2.7% w/v, Chlorbutol IP 5%, Turpentine Oil 15% w/v
10ml vial
383 1236 Nasal Drop. Xylometazoline Each vial to contain : Xylometazoline IP 0.05%
10ml vial
384 1237 Nasal Drop. Oxymetazoline Containing : Oxymetazoline IP 0.025% w/v- 10ml
10ml vial
385 1238 Beclomethasone Nasal Spray Each actuation to deliver: Beclomethasone Dipropionate IP 50 mcg.
200 doses
386 1239 Nasal Spray. Budesonide Each Actuation to deliver 100mcg 150 doses 387 1240 Gel. Containing : Choline Salicylate 9.0% w/v Benzalkonium
Chloride 0.02%
10ml/bottle
388 1241 Ointment Containing: Salicylic Acid IP 6% w/w, Benzoic acid IP/BP 12% w/w, Hydrocortisone Acetate IP 0.5% w/w
15gm tube
41/71
389 1242 Cream Containing: Urea 12% w/w, Lactic acid IP 6% w/w, Glycine IP 3% w/w, Ammonium Chloride IP 0.5% w/w, Sod. Chloride IP 0.5% w/w, Potassium Chloride IP 0.5% w/w, calcium lactate IP 0.5% w/w, Magnesium Chloride IP 0.3% w/w, Sod. Dihydrogen Phosphate IP 0.5% w/w
50gms Jar
390 1243 Ciclopirox Ointment Each gm to contain : Ciclopirox Olamine 10mg
15gm tube
391 1246 Lotion. Gamma Benzene Hexachloride Containing : Gamma Benzene Hexachloride 1%
500ml bottle
392 1248 Povidone Iodine Solution IP 5.00 % w/v 500ml 500ml bottle 393 1249 Cream. Framycetin Sulphate Each tube to contain : Framycetin
Sulphate 1% w/w
100gm tube
394 1251 Polymixin Neomycin Eye Oint. Containing per gm. Polymixin B sulphate 5000 IU Neomycin suphate 3400 IU Zinc Bacitracin 400 IU
5gm tube
395 1252 Clobetasol Oint Containing: Clobetasol Propionate IP 0.05% 10gm tube 396 1253 Oint. Betamethasone Each tube to contain: Betamethasone IP (
asValerate) 0.1% 20gm tube
397 1257 Cream Tretinoin- Each tube to contain: Tretinoin (Trans Retionic Acid) 0.05%
20gm tube
398 1271 Glycerine Each Bott. to contain : Glycerine IP- 500gm 500gm bottle 399 1272 Phenol IP (Carbolic Acid)- Each Bott. to contain : Phenol 500gm 500mg bottle 400 1277 Inj. Thiopentone Sodium Each vial to contain : Thiopentone
Sodium IP 0.5gm per vial 1 vial
401 1286 Pancuronium Inj. Each ml. to contain: Pancuronium 2 mg. 2ml amp 402 1289 Atropine Each ml. to contain: Atropine Sulphate IP 0.6mg. 1ml amp 403 1290 Inj. Fentanyl- Each ml to contain: Fentanyl IP 50mcg. 2ml amp 404 1294 Vitamin B Complex Inj. Each Amp. to contain: Vit. B1 100 mg.,
Vit B2 5 mg., Vit. B6 100 mg., Vitamin B12 1000 mcg. Nicotinamide 100 mg., D-Panthenol 50 mg.
1 amp
405 1295 Iron Cap. Each Timed release Cap. to contain : Ferrous Fumarate 200mg., Cyancobalamin 15mcg., Folic Acid 1.5mg.
10 cap
406 1297 Tab. Folic Acid Each tab. to contain: Folic Acid IP 5mg 10 tab 407 1299 Chole Calciferol Granules- Each gm to contain: Vit D3 60000 IU 1gm sachet 408 1305 Vit. B complex Tab. Each tab. to contain : NFI- III Prophylactic 10 Tab 409 1307 Cap. Multivitamins + Zinc Each cap to contain : Zinc Sulfate
Monohydrate 61.8 mg. (eqv. To 22.5 mg. of elemental Zinc.) Vit. B1-10mg., vit. B6-2mg., Vit. B12-5mcg., Ca. Pantothenate 12.5mg., Vit. E Acetate 15mg., Vit. C150mg., Nicotinamide 50mg. And Vit. B2-10mg.
30 cap
410 1311 Syp. Aminoacid and Iron- Each 10ml. to contain L-Histidine HCl 4mg., L-Lysine HCl 25mg., Thiamine HCl 5mg., Riboflavin 3mg. Nicotinamide 25mg., Pyridoxin HCl 1.5mg., Cyanocobalamin 2.5mcg., Folic Acid 0.5mg., Ascorbic Acid 40.0mg., D-Panthenol 2.5mg. Ferrous Glycinc Sulphate 275mg.
200ml bottle
411 1312 Syp. Coloidal Iron + Vitamin Syp. Each ml to contain: Coloidal Iron eqv to elemental Iron 250mg, Folic Acid 500mcg, Vitamin B12-5mcg
200ml bottle
42/71
412 1313 Drop Iron & Folic Acid - Each ml to contain: Colloidal Iron eqv.to elemental iron 25mg. Lysine Hydrochloride 200mg. Vit. B12-5mcg. Folic Acid 200mcg.
15 ml vial
413 1314 Iron Dextran Inj. Each ml. to contain: Iron Dextran eqv. to Elemental Iron 50 mg.
2ml amp
414 1315 Cap. Amino Acid + Vitamin - Each cap to contain: L- Leucine 18.3mg., L- Isoleucine 5.9mg., L-Lysine Hydrochloride 25.0mg., L-Penylalamine 5.0mg., L- Valine 6.7mg. L- Tryptphan 5.0 mg., DL- Methionine 18.4mg., 5- Hydroxy Anthranillic Acid Hydrochloride .02mg., Vit. A concentrate 2500 IU, Vit D3 200 IU, Thiamine Mononitrate g., Folic Acid 0.75mg., Calcium Pantothenate IP 5.0mg., Vit. B12 2.5mg., Vit. C 40.0mg., Vit. E acetate 7.5 IU., L- Threonine 4.2mg.
10 cap
415 1319 DEXTROSE WITH NaCl SOLN IP - Each 100ml to contain: Dextrose Anhydrous 5gm, Sodium chloride 0.45gm
500ml bottle
416 1320 Maintenance solution for paediatric use Each 100ml to contain (in mmol/L) sodium IP 23.0 Chloride IP 20.0, Potassium IP 20.0 Acetate IP. 23.0, Magnesium IP 1.50 Phosphate IP 1.50
500ml bottle
417 1321 Oral Rehydration Salt (WHO Formula) Each sachet to contain : Sodium Chloride 2.6gm, Potassium Chloride 1.5gm. Sodium Citrate 2.9 gm Dextrose (Anhydrous) 13.5gm.
21gm Sachet.
418 1322 Amino Acid (FOR IV INFUSION)- Each ml to contain: L- Arginine Hcl 8.0mg. L-Histidine Hcl. 4.0mg. L- Isoleucine 5.5mg., L-Lysine Hcl. 22.3mg., L-Methionine 7.1mg., L- Theonine 5.4mg., L- Phenylalanine 8.7mg., L-Leucine 12.3mg., L-Valine 6.1mg., Glycine 10.0mg. L-Tryptophan 1.8mg., Sorbitol 50.00mg.
200ml glass bottle
419 1325 Mannitol Injection 20% 100 ml bottle
420 1326 Sodium Bicarbonate Inj. Containing: Sodium Bicarbonate 7.5% 10ml amp 421 1327 Each ml. to contain: Inj Potassium Chloride BP 0.15 gm. 10ml amp 422 1328 Interferon Inj. Each vial to Contain Interferon Alpha 2A : 3Mil.
I.U. 1 vial
423 1333 Inj. Methotrexate - Each vial to contain: Methotrexate IP 50mg 1 vial 424 1334 Tab. Tamoxifen - Each tab. to contain: TamoxifenIP 20mg 10 Tab. 425 1336 Syp. Cyclosporin Each ml to contain: Cyclosporin 100mg 50 ML 426 1341 Tetanus Vaccine (ADSORBED) Each 0.5 ml. to contain: Tetanus
Toxoid IP 5/LFS 0.5ml Amp
427 1343 Cough Syp. Each 5ml. to contain : Methdilazine 2.5mg,Amm. Chloride 100mg, sodium citrate 50mg.
115ml bottle
428 1344 Syp. ANTACID GEL- Each 5ml to contain: Aluminium Hydroxide 6mg. Hydroxide 80mg. Activated Dimethicone 100mg. Deglycycrrhizimated Liquorice eqv.to Liquoprice 400mg.
180ml. Bot.
429 1345 Laxative Enema- Each bottle to contain: Glycerin I.P. 15%, Sodium Chloride I.P. 15%
30ml bottle
430 1346 Dicyclomine & Mefenamic Each Tab. to contain : Dicyclomine 10mg., Mefenamic acid 250mg.
10 tab
431 1347 Cap. Thiocolchicoside- Each cap to contain: Thiocolchicoside IP 4mg
10 Cap
432 1348 Tab. Valsartan Each tab. to contain: Valsartan 80mg 10 tab 433 1349 Metolazone Each Tab. to contain : Metolazone 5mg. 10 tab
43/71
434 1352 Meropenam Trihydrate Inj Each vial to contain : Meropenam Trihydrate eqv. to Anhydrous Meropenam 500mg
1 Vial
435 1354 Ampicillin Sod. + Sulbactum Inj. Each vial to contain: Ampicillin Sod., IP 1gm, Sulbactum Sod. 0.5gm
1 vial
436 1355 Azelastine Nasal Spray Containing: Azelastine 0.05% 10ml Pack 437 1356 Inj. Methylprednisolone Sod. Succinate- Each vial to contain:
Methylprednisolone Sod. 125mg 1 vial
438 1357 Inj. Methylprednisolone Sod. Succinate- Each vial to contain: Methylprednisolone Sod. 500mg
1 vial
439 1361 Surgical Spirit IP Containing: Surgical Spirit 500ml 440 1364 Salicylic Acid + Beta Ointment Containing Betamethasone IP
0.05%, Salicylic Acid IP 6% 20gm tube
441 1365 Cream. Each tube to contain: Dimethicone 20%, Zinc Oxide 5%, Calamine 1.5%, Cetrimide 1.125%, Cholocresol
20gm tube
442 1366 Lotion. Clobetasol Each to contain: Propionate IP 0.05%- 15ml 443 1370 Tab. Torsemide- Each tab. to contain: Torsemide IP 10mg 10 tab. 444 1371 Tab. Mebeverine- Each tab. to contain: Mebeverine HCl IP135mg 10 Tab 445 1372 Tab. Perindopril + Indapamide- Each tab. to contain: Perindopril
Erbumine 4mg + Indapamide 1.25mg 10 tab.
446 1373 Tab. Atenolol + Amlodipine Each tab. to contain: Atenolol 50mg + Amlodipine 5mg
10 tab.
447 1374 Tab. Trimetazidine SR- Each tab. to contain: Trimetazidine SR 60mg
10 Tab
448 1376 Tab. HydroxyChloroquine- Each tab. to contain: HydroxyChloroquine Sulphate IP 200mg
10 Tab
449 1377 Tab. Losartan + Amlodepine- Each tab. to contain: Losartan Potassium 50mg, Amlodepine 5mg
10 tab
450 1378 Syp. Ofloxacin Each 5ml to contain: Ofloxacin IP 50mg 30ml bottle 451 1379 Syp Azithromycin- Each 5ml to contain: Azithromycin IP
100mg/5ml-15ml 15 Ml. bottl.
452 1380 Susp- Colistin Sulphate- Each 5ml to contain: Colistin Sulphate USP 12.5 mg.
60ml
453 1381 Dry Syp. Cefixime- Each 5ml to contain: Cefixime IP 50mg 30 Ml. bottl. 454 1382 ED. Tobramycin - Each vial to contain: Tobramycin USP 0.3%w/v 5ml vial 455 1384 Ciprofloxacine Eye Oint. Containing: Ciprofloxacin Hydrochloride
IP 0.3% w/w 5gm
456 1386 Oint. Sodium Fusidate Each 1gm to contain: Sodium Fusidate IP 20mg
5gm tube
457 1387 Gel. Clindamycin Gel- Each tube to contain: Clindamycin IP 1% 20gm tube 458 1388 Cap. Mecobalamin + Lipoic Acid- Each cap. to contain:
Mecobalamin 0.5mg, Alpha Lipoic Acid 100mg 10 Cap
459 1389 Infusion. Mannitol + Glycerin Infusion.- Each bottle to contain: Mannitol I.P. 10%, Glycerin I.P. 10%
100ml bottle
460 1390 Clobetasol Gentamysin Miconazole Oint. Each tube to contain: Propionate 0.05% w/w, Gentamycin Sulphate 0.1% w/w, Miconazole Nitrate 2% w/w
5gm tube
461 1391 Cream Acyclovir- Each tube to contain: Acyclovir 5% w/w. 5gm tube 462 1392 Tab. Oxcarbazepine- Each tab. to contain: Oxcarbazepine IP
150mg
10 Tab.
44/71
463 1393 Tab. Mefenamic + Tranexamic acid- Each tab. to contain: Mefenamic Acid 250mg, Tranexamic acid 500mg
10 tab.
464 1394 Lotion. Fluocinolone - Each to contain: Fluocinolone IP 0.01% w/v
15ml
465 1395 Mifepristone tab. Each Tab. to contain: Mifepristone 200 mg. 10 tab. 466 1396 Levonorgestrel Tab. Each Tab. to contain: Levonorgestrel IP
75mg. 10 tab.
467 1397 Gel Clotrimazole- Each tube to contain: Clotrimazole IP 2% 30gm Tube 468 1398 Dry Syp. Cefixime + Lactic Bacillus- Each 5ml to contain:
Cefixime 50mg, Lactic Acid Bacillus 30million Spores 30ml
469 1399 Cefixime + Lactic Bacillus Each Tab. to contain: Cefixime IP/USP 200mg. Lactic Acid Bacillus 60 million Spores.
6/10 Tab.
470 1403 Tab. Antioxidant- Each tab./cap to contain: Carotenoids and micronutrients from carrots 100mg. (Eqv.to 100mcg.of carotenoids calculated as beta carotene) Beta Carotene7.5% dispersion 40mg.(Naturalcarotenoids),Vit. C 150mg.vit.E Acetate 25mg. Selenium dioxide75mcg (Eqv.45.9mcg of selenium),Zinc sulphate 70mg. eqv. to 15.9mg zinc).
10 tab./cap.
471 1404 Inj. Docetaxel- Each Inj to contain: Docetaxel 80mg 1 Vial 472 1405 Inj. Peginterferon Alfa-2A Each Inj. to contain: Peginterferon Alfa-
2A 180 IU 1 vial
473 1406 Tab./Cap. Temozolomide Each Tab./Cap. to contain : Temozolomide I.P. 250mg
5 Tab.
474 1413 ANTACID- Each Sachet (0.67g) contains: Water Soluble Azulene (Sodium Azulenesulfonate) JPC 2.01mg. L-Glutazene JPC 663.3mg.
Sachet
475 1414 Sachet- Bifilac -Prebiotic and probiotic -Streptococcus faecalis T-110 30 million Clostridium butyricum To-A 2 million bacillus mesentericus To A 1 million Lactic Acid bacillus 50 million (Lactobacillus sporogenes)
Sachet
476 1415 Tab. Ornidazole Each tab to contain : Ornidazole IP 500mg 10 Tab 477 1416 Meclizine HCL + Caffeine Tab.
Each tab to contains : Meclizine Hcl 25 mg + Caffeine 20 mg 10 Tab
478 1417 Aceclofenac Inj. Each ml to contain : Aceclofenac 150mg 1ml. Amp/vial
479 1418 Cap.Thiocolchicoside Each tab to contian:Thiocolchicoside IP8mg 10 cap 480 1420 Tab. Telmisartan Each tab to contain : Telmisartan IP 40mg 10 Tab 481 1421 Tab. Perindopril + Amlodipine- Each tab. to contain: Perindopril
4mg, Amlodipine 5mg 10 tab
482 1424 Tamsulosine Tabs./caps Each Tabs./caps to contain: Tamsulosine IP 0.4mg
10 tab/cap
483 1425 Tamsulosin & Dutasteride Tab./Cap. Each tab to contain : Tamsulosin 0.4mg. + Dutasteride 0.5g.
10 Tab./Cap.
484 1427 Loratadine Syp. Each 5ml to contain: Loratadine USP 5mg 30ml bottle 485 1428 Lotion. Clotrimazole + Beclomethasone dipropionate -
Containing: Clotrimazole 1% w/w, Beclomethasone dipropionate 0.025% w/v base- 15ml
15ml bottle
486 1432 ED. Olopatadine- Each vial to contain : Olopatadine 1.0mg. 5ml vial 487 1434 Azelastine eye drops Containing: Azelastine 0.05% w/v
5ml vial
45/71
488 1436 Drop. Multivitamin- Each ml to contain: Vitamin A Concentrate (as palmitate) oily form:3000 Cholecalciferol 400 IU Ascorbic Acid 40mg. Thiamine Mononitrate:2mg. Riboflavin Sodium Phosphate eqv. To Riboflavin:1mg NIcoinamide 10.5mg Pyridoxine Hydrochloride:1mg D- Panthenol 3mg. Tocopheryl Acetate 5.25IU Flavoured Aqueous base (Appropriate overages of vitamins added to compensate for loss on storage)
10ml Phial
489 1437 Iron Inj. containing: Iron sorbitol citric acid complex 50mg 1.5ml Amp 490 1438 Inj. Iron- Each ml to contain: Fe Sucrose 20mg 5ml Amp 491 1440 Gel containing: Feracrylum 1% w/w 15gm tube 492 1441 Powder Containing: Zinc Bacitracin 400U, Polymyxin B Sulphate
5000U, Neomycin Sulphate 3400U 10gm Phial
493 1444 Cream Containing: Betamethasone Dipropionate 0.5% w/w, Neomycin Sulphate 0.5% w/w.
15gm tube
494 1445 Cream containing: GBHC IP 1% Benzocaine IP 2% cream base 25gm tube 495 1448 Inj. Nimotuzumab- Each vial to contian: Nimotuzumab 50mg 10ml vial 496 1450 Inj. Anti Hemophillic- Each vial to contain: Anti Hemophillic Factor
VIII Monoclonal Purified 250 IU 1 vial
497 1451 Inj. Anti Hemophillic- Each vial to contain: Anti Hemophillic IX 600IU
1 vial
498 1453 Tab. Letrozole - Each tab. to contain: Letrozole 2.5mg 10 tab 499 1456 Low Calcium CAPD- Each to contain: CAPD Bag 7.5% of
Icodextrin with asymmetrical Y Connector 2Ltr Bag
500 1458 Tab. Amiodarone- Each tab. to contain: Amiodarone IP 200mg 10 tab 501 1459 Cough Syp. Each 5ml to contain : Ambroxol HCl 30mg,
Terbutaline 1.25mg,Guaiphenesin 50mg Menthol 0.5mg 100ml Bott.
502 1461 Tab. Hydroxyzine HYDROCHLORIDE Each tab. to contain: Hydroxyzine HCl IP 25mg
10 tab
503 1462 Tab. Itraconazole Each tab. to contain: Itraconazole 100mg 4 tab. 504 1463 Polymyxin, Neomycin & HC Ear Drops Ear Drops containing:
Polymyxin B sulph. IP/BP/USP 10000 IU, Neomycin sulphate IP 3400 IU & Hydrocortisone IP 10mg w/w
5ml vial
505 1464 Mouth Paint containing: Clotrimazole IP 1% Propylene Glycol IP, Glycerin IP base
15ml bottle
506 1465 Inj. Paclitaxel- Each vial to contain: Paclitaxel IP 300mg 1 vial 507 1466 Inj. PEG Filgrastim- Each PFS to contain: PEG Filgrastim 1ml PFS 508 1468 Medroxy- Progesterone Inj. Containing: Medroxy Progesterone
Acetate IP 150mg 1ml PFS
509 1469 Inj. Menotrophin-Each amp/vial to contain:-Recombinant FSH 75IU
1 amp/vial
510 1470 Tab. Ethinylestradiol + Desogestrel- Each tab. to contain:Ethinylestradiol 0.02mg + Desogestrel 0.15mg
21 tab
511 1471 Human Albumin 20% Inj. Containing: Human Albumin 20% 50ml bottle 512 1472 Immunoglobulin Inj. Containing: Immunoglobulin 5% 100ml bottle 513 1475 Tab. Anastrozole Each tab to contain : Anastrozole1mg 10/14 tab. 514 1477 Inj. Pemetrexded Disod.- Containing: Pemetrexded Disod.
500mg 1 vial
515 1478 Low dose Progesterone Oral PillEach Tab. to contain: Desogestrel 75mcg.
28 tab
516 1479 Lornoxicam Inj. Each 2ml to contain : Lornoxicam 8mg 2ml amp/vial
46/71
517 1480 Inj. Clarithromycin- Each vial to contain: Clarithromycin 500mg 1 vial 518 1481 Amoxycillin+Clavulanic Acid Disp Tab. Each Tab. to contain:
Amoxycillin IP 200mg, Clavulanic acid IP 28.5mg 10 tab
519 1482 Cefotaxime+Sualbactam Inj. Each vial to contain : Cefotaxime IP 500mg + Sulbactam IP/USP 250mg
1 vial
520 1483 Cefotaxime+Sualbactam Inj. Each vial to contain : Cefotaxime IP 500mg + Sulbactam IP/USP 250mg
1 vial
521 1484 Inj. Imipenem + Cilastatin- Each vial to contain: Imipenem 500mg, Cilastatin 500mg
1 vial
522 1486 Inj. Insulin Glargine Each vial to contain: Insulin Glargine100 units/ml
3ml vial
523 1487 Inj. Insulin Aspart Each vial to contain: Insulin Aspart (R-DNA origin)
10ml vial
524 1488 Inj. Biphasic Insulin Aspart - Each penfill to contain: Biphasic Insulin Aspart (R-DNA origin)
3ml penfill
525 1489 Inj. Drotaverine - Each ml to contain: Drotaverine 20mg 2ml amp/vial
526 1490 Tab. Sitagliptin Each tab. to contain : Sitagliptin IP 100mg 7 Tab. 527 1492 Human Epidermal Growth- Each gm to contain: 150µ
Recombinant Human Epidermal Growth Factor gel
7.5mg
528 1493 Calcium & Minerals Tabs. Each Tab. to contain Calcium Citrate eqv to elemental calcium IP 200mg, Zinc sulphate IP 4mg, Monohydrate, Magnesium Hydroxide IP 50mg, Vit D3 IP 200 I.U Excepients q.s.
10 tab
529 1494 Lactobacillus Cap. - Each cap to contain: 1 billion C.F.U Lactobacillus Rhamnosus GR-1 Lactocacillus reuteri RC-14
10 Cap
530 1495 ANTACID GEL- Each 5ml to contain: Dried Aluminium Hydroxide Gel 250mg. Activated Simethicone 40mg.
170ml. Bot.
531 1496 Rabeprazole sodium + Mosapride Citrate Cap., Rabeprazole sodium 20mg Mosapride Citrate 15mg Sustained release
10 Cap
532 1498 Meclizine HCL+Nicotinic acidEach Tab. to contain : Meclizine HCL 12.5mg, Nicotinic acid 50mg.
10 tab
533 1499 Otilonium bromide tab. Each Tab. to contain : Otilonium bromide 40mg
10 tab
534 1501 Ofloxacin+Ornidazole tab. Each Tab. to contain : Ofloxacin 200mg, Ornidazole 500mg.
10 tab
535 1503 Syp. LIVER DISORDERS- Each 5ml to contain: Tricholine Citrate 250mg. Kalmegh IP eq. to andographolides 250mcg. Sorbitrol solution IP (70%) in a flavoured base
200ml bott.
536 1504 Syp. LIVER DISORDERS- Each 5ml to contain: Tricholine Citrate 0.55mg., Sorbitol 7.15gm
200 ml
537 1505 Metadoxine Tab Each Tab. contain: Metadoxine 500mg 10 tab 538 1506 Susp. Bacillus clausII spores- Each 5ml to contain: Bacillus
clausii spores 2 Billion spores, susp in 5ml distilled water 5ml
539 1507 PRE & PROBIOTIC- Each cap. to contain: Streptocoocus Faecalist -110 60 million, clostridium Butyrlcum TO-A4 Million, Bacillus Mesentericus TO-A2 Million, Lactic Acid Bacillus 100 million, (Lactobacillus sporogenes
10 cap
47/71
540 1511 Euphorbia Prostata- Each tab. to contain: Euphorbia Prostata dry extract ethanolic 80%(v/v) 100mg.
7 Tab.
541 1512 Tab. AMBROXOL HCL+ N- ACETYL -L-CYSTEINE - Each tab. to contain: Ambroxol Hydrochloride 30mg, N-Acetyl-L- Cysteine 200mg.
10 tab
542 1513 Tab. Montelukast + Levocetrizine- Each tab. to contain: Montelukast 10mg, Levocetrizine 5mg
10 tab
543 1516 Each 5ml. to contains : (Cough Syp.) Dextromethorphan hydrobromide 10mg. Phenylephrine hydrochloride 5mg, chlorpheniramine maleate 4mg. Guaiphenesin 100mg.
50ml bottle
544 1517 Cough Syp. Each 5ml to contain : Terbutaline sulp. 1.25mg, ambroxol hyd. 15mg, guaiphensesin 50mg, menthol 1mg
100ml bottle
545 1518 Cough Syp.:- Each 10ml to contain: Carbinoxamine Maleate IP/BP/USP 4 mg, Ammonium Chloride IP 240 mg, Sodium Citrate IP 240 mg,
100ml
546 1519 INHALER - Each metered to contain: Budesonide 160mcg, Formoterol Fumarate Dihydrate 4.5mcg , Lactose Monohydrate 730mcg.
60 doses
547 1520 Inhaler Containing : Moulded plastic device containing a foil strip with 30/60 regularly placed blisters each containing 50 mcg of salmeterol xinafoate and 250 mcg of fluticasone propionate
30/60 doses
548 1521 INHALER- Each metered dose to contain: Tiotropium Bromide Monohydrate eqv. Tiotropium 9mcg.
120 doses
549 1522 INHALER- Each metered dose to contain: Ipratropium 20mcg, Levosalbutamol 50mcg
200 doses
550 1524 Budesonide Resp. Each 2ml to contain : Budesonide 1mg steroid nebulizing fluid
2ml
551 1525 Tiortropium Bromide Rotacaps- Each Rotacaps to contain : Transcap - Tiortropium Bromide I.P./BP eqv. To Tiotropium Bromide Monohydrate 18 mcg.
30 Cap
552 1526 Ipratropium + Levosalbutamol- Each 2.5ml. to contain : Ipratropium I.P. 500mcg, Levosalbutamol 1.25mg.
2.5ml resp
553 1528 digoxin Elixir Each ml to contain : Elixir digoxin 0.05mg 30ml 554 1529 Inj. Adenosine Each 2ml. to contain : Adenosine 6mg 2ml 555 1530 Tab. Ivabradine Each tab. to contain: Ivabradine 5mg 10/14tab 556 1531 Tab. Nicorandil Sustained release- Each tab. to contain :
Sustained release- Tablets of Nicorandil 20mg. 10 tab
557 1532 Tab. Isosorbide Dinitrate Each tab. to contain Isosorbide Dinitrate IP 5mg
10 tab
558 1536 Fondaparinux sodium Inj.Each PFS: (0.5ml) syringe contains: Fondaparinux sodium 2.5 mg
0.5ml PFS
559 1538 Vitamin K Inj. Each amp to contain: Vitamin K IP 1.0mg 0.5ml Amp 560 1541 Inj. Paracetamol Each ml. to contain : Paracetamol 10mg 100ml 561 1543 Tab./Cap Diacerein Each tab./cap. to contain: Diacerein IP 50mg 10 tab/cap 562 1544 Thiocolchicoside +Diclofenac Sodium Each tab. to contain :
Thiocolchicoside Fr. Ph, 4mg. Diclofenac Sodium I.P. 50mg 10 Tab
563 1546 Spray Containing: Diclofenac Diethylmine 1.16%, Methly Salicylate 10%w/w, Linseed oil ( oleum lini)- 3%w/w, Menthol 5%w/w Excipients & Propellant q.s. 100% w/w
100gm
48/71
564 1547 Analgesic Cream- Each tube to contain : Methyl Salicylate 8% w/w, Mephenesin 5%w/w, Methyl Nicotinate 1% w/w, Menthol 2% w/w
20gm tube
565 1548 Strontium Renelate Sachet Each sachet to contain: Strontium Renelate granules-2gm
Sachet
566 1549 Inj. Teriparatide Each 2.4ml. PFS/PFP to contain : Teriparatide 600mcg PFS/PFP
1PFS/PFP
567 1550 Tab. Linezolid Each tab. to contain : Linezolid IP 600mg 4 tab 568 1554 Levofloxacin Inj. Each vial to contain: Levofloxacin IP 500mg 1 vial 569 1556 Each vial to contain: Piperacillin Sodium IP/BP/USP 4 gm ,
Tazobactum Sodium 0.5 gm 0.5 gm 1 vial
570 1559 Linezolid Inj. Each vial to contain: Linezolid IP 600 mg 1 vial 571 1561 Inj. Ertapenem Sodium Each vial to contain : Ertapenem 1gm
(eqv. To Ertapenem sod.1.046gm.) IV/IM 1 vial
572 1563 Fluconazole +Azithromycin+ Secnidazole Tabs., IP Each Tab. to contain: Fluconazole 150 mg,(1 Tabs.) Azithromycin IP 1 gm(1 Tabs.)Secnidazole IP 1 gm(2 Tabs.)
1 kit
573 1564 Inj. Artisunate Each vial to contain : Artisunate 60mg per vial 1 vial 574 1565 Primaquin Tab., IP Each Tab. to contain: Primaquine 15mg. 7 Tab. 575 1566 Inj. Acyclovir Each vial to contain : Acyclovir IP 500mg 1 vial 576 1567 Lamivudine, Nevirapine,Stavudine Tabs. Each Tab. to contain:
Lamivudine IP 150 mg, Nevirapine IP 200 mg, Stavudine IP 30 mg
10 tab
577 1568 Tab. Lorazepam Each tab. to contain : Lorazepam IP 1mg 10 tab 578 1569 Chlordiazepoxide tab. Each Tab to contain: Chlordiazepoxide IP
10 mg, 10 tab
579 1570 Hydroxyzine Hydrochloride Syp. Each 5ml to contain: Hydroxyzine Hydrochloride IP/BP/USP 10 mg
100ml
580 1571 Syp. Phenobarbitone Each 5ml. to contain : Phenobarbitone 20mg
60ml. Bott.
581 1572 Syp. Triclofos, Each 5ml to contain: Triclofos sodium BP 500mg 30ml bottle 582 1573 Tab. Piracetam Each tab. to contain :Piracetam IP 400mg 10 tab 583 1574 Tab. Piracetam Each 5ml. to contain :Piracetam IP 500mg 100ml bot. 584 1575 Cap./Tab. Pregabalin + Methylcobalamine Each cap./tab. to
contain Pregabalin 75mg, Methylcobalamine 750mcg 10 Cap/ tab
585 1576 Cap./Tab. Gabapentine+ Methylcobalamine Each cap./tab. to contain Gabapentine 300mg, Methylcobalamine 500mcg
10 Cap/ tab
586 1577 Tab./Cap. Dutasteride Each tap./cap. to contain : Dutasteride 0.5mg
10 Cap/Tab
587 1578 Alfuzosin tab. Each Tab. to contain: .Alfuzosin IP/Eur.Ph. 10 mg 588 1579 Mix Lactobacill Vaginal Tab - Each vaginal Tab to contain: Mix
Lactobacill (L. brevis, L. salivarious and L. plantarum) 10E9 4 tab
589 1580 Sertaconazole Nitrate Vaginal Tab: Each veginal Tab. Contains: Sertaconazole Nitrate B.P.500 mg
1 vaginal tab with applicator
590 1582 Levocetrizine Tabs. Each Tab. to contain: Levocetrizine IP 5mg 10 tab 591 1583 Cetrizine HCL drops Each ml to contain : IP 10mg Cetrizine HCL 10ml Phial 592 1584 Cap. Natural Micronised Progesterone- Each cap to contain:
Natural Micronised Progesterone 100mg 10 cap
593 1585 Inj. Noradrenaline Each 2ml to contain : Noradrenaline 4mg. 2ml.amp
49/71
594 1586 Inj. Somatropin (R-DNA)- Each PFS contain: Somatropin (R-DNA) origin Bio synthetic Human Growth Hormone Solution 10mg/1.5ml= 30IU
1 PFS
595 1589 Betamethasone Tab Each Tab to contain:Betamethasone IP 1mg 10 tab 596 1591 Tab. Saxagliptin Each tab. to contain : Saxagliptin 2.5mg 14 tab 597 1592 Inj. Liraglutide - Inj. Human GLP -1 analogue contains :
Liraglutide 6mg/ml- 3ml 3ml
598 1593 Inj. Insulin Detemir Each inj. to contain: Insulin Detemir 100 IU/ml (R-DNA)
3ml
599 1594 Gatifloxacin Eye drop containing Gatifloxacin soln. IP 0.3 % w/v 5ml vial 600 1595 ED- Levofloxacin Coontaining: Levofloxacin IP 0.5% 5ml vial 601 1597 ED- Moxifloxacin Containing: Moxifloxacin 0.5%- 5ml 5ml vial 602 1600 Ofloxacin + Prednisolone Eye drop Containing: Ofloxacin IP 0.3%
+ Prednisolone Acetate IP 1.0% 5ml vial
603 1601 ED. Dorzolamide + Timolol Each vial to contain: Dorzolamide 2% + Timolol 0.5%
5ml vial
604 1602 Travoprost Eye drop Containing: Travoprost 0.004% 5ml vial 605 1604 Natamycin Eye drop Containing: Natamycin IP/BP/USP 0.5%
w/v-3ml 3ml vial
606 1607 Latanoprost Eye Drop Containing: Latanoprost 50 mcg Benzalkonium Chloride 0.01% w/v Aqueous Buffered Vehicle q.s
2.5ml vial
607 1612 Cream. Sertaconazole Each tube to contain : Sertaconazole Nitrate 2%
10gm tube
608 1613 Tolnaftate Lotion Each ml to contain: Tolnaftate IP/BP/USP 10mg 10ml 609 1614 Oint. Zinc Oxide Each tube to contain : Zinc Oxide I.P. 20gm tube 610 1616 Mometasone +Salicyclic Acid Oint Containing Mometasone
Furoate IP/BP/USP 0.1% + Salicylic Acid 5% IP 5gm tube
611 1617 Clobetasol Salicylic Acid Oint Containing: Clobetasol Propionate BP 0.05% w/w Salicylic Acid IP 6% w/w, 10 gm
10gm tube
612 1619 Hydroquinone + Tretinoin + Mometasone Cream- Each tube to contain: Hydroquinone IP/BP/USP 4.0%w/w, Tretinoin IP/BP/USP 0.025%w/w, Mometasone Furoate IP/BP/USP 0.1%-
30gm
613 1624 Spray. Lidocaine containing : Spray. Lidocaine 1.0%, Cetrimide 0.1%, Polyvinyl Polymer 2.8% solvent & propellent
100gm Pack
614 1628 Hydrogen Peroxide Each bott. to contain : Hydrogen Peroxide IP - 400ml
400ml bottle
615 1629 Liq. Paraffin Cotaining: Liq.Paraffin IP 400ml bottle 616 1632 Vitamin D3 Inj. Each amp. to contain: Inj. Vitamin D3 IPO 3 lac
IU 1 amp
617 1633 Inj. Methylocobalamin Each ml. to contain : Methylocobalamin 500mcg-1ml
1ml Amp
618 1634 Each Tab. to contain: (Calcium with Vitamin D NFI) calcium Gluconate NFI 0.5gm, Calcium Phosphate NFI 0.15gm Calciferol NFI equ. To 500 units of Vit. D
10 tab
619 1635 Calcium Syp.- Each 5ml. (Inj. Hepagard-10ml) contain : calcium Lactodionate 1.50gms (equivalent0.87 g of calcium Gluconate), calcium gluconate 0.25g, Cholecalciferol (Vitamim D3) - 200IU, Cyanocobalamin - 2.5mcg, Magnesium Chloride - 21.25mg (equivalent to 2.5mcg of lemental Magnesium), Flavoured base.- q.s.
120ml bottle
50/71
620 1636 Ferrous Gluconate Syp. Each 15ml to contain: Syp. Ferrous Gluconate IP 400 mg
200ml
621 1640 Lapatinib Tab. Each tab.to contain: Lapatinib 250 mg 10 tab. 622 1641 Tab./Cap. Aprepitant - Each pack to contain: (125 mg one
tab/cap and 80mg two tab/cap) 3Tab/cap pack
623 1642 Leuprolide Inj. Each vial to contain: Leuprolide Acetate 7.5 mg 1 vial 624 1643 Tab. Sevelamer Each tab. to contain : Sevelamer 400mg 10 tab 625 1645 Inj. Paclitaxel Each vial to contain : Inj. Paclitaxel IP 30mg 1 vial 626 1646 ALBUMIN-BOUND PACLITEXEL Each vial to contain: Inj.
Nanoptechnology based ALBUMIN-BOUND PACLITEXEL 100MG
20ml vial
627 1647 Inj. Bevacizumab Each vial to contain : Inj. Bevacizumab 100mg 1 Vial 628 1648 Inj. Trastuzumab Each vial to contain : Inj. Trastuzumab 440mg 1 Vial 629 1649 Inj. Human Interferon Beta 1A, Each PFS/vial to contain:
Recombinant Human Interferon Beta 1A 44mcg in each PFS/vial
1 PFS/vial
630 1651 Vaccine. Polysaccharide Pneumococcal Each 0.5ml to contain : 0.5ml. Vaccine. Polysaccharide Pneumococcal 0.5ml.
1 pfs/vial
631 1654 Inj. Rabeprazole Each amp/vial to contain : Inj. Rabeprazole 20mg (amp/vial)
1amp/vial
632 1655 Tab. Ilaprazole Each tab. to contain : Ilaprazole 10mg 10 tab 633 1656 LAXATIVE POWDER - Each pouch to contain : Polyethylene
Glycol 118gm. Potassium Chloride 1.484gm. Sodium Bicarbonate 3.37gm. Sodium Chloride 2.93gm. Sodium Sulphate 11.36gm.
137.15gm/1 pouch
634 1657 Inj. Palonosetron Hydrochloride Each 1.5ml. to contains : Palonosetron Hydrochloride equivalent to Palonosetron 0.075mg Water for Inj.- q.s.
1.5ml
635 1658 Syp. Zinc Elemental Zinc Each 5ml. to contain : Elemental Zinc 20mg
100ml
636 1662 Ebastine + montelukast Tab. Each Tab. to contains : Ebastine 10mg,montelukast 10mg
10 tab
637 1663 Cough Drop - Each ml. to contain : Phenylephrine HCL IP - 2.5 mg. Chlorpheniramine Maleate IP 2.0 Mg. Flavoured Base q.s.
15ml.
638 1664 Cough Syp. - Each 100ml. Solution to contain : Dried IVY leaf extract 0.7gm
100ml bott.
639 1665 INHALER - Each metered dose to contain : Tiotropium 9mcg. Formoterol 6mcg, Ciclesonide 200mcg.(CFC Free)
120 MDI
640 1666 Rotacap Ipratropium bromide Each Rotacap to contain : Ipratropium bromide B.P. eqv. to Ipratropoium bromide (anhydrous ) 40mcg
30 cap
641 1667 Dronedarone hcl Tab. Each Tab. to contain : Dronedarone hcl 400 mg
10 tab.
642 1668 Tab./Cap. Olmesartan Each tab./Cap. to contain : Olmesartan 20mg
10 tab.
643 1670 Haemostatic- Each 5ml to contain: Haemostatic Matrix with Prefilled Gelatin Granules in Syringes
5ml
644 1671 Tab. Acenocoumarol Each tab. to contain : Acenocoumarol 4mg 10 tab 645 1672 Anti Coagulants Two componant fibrin sealant with fast & slow
setting of human thrombin 2ml
646 1674 Tab. Sumatriptan Each tab. to contain : Sumatriptan 50mg 10 tab
51/71
647 1675 Tab. Lornoxicam SR - Each SR tab. to contain: Lornoxicam 16mg
10 tab
648 1676 Aceclofenac Tab., Each tab. to contain : Aceclofenac 100mg 10 Tabs 649 1677 Etanercept Inj. Each PFP/PFS to contain : Etanercept 50mg -
Etanercept 50mg. 1 PFP/PFS
650 1678 ER Tab. Zolpidem Tartrate Each ER tab. to contain : Zolpidem Tartrate IP 12.5mg
10 tab
651 1679 Lorazepam Inj. Each ml to contain: Lorazepam 2 mg 1 amp 652 1681 Tab. Citicoline Each tab. to contain : Citicoline IP 500mg 10 Tab. 653 1682 Divalproex Sod. Tab Each tab to contain: Divalproex Sod.250 mg 10 Tab. 654 1683 Divalproex Sod Tab. Each tab to contain: Divalproex Sod 500 mg 10 Tab. 655 1685 Tab. Dexcholrpheniramine SR- Each SR tab. to conatain:
Dexcholrpheniramine 6mg 10 tab
656 1686 Tab. Fexofenadine Each tab. to contain : Fexofenadine IP180mg 6/10 Tab. 657 1687 Tab. Loratidine Each tab. to contain: Loratidine USP 10mg 10 tab 658 1688 Each Tab to contain: Thyroxine sodium IP 25 mcg 100 tab 659 1689 Tab. Saxagliptin Each tab. to contain : Saxagliptin 5mg 14 tab 660 1690 Tab. Vildagliptin Each tab. to contain : Vildagliptin 50mg 14 tab 661 1691 Insuline Inj. - Each Cartridge to contain: 25% Lispro and 75%
Lispro Protamine Suspension (100 IU/ml)[Monocomponent insulin, recombinant DNA origin]
3ml Cartridge
662 1692 Insuline Inj. - Each Cartridge to contain: 50% Lispro and 50% Lispro Protamine Suspension (100 IU/ml)[Monocomponent insulin, recombinant DNA origin]
3ml Cartridge
663 1693 Tab. Clarithromycin Each tab. to contain Clarithromycin IP 500mg 10 Tab. 664 1694 Inj. Colistimethate Sodium Each vial to contain: Colistimethate
Sodium BP 1000000 IU 1 vial
665 1696 Micafungin Sodium Inj. Each vial to contain: Micafungin Sodium equivalent to 50 mg Micafungin
1 vial
666 1697 Inj. Caspofungin Acetate Each vial to contain : Caspofungin Acetate 50mg
1 Vial
667 1698 Tab. Terbinafine hydrochloride Each tab. to contain : Terbinafine hydrochloride 250mg
1/7/10 Tab.
668 1699 Inj. Alpha Beta Arteether Each vial to contain : Alpha Beta Arteether (150mg)
1 vial
669 1700 Tab. Ivermectin Each tab. to Contain: Ivermectin6mg 4/10 Tab. 670 1703 Terbinafine Ointment Containing: Terbinafine Hcl USP1% 10gm tube 671 1704 Antifungal Gel - Each tube to contain : Adapalene 0.1%w/w (as
microsheres), Clindamycin Phosphate USP Eqv. to clindamycin 1.0% w/w In an aqueous gel base-q.s.
15gm tube
672 1705 Lotion Containing: Minoxidil 5%, Amenexil 1.5% 60ml 673 1708 Oint. Tacrolimus Each tube to containb : Tacrolimus 0.03% 10 gm. Tube 674 1709 Oint. Tacrolimus Each tube to contain : Tacrolimus 0.01% 10 gm. Tube 675 1711 Lotion. Sertaconazole Nitrate Each phial to contain:
Sertaconazole Nitrate 2% w/v Propylene glycol base QS. 15ml phial
676 1712 Gel Benzoyl Peroxide Each to contain Benzoyl Peroxide 2.5% 20gm 677 1714 Cream. Mometasone Each tube to contain : Mometasone
Furoate IP 0.1% 10/15gm tube
678 1715 Triamcinolone Acetonide Containing: Triamcinolone Acetonide IP 0.1%
5gm
52/71
679 1716 Cream. Mometasone + Fusidic Each tube to contain : Mometasone 0.1% & Fusidic 2%- 10gm
10gm tube
680 1717 Ointment Containing: Hydrocortisone Acetate 1% 10/20gms 681 1718 Gel Adapelene Each tube to contain Adapelene 0.1% 15mg tube 682 1719 Azelaic acid Cream Containing: Azelaic acid 10% 15gm tube 683 1720 Isotretenoin Cap. Each Caps. to contain: Isotretenoin 20 mg 10 cap 684 1722 Oint. Coal tar + Salicylic acid- Each to contain : Coal tar 6%,
Salicylic acid 3%- 75gm 75gm
685 1723 Spray. Each to contain : Isopropyl Alcohol- 55% w/w, Purified Water- 10%w/w, Propellant Hydrocarbon-35% w/w- 200gm
200gm
686 1725 Drop. Each ml. to contain : Peptonised Iron 117.67mg ((eqv. To 20mg, of elemental iron), Protein (as Peptone) 30mg., Floic Acid IP 200mcg, Vitamin B12-4mcg, Palatable base q.s.
15ml bottle
687 1726 Ringer Lactate Inj. Containing: Ringer Lactate 500ml Self Collapsible IV Fluid PVC Bag having separate administration port with recessed membrane with plastic sterility barrier & self sealing Inj port with silicon septum, no air vent required.
500ml
688 1727 DNS Inj., Containing: DNS 500ml Self Collapsible IV Fluid PVC Bag having separate administration port with recessed membrane with plastic sterility barrier & self sealing Inj port with silicone septum, no air vent required
500ml
689 1728 Tab. Gefitinib Each tab. to contain : Gefitinib IP 250mg 30 tab. 690 1729 Inj. Asparaginase Each vial to contain : Asparaginase 10000 unit 1 vial 691 1731 Rasburicase Inj. Each vial to contain: Rasburicase 1.5 mg 1ml vial 692 1732 Inj. Decitabine Each vial to contain: Decitabine 50mg 1 vial 693 1733 Cap. Nilotinib Each cap to contain : Nilotinib 150mg 4 cap 694 1734 Octreotide Inj. Each Pack to contain: Octreotide 10mg (in form of
microspheres)- 1vial, I pre filled syringe of 2.5ml Vehicle for 2.5ml suspension 2 sterile injection needles
1vial/pack
695 1735 Cap./Tab. Imatinib Mesylate Each cap./tab. to contain : Imatinib Mesylate IP 400mg
10/30 cap/tab
696 1736 Tab. Bicalutamide Each tab. to Contain : 50mg 10 tab 697 1738 Tab. Sevelamer HCl Each tab. to contain: Sevelamer HCl 800mg 10 tab 698 1739 Pralidoxime Inj. Each vial to contain: Pralidoxime 1gm 1 vial 699 1740 Antacid Gel. Each 10ml to Contain: Sucralfate 1000mg,
oxetacaine 20mg. 100ml bottel
700 1742 PRE & PROBIOTIC AND ORAL REHYDRATION- Sodium Chloride 0.52gm. Sodium Citrate 0.58gm. Potassium Chloride 0.3gm. Dextrose Anhydrous 2.7gm. Pre & Probiotic Pack 0.5mg. Contains: Streptococcus Faecalis T-110 7.5 million. Clostridium Butyricum TO-A 0.5 Million Bacillus Mesentericus TO A 0.25 Million, Lactobacillus Sporogenes 20.0 Million
Sachet
701 1745 Tab. Doxofylline Each tab. to contain : Doxofylline IP 400mg 10 tab 702 1746 Inj. Omalizumab Each vial to contain : Omalizumab150mg Vial 703 1748 Cough Syp. Each 5ml to contains : Cetirizine hydrochloride 5mg,
phenylephrine hydrochloride mg, dextromethophan hydrobromide 10mg, menthol 1.5mg.
60ml bottle
704 1749 Levosalbutamol (Inhaler) Each metered dose to contain : Levosalbutamol tartrate 50mcg.
200 doses
53/71
705 1750 Nebivolol 2.5mg Tab./Cap. Each Tab./cap. to contain : Nebivolol 2.5 mg.
10 tab/cap
706 1751 Nebivolol 5Tab./Cap. - Each Tab./Cap. to contain : Nebivolol 5mg
10 tab/cap
707 1753 Telmisartan , Amlodipine Tab. - Each tab. to contain : Telmisartan 40mg, Amlodipine Besylate equivalent to Amlodipine 5mg
10 tab
708 1754 Indapamide SR +Amlodipine Tab. - Each tab. to contain : Tab. Indapamide SR 1.5mg, Amlodipine Besylate equivalent to Amlodipine Besylate equivalelodipine 5mg
10 tab
709 1756 Haemmorrhoidal oint. Containing : Lignocaine hydrochloride 2% w/w, hamamelis water 5%,zinc oxide 10% w/w.ointment base q.s.
20gm tube
710 1757 Etoricoxib Tab.-Each tab to contain : Etoricoxib IP 90mg 10 tab 711 1758 Diclofenac colestyramine Cap. Each cap. to contains :Diclofenac
colestyramine 145.6mg.(Diclofenac resinate). 10 cap
712 1759 Tolfenamic acid Tabs./cap. Each Tabs./cap. to contain : Tolfenamic acid 200 mg.
10 cap/tab
713 1760 Hylan G-F20 Inj. Each contain : Hylan G-F20 6ml PFS 714 1761 Inj. Tocilizumab 80mg- Each vial to contain Tocilizumab 80mg 4 ml vial 715 1762 Tocilizumab 200mg Each vial to contain : Tocilizumab 200mg. 10ml vial 716 1763 Tocilizumab 400mg Each vial to contain : Tocilizumab 400mg. 20ml vial 717 1764 Zolpidem Tartrate ER 6.25 mg. Each Extended Release Tab. to
Contain: Zolpidem Tartrate 6.25 mg. 10 tab
718 1765 Tab. Voglibose Each tab. to contain : Voglibose 0.2mg 10 tab 719 1766 Sitagliptine 50mg+ Metformin 500 mg. Each Tab. to contain:
Sitagliptine 50mg, Metformin 500 mg. 14 tab
720 1767 Tab. Sitagliptin 50mg + Metformin 1000mg Each tab. to contain : Sitagliptin 50mg + Metformin
14 tab
721 1768 Vildagliptin 50 mg+ Metformin 500mg. Tab. Each Tab. to contain: Vildagliptin 50 mg, Metformin hydrochloride 500 mg
10 tab
722 1769 Vildagliptin 50 mg+ Metformin 1000mg. Each Tab. to contain: Vildagliptin 50 mg, Metformin hydrochloride 1000 mg.
10 tab
723 1770 Inj. Insulin Lispro Each cartridge contain : Insulin Lispro (100 IU/ml) [Monocomponent Insulin, recombinant DNA origin]
3ml
724 1771 Tab./Cap. Clindamycin Each tab./cap. to contain Clindamycin 300mg
10 cap/tab
725 1772 Inj. Clindamycin Each vial to contain : Clindamycin 600mg 1 vial 726 1773 Inj. Tigecycline Each vial to contain : Tigecycline 50mg per vial 1 vial 727 1774 Tobramycin Inj. Each vial to contain: Tobramycin 20mg vial 728 1775 Tobramycin Inj. Each vial to contain: Tobramycin 60mg vial 729 1776 Tobramycin Inj. Each vial to contain: Tobramycin 80mg vial 730 1777 Inj. Amphotericin B Each vial to contain : Amphotericin B 50mg 1 vial 731 1778 Entecavir oral solu. Each ml to contain: Entecavir 0.05 mg. 210ml bottle 732 1779 Inj. Interferon beta 1-a Each PFP to contain : Interferon beta 1-a
30mcg per PFP (6 million IU) 0.5ml PFP
733 1780 Telbivudine Tab. Each Tab. to contain: Telbivudine 600 mg. 15 tab 734 1783 Ranibizumab Inj. Each ml to contains: Ranibizumab 10 mg. 0.23ml 735 1784 Lotion. Desonide Each Bott. to contain : Desonide 0.05% 30ml bottle 736 1785 Mometasone Furoate Solution Containing: Mometasone Furoate
0.1% w/v. 15ml bottle
54/71
737 1786 Oint. Calcitriol Each gm to contain : Calcitriol 3mcg.- 20gm 20gm tube 738 1787 Feracrylum 3% dressing Containing: Feracrylum 3% Gauze
Dressing Sterile, Cotton dressing impregnated with water soluble base.
Pouch of 10cmx10cm
739 1791 Vitamin & MineralsTabs. Each Tab. to Contain: Thiamine Mononitrate 10mg, Riboflavin 10mg,Nicotinic Acid 25mg,Niacinamide 75mg, Pyridoxin Hydrochloride 3mg,Calcium Pantothenate 50mg,Folic Acid 1.5mg,Vitamin B12 15mcg,Vitamin C 150mg,Biotin 260mcg, Light Magnesium Oxide Equivalent to elemental Magnesium 32.4mg.
15 tab
740 1792 Syp. Haematinic - Each 5ml. to contain : Peptonised Iron 176.5mg, (Eqv. To 30mg. Of elemental Iron) Protein 100mg, Folic acid 200mcg, Vitamin B12 2.5mcg per 5ml
100ml bottle
741 1793 Tab. Calcium- Each tab. to contain : Citrate Malate Equivalent to Elemental Calcium 250mg+ Calcitriol 0.25mcg+Vitamin K2-7 50mcg
10 tab.
742 1794 Calcium & Minerals Tab. Each tab. (Inj. Hepagard-10ml) contain : Calcium Carbonate 1000mg, from Organic Heavy Magnesium Oxide 150mg, Zinc Sulphate Monohydrate 13.75mg, L-Lycine HCl 100mg, Pyridoxine HCl 1.5mg, Cholecalciterol 200 IU
15 tab
743 1795 CALCIUM CAP.- Each cap. to contain: Elemental Calcium 150mg (In the form fo Calcuim hydroxide & calcium oxide pretreated with heated algae), zinc sulphate monohydrate equivalent to elemental zinc-7.5mg, calcitriol-0.25mcg
10 cap
744 1800 Fluids Each 100ml to Contain: Invert Sugar 10 g, Water for Injection q.s.
500ml bottle
745 1801 Fluids Each 100ml to Contain: Invert Sugar 10 g, Sodium Chloride 0.9 g, water for injection q.s.
500ml bottle
746 1802 Tab. Methotrexate Each tab. to contain : Methotrexate 7.5mg 10 tab 747 1803 Tab. Sorafenib - Each tab. to contain: Sorafenib Tosylate 200mg 10 tab 748 1804 Tacrolimus 1mg Tab. Each Tab. to contain: Tacrolimus 1mg. 10 tab 749 1805 Tab. Tacrolimus 2mg Each tab. to contain : Tacrolimus 2mg 10 tab. 750 1807 Tab. Erlotinib Each tab. to contain : HCl Eqv. Erlotinib 100mg 10 tab 751 1808 Inj. Bortezomib Each vial to contain : Bortezomib 1mg 1 vial 752 1809 Inj. Bortezomib Each vial to contain : Bortezomib 3.5mg 1 vial 753 1810 Cap. Nilotinib Each cap. to contain : Nilotinib 200mg 4 cap 754 1811 Cabazitaxel Inj. Each 1.5ml contain: Cabazitaxel 60mg. (Diluent
5.7ml of 13% w/wEthanol in water for injection). vial
755 1812 Inj. Cetuximab 100mg- Each vial to contain: Cetuximab 5mg 20ml vial 756 1813 Inj. Cetuximab 500mg Each ml to contain: Cetuximab 5mg 100ml vial
/bottle
757 1815 Inj. Factor Eight Bypassing activity, Containing : Factor Eight Bypassing activity, Anti-Inhibitor-Coagulant Complex 500IU
Vial
758 1816 Inj. Recombinant Anti Hemophillic Factor Containing : Recombinant Anti Hemophillic Factor VIII 250 IU
Pack
759 1817 Inj. Recombinant Anti Hemophillic Factor Containing : Recombinant Anti Hemophillic Factor VIII 500IU
Pack
760 1818 Inj. Recombinant Anti Hemophillic Factor Containing : Recombinant Anti Hemophillic Factor VIII 1000IU
Pack
55/71
761 1822 Syp Lactulose Each 15ml. to contain : Lactulose USP 10gm. 200ml Bott. 762 1823 Syp Lactulose Each 15ml. to contain : Lactulose USP 10gm. 450ml Bott. 763 1824 Lactulose Granules Each 15gm of Granules to contain :
(Lactulose BP 10gm, Ispaghula Husk IP 3.50gm in 15gm) Pack of 90 gm.
764 1828 Syp. Ondansetron Each 5ml. to contain : Ondansetron IP 2mg. 30ml Bott. 765 1829 Tab Mefenamic Acid Each tab. to contain: Mefenamic Acid IP
500mg 10 Tab
766 1830 Tab. Racecadotril Dispersible Each tab. to contain Racecadotril Dispersible10mg
10 tab
767 1831 Tab. Racecadotril Dispersible Each tab. to contain Racecadotril Dispersible30mg
10 tab
768 1832 Tab/Cap. Racecadotril Each .to contain: Racecadotril 100mg 10 tab./cap 769 1834 Pre & Probiotic Capsule- Each cap. to contain: Lactobacillus
Plantarum Lp 299v 10billion CFU 10 cap.
770 1835 Pre & Probiotic Capsule- Each cap. to contain: 2billion spores of polyantibiotic resistant Bacillus Claussi
4 cap
771 1836 HAEMORRHOIDAL CREAM - Each gm to contain : Euphorbia Prosttrata dr extract etract ethanolic 80% (v/v) ((35-70):1) 10mg ( Containing 0.315-0.825 rhg totel flavonoids calcluated as apigenin-7 glucoside and 1.26-4.40 mg totel phenolics calculated as gallic acid) cream
30 mg tube
772 1837 Cap. EPL & Etophylline- Each cap. Each tab. to contain: contain : Essential phospholipids (EPL substances ) 300mg, Hydroxyethyl Theophyline (Etophylline )BP. 50mg. Excipients QS. Approved colour used in Empty capsule shell.
10 Cap.
773 1838 Tab. Garenoxacin - Each film coated tab. to contains : Garenoxacin Mesylate equivalent to Garenoxacin 200mg exceipients qs
10 tab
774 1839 Autohaler- Each delivered of Autohaler to contain : Formoterol Fumarate Dihydrate 6mcg, Budesonide IP 200mcg Suspended in propellant HFA 134a q.s. Also contains Absolute alcohol IP 3.07% v/v (Inh. FORACORT 200 Autohaler)
200 MDI
775 1840 INHALER - Each delivers dose to contain : Salmetrol xinafoate IP Equivalent to salmetrol 25µg Fluticasone Propionate IP 250µg Excipients & Propellant 1, 1, 1, 2 Tetrafluoro Ethane HFA 134a
150 MDI with/without SPACER
776 1841 Inhaler -Each actuation to deliever Formoterol Fumarate Dihydrate IP eqv. To Anhydrous Formoterol Fumarate 6mcg, Budesonide IP 400mcg Excipients & Propellant 1,1.1.2 Tetrafluoro Ethane HFA 134a
150MDI with/without spacer
777 1843 Autohaler- Each delivered Autohaler to contain : Salmeterol (as salmeterol xinafolate )IP 25mcg, Fluticasone Propionate IP 250mcg Suspended in Propellant 134a q.s. (contains Absolute Alcohol IP 5% V/V
200 MDI
778 1844 SPACER DEVICE-Spacer-suitable for MDI inhaler of all brand 1 piece 779 1845 Tab. Metoprolol Succinate SR Each SR to contain : eqv.
Metoprolol Succinate 23.75 mg. Metoprolol tartrate 25mg 10 Tab
780 1846 Tab. Propranolol Each tab. to contain : Propranolol IP10mg 10 Tab 781 1848 Tab. Ranolazine Each tab. to contain: Ranolazine 500mg 10 tab./ cap 782 1849 Inj. Labetalol Each ml. to contain : Labetalol HCL IP 5mg 4ml 783 1850 Tab. Labetalol Each tab. to contain : Labetalol 100mg IP 10 tab
56/71
784 1852 Tab. Cilnidipine Each tab. to contain : Cilnidipine10mg 10 tab 785 1854 Tab. Cilostazol Each tab. to contain: Cilostazol 100mg 10 tab 786 1855 Tab. Tramadol & Acetaminophen Each Film coated tab. to
contain L Tramadol HCl IP 18.75 mg Acetaminophen 162.5mg 10 Tab
787 1856 Tab./Cap. Tramadol & Paracetamol Each tab./Cap. to contain : Tramadol 37.50mg, Paracetamol 325mg
10 Tab/Cap
788 1857 Buprenorphine Transdermal Patch - Each Transdermal Patch to contain : Buprenorphine 5mcg/hr. Area containing active substance 6.25sqcm
6.25sqcm Path
789 1858 Buprenorphine Transdermal Patch - Each Transdermal Patch to contain : Buprenorphine 10mcg/hr. Area containing active substance 12.5sqcm
12.5sqcm Path
790 1859 Buprenorphine Transdermal Patch - Each Transdermal Patch to contain : Buprenorphine 20mcg/hr. Area containing active substance 25sqcm
25sqcm path
791 1862 Tab. Febuxostat Each tab. to contain : Febuxostat 40mg 10 Tab 792 1865 Tab. Tolperisone & Diclofenac -Each film to contain: Tolperisone
Hydrochloride JP 150mg & Diclofenac Sod. IP 50mg 10 tab
793 1866 Analgesic Cream- Each tube to contain: Methyl salicylate 30% w/w, Menthol 10% w/w, Camphor 4% w/w Excipients q.s
30gm tube
794 1869 Tab. Amisulpride- Each tab. to contain: Amisulpride IP 50mg 10 tab 795 1870 Tab. Quetiapine- Each tab. to contain: Quetiapine 25 IP mg 10 tab 796 1871 Tab. Quetiapine Each tab. to contain: Quetiapine IP 100mg 10 tab 797 1872 Tab. Bupripion- Each tab. to contain: Bupripion ER 150mg 10 tab 798 1873 Tab. Paroxetine- Each tab. to contain: Paroxetine IP 25mg 10 tab/ cap 799 1874 Tab. Duloxipine Each tab./cap. to contain: Duloxipine 30mg 10 tab/cap 800 1879 Tab. Levetiracetam Each tab. to contain: Levetiracetam IP
500mg
10 Tab.
801 1880 Tab. Levetiracetam Each tab. to contain: Levetiracetam IP 250mg
10 Tab.
802 1881 Syp. Phenytoin Sodium Each ml to contain: Phenytoin Sodium IP 25mg.
100ml bottle
803 1882 Tab. Lamotrigine Disperisble Each tab. to contain : Lamotrigine 25mg
10 Tab.
804 1883 Tab. Lamotrigine Disperisble Each tab. to contain : Lamotrigine 25mg
10 Tab.
805 1885 Inj. Levetiracetam Each ml to contain: Levetiracetam100mg. 5ml vial 806 1887 Tab. Sildenafil Each tab. to contain : Sildenafil IP 50mg 4 Tab. 807 1890 Syp. Chlorpheniramine & Phenylephrine : Each 5ml to contain:
Chlorpheniramine 1mg, Phenylephrine 2.5mg 60 ml. bott.
808 1891 Tab. Misoprostol Each tab. to contain: Misoprostol 25mcg 4 tab. 809 1893 Levonorgestrel - Each sterlite Intrauterine system to contain:
Levonorgestrel 52mg (Levonorgestrel 20mcg/24hours intra uterine Delivery System)
1 pack
810 1894 Tab. Saxagliptin & Metformin (ER) - Each film coated to contain: Saxagliptin 5mg + Metformin HCl 500mg (ER)
7 tab
811 1895 Tab. Saxagliptin 5mg + Metformin HCl 1000mg (ER) 7 tab 812 1896 Tab. Linagliptin- Each film coated tab to contain: Linagliptin 5mg
10 tab
57/71
813 1897 Gliclazide I.P. & Metformin (ER) Tab. - Each uncoated bilayered scored tab. to contain: Gliclazide I.P. (ER) 60mg + Metformin HCl I.P. (ER) 500mg
14 tab.
814 1898 Inj. Insulin Degludec Each1ml of the Solution for subcutaneous inj. to contain: Insulin Degludec (R-DNA origin) 100 unit/ml Pre Filled Pen
3ml/pfp
815 1899 Inj. Insulin Glargine- Each ml to contain: Insulin Glargine 100units
3ml x 5cartridge
816 1900 Inj. Insulin Glulisine Each ml to contain: Insulin Glulisine 100IU, m-cresol 3.15mg- (as preservative excipients)
10ml vial
817 1901 Inj. Insulin Glulisine Each ml to contain: Insulin Glulisine 100IU, m-cresol 3.15mg- (as preservative excipients)
3ml cartridge
818 1902 Cap. Cefixime and Pre&Probiotic- Each cap. to contain: Cefixime IP as Trihydrate eqv. to Anhydrous Cefixime 200mg and Each Inner cap. To contain: Sterptococcus Faecalis T-110 JPC 60 Millin clostridium Butyricum TO-A 4 million Bacillus Mesentericus TO-AJDC2 million Lactic Acid Bacillus 100million
10 cap
819 1903 Tab. Nitrofuradantin SR Each SR Tab. to contain : Nitrofuradantin IP100mg
10 tab
820 1907 Tab. Voriconazole Each tab. to contain : Voriconazole 200 mg 4 tab 821 1909 Anti Malarial Kit- Each Combikit to contain: (A) 2 tab
Sulphadoxine 750mg & Pyrimethamine 37.5mg IP (B) 3tab Artisunate 200mg
1 kit.
822 1910 Cap. Clofazimine Each cap. to contain : Clofazimine IP 100mg 10 cap 823 1922 ED. Brimonidine & Timolol- Each vial to contain: Brimonidine
0.15% Timolol 0.5% 5ml vial
824 1923 ED. Carboxy Methyl Cellulose- Each ml to contain: Sodium Carboxy Methyl Cellulose 5mg.
10ml vial
825 1924 ED. Dorzolamide Each vial to contain: Dorzolamide 2% 5ml vial 826 1927 ED. Hydroxypropylmethylcellulose- Each vial to contain:
hydroxypropylmethylcellulose 0.3% 5ml vial
827 1935 Nasal Spray. Fluticasone Each Spray delivers Fluticasone Propionate 50mcg to contain : Fluticasone Propionate IP 0.05% W/V Benzalkonium Chlocride IP 0.01% w/v (As Preservative) Phenyl Ethyl Alcohl Usp 0.25% (As Preservative)
100 MD
828 1936 Soln. Chlorhexidine Gluconate Each bottle to contain: Chlorhexidine Gluconate 0.2% solution IP
150ml bottle
829 1937 Potassium Nitrate & Monofluoro Phosphate Paste Each tube to contain: Potassium Nitrate 5% w/w, Sod. Monofluoro Phosphate 0.7% w/w
100gm tube
830 1938 Oral Gel. Metronidazole- Each tube to contain: Metronidazole 1%, Chlorhexidine 0.25%
20gm tube
831 1940 Lotion. Ketoconazole- Each bottle to contain: Ketoconazole 2% w/v
50ml bottle
832 1942 Clotrimazole Dusting Powder- Each to contain: Clotrimazole Dusting Powder 1% w/w
75gm
833 1946 Lotion Minoxidil- Each bott. to contain: Minoxidil 2% 60ml. Bott. 834 1947 Lotion Minoxidil- Each bott. to contain: Minoxidil 5% 60ml. Bott. 835 1956 Paraffin Guaze- Each piece to contain: Paraffin Guaze 10cm x
10cm- 10pcs 10 pieces
58/71
836 1957 Tab. Ferrous Ascorbate Each film coated tab. to contain: Ferrous Ascorbate equivalent to elemental Iron 100mg, Folic Acid IP 1.5mg, Cyanocobalamin IP 15mcg, Zinc Sulphate Monohydrate IP equ.to elemental Zinc 22.5mg excepients q.s
10 tab
837 1958 Cap. Multivitamin - Each hard gelatin cap. to contain: Ferrous Fumarate I.P. eqv.to Elemental Iron 30mg. Folic Acid I.P. 250mcg Zinc Sulphate Monohydrate B.P. eqv. To Zinc 20mg, thiamine Mononitrate (Vit.B1)I.P. 1.2mg Riboflavin (Vit. B2) I.P. 1.2, Niacinamide I.P. 10mg, Pyridoxine Hydrochloride (Vit B6) I.P. 1mg, Cyanocobalamin (Vit. B12) I.P. 2.5mcg Ascorbic Acid coated (Vit.C) I.P. 40mcg
10 tab
838 1959 Cap. Multivitamin with Amino Acid- Each Cap. to contain: L- Arginine Hydrochloride USP 13.28mg. Histidine Hydrochloride H20 BP 3.71mg. L-Isoleucine USP 5.9mg. L-Leucine USP 18.3mg L- Lysine HCL USP 25mg DL- Methionine BP 18.4mg L-Phenylalanine USP 5mg. L-Threonine USP 4.2mg L-Tryptophan USP 5mg. L-USP 6.7mg. 5-Hydroxy Anthranilic Acid HCL 0.2mg. Cholecalciferol IP 200 IU Nicotinamide IP 25mg. Pyridoxine HCL IP 1.5mg. Methylcobalamin 500mcg. Biotin USP 30mcg. Folic Acid IP 0.75mg. Copper Sulphate BP 4mg. Ferrous Sulphate IP 20.5mg Magnesium sulphate IP 7.43mg. Magnesium sulphate BP1.4mg. Potassium lodide IP 0.1mg. Sodium Selenite BP 10.0mcg. Zinc Sulphate IP 15mg. Chromium Polynicotinate 200mcg.
10 cap.
839 1961 Cap. Antioxidant - Each cap to contain: Methylcobalamin 500mcg, Folic Acid IP 1.5mg, Zinc Sulphate IP 25mg, Chromium Polynicotinate 200mc, Selenium 65mcg as Sodium Selenite USP Pyridoxine HCL IP 1.5mg, Inositol 100mg, Alpha Lipoica Acid USP 50mg. Each Inner capsule contains: Streptrococcus Faecalis T-110 JPC 30 million Clostridium Butyricum T-OA 2 million Bacillus Bacillus Mesentericus T-OA JPC 1 million Lactic Acid Bacillus 50 million (Lactobacillus Sporogenes)
10 Cap
840 1962 Tab. Ferrous Ascorbate with Amino Acids & Zinc- Each film coated tab. to contain: Ferrous Ascorbate equivalent to elemental Iron 100mg. Methylcobalamin 1000mcg. Folic Acid 1.5mg. L-Histidine Hcl H2O 4mg. L-Lysine Hcl 25mg. Glycine 10mg. Pyridoxine Hcl 1.5mg. Zinc Sulphate 50mg.
10 tab.
841 1964 TRIPLE CHAMBER BAG- Each to contain: Triple chamber bag with Lipid Eulsion (80% Olive Oil &20% Soya Oil ) Amino Acids Glucose and Electrolytes separated by peel seals for Peripheral intravenous
1000ml
842 1965 TRIPLE CHAMBER BAG- Each to contain: Triple chamber bag with Lipid Eulsion (80% Olive Oil &20% Soya Oil ) Amino Acids Glucose and Electrolytes separated by peel seals for Central intravenous
2000ml
843 1966 Tab. Sirolimus Each tab. to contain: Sirolimus 1mg 10 tab. 844 1968 Tab. Valganociclovir Each tab. to contain: Valganociclovir 450mg 4 Tab. 845 1970 Tab. Mycophenolate- Each tab. to contain: Mycophenolic acid (as
Sodium salt ) 360mg 10 tab.
846 1972 Inj. Leuprolide- Each PFS/VIAL to contain: Leuprolide Acetate Depot 3.75mg
1PFS/VIAL
59/71
847 1975 Inj. Botulinum Each vial to contain: Botulinum A Toxin 50 IU 1 vial 848 1976 Inj. Botulinum Each vial to contain: Botulinum A Toxin 100 IU 1 vial 849 1979 Inj. Leucovorin Each vial to conain: Leucovorin 50mg 1 vial 850 1980 Cap. Lenalidomide Each cap. to contain : Lenalidomide 5mg 10 cap 851 1981 Cap. Lenalidomide Each cap. to contain: Lenalidomide 10mg 10 cap. 852 1982 Inj. Oxaliplatin- Each vial to contain: Oxaliplatin 50mg 1 Vial 853 1983 Inj. Oxaliplatin- Each vial to contain: Oxaliplatin 100mg 1 Vial 854 1984 Inj. Paclitaxel- Each vial to contain: Paclitaxel IP 260mg 1 Vial 855 1985 Cap. Temozolomide- Each tab. to contain: Temozolomide 100mg 5 cap. 856 1986 Inj. Zoledronic Acid Each vial to contain: Zoledronic Acid 4mg 1 vial 857 1987 Inj. Octreotide Each vial /pack to contains : Octreotide 30mg
Long Acting Release 1 vial/pack
858 1988 Cap./tab. Tacrolimus- Each tab. to contain: Tacrolimus 0.5mg 10 tab./cap 859 1990 Sachet. Sevelamer Each Sachet to contain: Sevelamer
Carbonate 800mg 90 Sachet
860 1991 Syp. Liver Disorders- Each 15ml contains: DL Methionine BP 100mg. Choline Dihydrogen Citrate NFXII 100 Mg. Leucine USP 19 mg. L-Isoleukcine Usp 10 mg. L-Valine USP 11 mg. Pyridoxine HCL 1.5 mg. Nicotanamide IP 22.5 mg . Biotion Usp 0.1 mg. Folic Acid 0.5 mg.
200ml Bott.
861 1992 Tab. Liver Disorders- Each tab. to contain: DL Methionine BP 200mg. Choline bitarate USP 200mg. L-Leucine USP 19 mg. L-Isoleucine USP 10 mg. L-Valine USP 11 mg. Pyridoxine HCL 1.5 mg. Nicotanamide IP 22.5 mg . Biotion Usp 0.1 mg. Folic Acid 0.5 mg. Cyanocobalamin IP 3.0mcg, Inositol BP 50mg.
10 Tab
862 1995 Vitamin B Complex, Vitamin C & Zinc Cap/Tab- Each Cap/Tab to contain : Zinc Sulphate Monohydrate 61.8 mg. (eqv. to Elemental Zinc 22.5mg.) Ascorbic Acid (as Coated) 150 mg. Nicotinamide 50mg. Thiamine Mononitrate 10 mg. Riboflavine 10 mg. Calcium Pantothenate 10mg. Pyridoxine HCL 3 mg. Folic Acid 1.5 Cyanocobalamin 10mcg.
10 cap/tab
863 1996 Ciprofloxacin & Tinidazole Ciprofloxacin250+Tinidazole300 Tab 10 Tabs 864 1997 Ciprofloxacin & Tinidazole , Each tab. to contain:
Ciprofloxacin500+Tinidazole600 Tab 10 Tabs
865 1999 Aceclofenac & Paracetamol Tab Aceclofenac+Paracetamol Tab 100+325mg
10 Tabs
866 2002 Cetrizine Syp. Each 5ml. to contain : Cetrizine 5 ml. 60 ml. 867 2003 Vitamin A Soln. Each ml. to contain : Vitamin A (As Palmitate)
100000 IU in Arachis oil (equivalent to about 1,09,500 IU per gm) 50ml.
868 2005 Cefoperazone Sodium Inj. Each vial to contain : Cefoperazone Sodium 1gm
1 Vial
869 2006 Cefoperazone & Sulbactum Each vial to contain : Cefoperazone 500+ Sulbactum 500 Inj.
1 Vial
870 2007 Ceftriaxone & Sulbactum Inj. Each vial to contain : Eqv to Anhydrous Ceftriaxone 1gm. + Sulbactum 500mg.
1 Vial
871 2008 Paracetamol & Diclofenac Tab Each tab. to contain : Paracetamol+Diclofenac Tab 325+50mg
10 Tabs
872 2010 Tab/Cap. Pantaprazole 40mg + Domperidone (SR) 30mg- Each tab./cap. to contain: Pantaprazole 40mg + Domperidone (SR) 30mg
10 Cap/ tab
60/71
873 2011 Susp. 1 G Sucralfate- Each 5ml to contain: Sucralfate 1 gm. 100ml bot. 874 2012 PRE & PPOBIOTIC DRY SYRUP - Each 5ml to contains:
Bifilac- 50ml Bottle - Streptococcus faecalis T-110 30 Clostridium butyricum TO-A 2 million Bacillus mesentericus TO-A1 million Lactic acid bacillus (Lactobacillus sporogenes)50 million Excipients
50 ml bottle
875 2014 Tab. Montelukast Sodium- Each tab. to contain: Montelukast Sodium IP 10mg
10 tab
876 2016 Budesonide 200mcg + Formoterol Fumarate 6mcg Rotacap -Each rotacap to contain : Budesonide 200mcg + Formoterol Fumarate 6mcg
30 cap
877 2018 Tab. Perindopril erbumine 8mg, Amlodipine besilate equivalent to Amlodipine 5mg. Excipients q.s. - Each uncoated tab. to contain : Perindopril erbumine 8mg, Amlodipine besilate equivalent to Amlodipine 5mg. Excipients q.s.
10 tab
878 2019 Tab. Indapamide (as SR) 1.5mg, Amlodipine besilate equvalent to amlodipine 2.5mg excepients q.s.
10 tab
879 2021 Tab. Perindopril erbumine 8mg, Indapamide 2.5mg excipients q.s. scored tab. to contain: Perindopril erbumine 8mg, Indapamide 2.5mg excipients q.s.
10 tab
880 2022 Tab. Acenocoumarol/Nicoumalone 2MG- Each tab to contain: Acenocoumarol/Nicoumalone IP 2mg
10 Tab
881 2026 Tab. N-Acetyl Cysteine 600mg Each tab. to contain : Acetyl Cysteine 600mg
10 tab
882 2027 Inj. Diclofenac IP 75mg IV Each 1ml. to contain : Diclofenac IP 75mg IV
1 ml Amp
883 2029 Inj. Teriparatide 750mcg- Each 3ml cartridge to contain : Teriparatide 750mcg
1 Cartridge
884 2032 Inj. Follitropin alpha 1050 IU/1.75 ml Each vial to contain : Follitropin alpha 1050 IU/1.75 ml
vial
885 2034 Tab. Teneligiptin 20mg Each tab. to contain : Teneligiptin 20mg 10 tab 886 2036 Tab. Artemether 20mg & Lumefantrine 120mg Each tab. to
contain : Artemether 20mg & Lumefantrine 120mg 8 tab
887 2040 Inj. Calcium Gluconate Each ml. to contain Calcium Gluconate IP 100mg
10ml amp/vial
888 2041 Tab. Methylcobalamin 500mcg Each tab. to contain : Methylcobalamin 500mcg
10 tab
889 2044 Inj. L-Ornithine L-Aspartate 5.0g- Each inj. to contain : L-Ornithine L-Aspartate 5.0g- 10ml
10ml amp
890 2047 Tab. Calcium Citrate 1000mg, Vit. D3 200 IU, Methylcobalmin 500mcg, Folic Acid 5mg, Pyridoxin IP 10mg - Each tab. to contain : Tab. Calcium Citrate 1000mg, Vit. D3 200 IU, Methylcobalmin 500mcg, Folic Acid 5mg, Pyridoxin IP 10mg
15 tab
891 1005a Tab. Famotidine- Each tab. to contain: Famotidine IP 20mg 892 1005b Tab. Famotidine Each tab. to contain: Famotidine IP 40mg 14 tab. 893 1015a Tab. Prochlorperazine Maleate Each tab. to contain :
Prochlorperazine Maleate IP 5mg 10 tab
894 1034a Terbutaline sulphate Tab., IP Each tab to contain: Terbutaline sulphate 2.5 mg
10 tab
895 1034b Terbutaline Tab Each Tab to contain:Terbutaline sulphate IP 5mg 10 tab
61/71
896 1040b Inh. Beclomethasone Each metered dose to contain : Beclomethasone Dipropionate 100mcg
200 doses
897 1043a Rotacap Salbutamol- Each rotacap to contain : Salbutamol 200mcg
30 cap
898 1043b ROTAHALER DEVICE- Rotahaler 1 piece 899 1056a Tab. Metoprolol Each tab. to contain : Metoprolol Tartrate IP
50mg 10 tab
900 1060a Tab. Iso-sorbide Mononitrate Each tab. to contain : Iso-sorbide 5 Mononitrate IP20mg
10 tab
901 1061a Tab. Glyceryl Trinitrate CR Each CR tab. to contain : Glyceryl Trinitrate 2.6mg
25 tab pack
902 1061b Glyceryl trinitrate CR Tab. Each CR Tab. to contain : Glyceryl trinitrate 6.4 mg.
25 tab pack
903 1065a Lisinopril Tab., Each tab. to contain : Lisinopril 2.5 mg. 10tab 904 1065b Lisinopril Tab., Each tab. to contain: Lisinopril 5 mg. 10tab 905 1065c Lisinopril Tab. Each tab. to contain: Lisinopril 10mg. 10tab 906 1066b Tab. Terazocin Each tab. to contain : Terazocin 2mg IP 10 tab 907 1067b Tab. Prazosin SR- Each SR tab. to contain: Prazosin HCl IP
2.5mg 14 Tab
908 1067c Tab. Prazosin SR- Each SR tab. to contain: Prazosin HCl IP 5mg 14 Tab 909 1068b Tab./Cap Ramipril Each Tab./Cap. to contain: Ramipril IP 2.5mg 10 tab/ cap 910 1068c Tab. Ramipril- Each tab. to contain: Ramipril IP 5mg 10 Tab 911 1069b Mephertermine Tab. Each ml. to contain : Mephertermine (as
sulphate) IP 30mg 10ml vial
912 1079a Parnaparin Inj Each PFS to contain: Low Molecular weight Heparin Sodium Salt (Parnaparin)-3200 I.U.
PFS
913 1082a Inj. Tramadol Each ml. to contain : Tramadol Hydrochloride IP 50mg
1ml
914 1082b Inj. Tramadol -Each ml to contain: Tramadol Hydrochloride IP 50mg
2ml
915 1115b Tab. Phenobarbitone- Each tab. to contain: Phenobarbitone IP 30mg
10 Tab
916 1118a Inj. Midazolam Each amp/vial to contain: Midazolam BP 5mg 1ml amp/vial 917 1118b Inj. Midazolam Each ml. to contain : Midazolam 1mg 5ml Amp/vial 918 1119a Lithium Tabs./ Cap. Each Tab. to contain: Lithium carbonate IP
150mg 10 Tab/Cap
919 1119b Lithium Tabs./ Cap. Each Tab. to contain: Lithium carbonate IP 300mg
10 Tab/Cap
920 1127a Tab. Carbamazepin IP CR- Each CR tab. to contain: Carbamazepin 200mg
10 tab
921 1127b Tab. Carbamazepin CR- Each CR tab. to contain: Carbamazepin IP 400mg
10 Tab.
922 1148b Didrogesttrone Tab., Each Tab. to contain: Didrogestrone IP/USP 10 mg.
10 Tab.
923 1153a Tab. Conjugated Oestrogen Each tab. to contain : Conjugated Oestrogen IP 0.625mg
28 tab
924 1157b Inj. Human Chorionic Gonadotropin Each AMP/Vial to contain : Human Chorionic Gonadotropin 5000 IU
1ml amp/vial
925 1175a Amoxycillin Cap/Tab Each Cap/Tab to contain : Trihydrate eqv to Amoxycillin Cap/Tab., 250mg
10 Tab/Cap
62/71
926 1175b Amoxycillin Cap/Tab Each Cap/Tab to contain : Trihydrate eqv to Amoxycillin Cap/Tab., 500mg
10 Tab/Cap
927 1177a Amoxycillin IP & Clavulanic acid cap/ Tab. Each cap/ Tab. to contain: Amoxycillin IP 500mg, Clavulanic acid IP 125mg
6 Tab/Cap
928 1177b Amoxycillin IP & Clavulanic acid Tab. Each cap/ Tab. to contain: Amoxycillin IP 250mg, Clavulanic acid IP 125mg
6 Tab/Cap
929 117a Tab. Clotrimazole Vaginal Each tab. to contain: Clotrimazole IP 200mg with applicator
3tab pack
930 1184a Ceftazidime Inj. Each vial to contain : Ceftazidime 500mg 1 Vial 931 1185a Ceftriaxone Inj. Each vial to contain : Ceftriaxone Sod. Eqv to
Anhydrous Ceftriaxone 500mg 1 Vial
932 1189a Amikacin Inj. Each 2ml to contain : Amikacin 100 mg (As Amikacin Sulphate)
2ml. Vial
933 1189b Amikacin Inj. Each 2ml to contain : Amikacin 250 mg (As Amikacin Sulphate)
2ml. Vial
934 1192a Amox. & Clav. Inj. Each vial to contain : Amoxycillin Sod. + Clavulanate Potassium 1200mg IP
1 Vial
935 1192b Amox. & Clav. Inj. Each vial to contain : Amoxycillin Sod. + Clavulanate Potassium 600mg IP
1 Vial
936 1192c Amoxycillin & Clavulanic Inj. Each vial to contain: Amoxycillin IP 250mg & Clavulanic Acid IP 50 mg.
1 Vial
937 1195a Ofloxacin Tab., Each tab. to contain : IP Ofloxacin 200mg 10 Tabs 938 1195b Ofloxacin Tab., Each tab. to contain : IP Ofloxacin 400mg 10 Tabs 939 1207a Secnidazole Tabs., IP Each Tab. to Contain: Secnidazole IP
500mg 4 tab
940 1207b Secnidazole Tabs., IP Each Tab. to Contain: Secnidazole IP 1gm 2 tab 941 1210b Tab. Levamisole Each tab. to contain : Levamisole IP 150mg 1 tab 942 1214b Homatropine eye drops IP Containing: Homatropine
Hydrobromide 2% 5ml vial
943 1218a ED- Timolol Maleate Each ml. to contain : Timolol Maleate IP 3.4mg/ml- 5ml
5ml vial
944 1218b ED- Timolol Maleate Each ml. to contain : Timolol MaleateIP 6.8mg
5ml vial
945 1255a Betamath + Salicylic acid Oint. Each gm. to contain: Betamethasone Dipropionate 0.64 mg. Salicylic Acid 30 mg.
10gm tube
946 1255b Betamath + Salicylic acid Oint Each gm. to contain: Betamethasone Dipropionate 0.64 mg. Salicylic Acid 30 mg.
20gm tube
947 1265a ANTICEPTIC LIQUID- Liq. Each Bott. to contain : Chloroxylenol 4.8% w/v Terpineol 9.0% v/v Alcohol absolute (denatured) 13.10% v/v
500ml Bott.
948 1265b Antiseptic Liquid- Each bottle to contain: Chloroxylenol 4.8%w/v, Terpineol 9.0%v/v, Alcohol absolute 13.10%v/v
5 ltr. Bottle
949 1270a Soln Cetrimide - Each bott. to contain: Cetrimide 3% w/v. Chlorhexidine1.5% w/v
1Ltr. Bottle
950 1270b Soln Cetrimide - Each bott. to contain: Cetrimide 3% w/v. Chlorhexidine1.5% w/v
2Ltr. Bottle
951 1274a Handloom Cotton rolled bandage Handloom Cotton rolled bandage (ISI marked) Roll of 6 cm. X 4 m.
10 roll pkt
952 1274b Handloom Cotton rolled bandage Handloom Cotton rolled bandage (ISI marked) Roll of 10 cm. X 4 m.
10 roll pkt
63/71
953 1276a Plaster of Paris Bandage- Plaster of Paris Bandage Roll BP of 10cm x 2.7m
10 roll pkt
954 1276b Plaster of Paris Bandage- Plaster of Paris Bandage Roll BP of 15cm x 2.7m
10 roll pkt
955 1284a Lignocaine Ointment Containing: Lignocaine 5% 20gm tube 956 1284b Lignocaine Jelly Containing: Lignocaine IP 2% 30gm tube 957 1285b Ketamine Inj., Each ml. to contain: Ketamine Hcl 50 mg. 2ml Vial 958 1285c Ketamine Inj., Each ml. to contain: Ketamine Hcl 50 mg. 2ml Vial 959 1302c Vitamin E cap. Each capsule to contain: Vit. E (alpha Tocopherol
acetate) 400mg. 10 cap
960 130a Progesterone Inj., IP Each inj. contain: Hydroxy-progesterone IP 250mg
1ml amp
961 130b Progesterone Inj., IP Each inj. contain: Hydroxy-progesterone IP 500mg
2ml amp
962 1325a Mannitol Inj. Containing : Mannitol 20% IV Infusion IP 350ml. 963 1328a Interferon Inj. Each vial to contain: Interferon Alpha IP 2B: 3Mil
I.U. 1 vial
964 1329a Inj. Cisplatinum Each vial to contain: Cisplatinum IP 10mg 1 vial 965 1329b Inj. Cisplatinum Each vial to contain: Cisplatinum IP 50mg 1 vial 966 132a Danazol Tab./Cap.- Each Tab./Cap. to contain: Danazol IP100mg 30 tab/ cap 967 132b Danazol Tab./Cap.- Each Tab./Cap. to contain: Danazol IP
200mg 30 tab/ cap
968 1330b Inj. Cyclophosphamide Each vial to contain : Cyclophosphamide IP 200mg
1 vial
969 1331a Mitomycin Inj., Each vial to contain: Mitomycin 2mg. 1 vial 970 1331b Inj. Mitomycin Each vial to contain : Mitomycin IP 10mg 1 vial 971 1335b Cap. Cyclosporine Each cap. to contain : Cyclosporine IP 25mg 50 cap 972 1338a Non-Ionic Contrast Media Each ml. to contain: Iohexol 518 mg
eqv. to Iodine 240mg.
10ml
973 1338b Non-Ionic Contrast Media Each ml. to contain: Iohexol 647 mg eqv. to Iodine 300mg.
20ml
974 1338c Non Ionic Contrast Media- Each ml. to contain : Iohexol 647mg. Eqv. To IODINE 300mg. 40ml
40ml
975 1338d Non-Ionic Contrast Media Each ml. to contain: Iohexol 755 mg eqv. to Iodine 350mg.
20ml
976 1339a Human Tetanus Specific Immunoglobulin Containing: Human Tetanus Specific Immunoglobulin 250 units.
1 vial
977 1339b Human Tetanus Specific Immunoglobulin Containing: Human Tetanus Specific Immunoglobulin 500 units.
1 vial
978 1352b Meropenem Trihydrate Inj., Each vial to contain: Meropenem Trihydrate IP eqv. to Anhydrous Meropenem 1gm
1 Vial
979 1353a Cefaclor Tab/Cap. Each cap/ Tab. to contain: Cefaclor IP 500mg 3 tab/cap 980 1353b Tab./Cap. Cefaclor- Each Tab./Cap. to contain: Cefaclor 250mg 6 tab/cap 981 1370b Tab. Torsemide- Each tab. to contain: Torsemide IP 20mg 10 tab. 982 1375a Tab. Leflunomide- Each tab. to contain: Leflunomide IP 10mg 10 Tab 983 1375b Tab. Leflunomide- Each tab. to contain: Leflunomide IP 20mg 10 Tab 984 1407a Inj. Epirubicin Each Inj. to contain : Epirubicin HCL 10mg 1 vial 985 1407b Inj. Epirubicin- Each inj. to contian: Epirubicin HCl 50mg
1 Vial
64/71
986 1409a Peritoneal Dialysis Fluid- Each 100ml to contain: IP 1.5%- Dextrose Anhydrous 1.5gm. Sodium Lactate 448mg. Na cl 538mg. Ca Cl 25.7mg. Mg Cl 5.08mg
2Ltr Bag
987 1409b Peritoneal Dialysis Fluids IP 1.5%- Each 100ml. to contain : Dextrose anhydrous 1.5mg. Sodium Lactate 448 mg. NaCl 538 mg. CaCl 25.7mg. MgCl 5.08mg. 5Ltr Bag (Dianeal 1.5%- 5 ltr)
5Ltr Bag
988 1410a Peritoneal Dialysis Fluid- Each 100ml to contain: IP 2.5%- Dextrose Anhydrous 2.5gm. Sodium Lactate 448mg. Na cl 538mg. Ca Cl 25.7mg. Mg Cl 5.08mg
2Ltr Bag
989 1410b Peritoneal Dialysis Fluids 2.5%- Each 100ml. to contain : Dextrose anhydrous 2.5mg. Sodium Lactate 448 mg. NaCl 538 mg. CaCl 25.7mg. MgCl 5.08mg. 5Ltr Bag (Dianeal 2.5%- 5 ltr)
5Ltr Bag
990 1411a Peritonial Dialysis Fluid IP 4.25%-Dextro Anhydrous 4.25gm. Sodium Lactate 448mg. Na Cl 538mg. Ca Cl 25.7mg. Mg Cl 5.08mg.
2Ltr Bag
991 1411b Peritoneal Dialysis Fluids 4.25%, Each 100ml to contain: Dextrose Anhydrous 4.25gm. Sodium Lactate 448mg., Na Cl 538mg., Ca Cl 25.7mg. Mg Cl 5.08mg.
5Ltr Bag
992 1423a Reviparin Sod. Inj. Each PFs to contain: Reviparin Sod. 0.6ml PFS 993 1423b Reviparin Sod. Inj. Containing: Reviparin Sod. 0.6ml vial 994 1426a Ebastine Tabs., IP Each Tab. to contain: Ebastine 10mg 10 Tab. 995 1426b Tab. Ebastine- Each tab. to contain: Ebastine IP 20mg 10 Tab. 996 1430a Tab. Mirtazapine Each tab. to contain: Mirtazapine IP 7.5mg 10 tab 997 1430b Tab. Mirtazapine Each tab. to contain : Mirtazapine IP 15mg 10 tab 998 1439a Vitamins & Mineral Inj.- Each PFS to contain: Methoxy
Polyethylene Glycol Epoetin-beta 50mcg 1PFS
999 1439b Vitamins & Mineral Inj.- Each PFS to contain: Methoxy Polyethylene Glycol Epoetin-beta 75mcg
1PFS
1000 1439c Vitamins & Mineral Inj.- Each PFS to contain: Methoxy Polyethylene Glycol Epoetin-beta 100mcg
1PFS
1001 1447a Tab. Dasatinib- Each tab. to contain: Dasatinib 20mg 60 tab 1002 1447b Tab. Dasatinib- Each tab. to contain: Dasatinib 50mg 60 tab 1003 1447c Tab. Dasatinib- Each tab. to contain: Dasatinib 70mg 60 tab 1004 1449a Inj. Rituximab Each vial to contain : Rituximab 100mg 10ml vial 1005 1449b Inj. Rituximab Each vial to contain : Rituximab 500mg 50ml vial 1006 1454b Tab. Capecitabine- Each tab. to contain: Capecitabine 500mg 10 Tab. 1007 1455a Low Calcium CAPD Containing: CAPD Bags with 1.5%
concentration containing 40 mEq/litre of lactate and 2.5 mEq/litre of Ca with asymmetrical Y connector
2ltr. Bag
1008 1455b Low Calcium CAPD Containing: CAPD Bags with 2.5% concentration containing 40 mEq/litre of lactate and 2.5 mEq/litre of Ca with asymmetrical Y connector
2ltr. Bag
1009 1473a Tab./Cap. Sunitinib Malate Each Tab./cap. to contain : Sunitinib Malate 12.5mg
7 tab/cap
1010 1473b tab./cap. Sunitinib Malate Each tab./cap. to contain: 25mg 7 Tab./Cap 1011 1473c Tab./Cap. Sunitinib Malate Each Tab./cap. to contain : Sunitinib
Malate 50mg 7 tab/cap
1012 1474a Tab. Everolimus Each tab. to contain : Everolimus 0.25mg 10 tab 1013 1474b Tab. Everolimus Each tab. to contain : Everolimus 0.5mg 10 tab 1014 1474c Tab. Everolimus Each tab. to contain : Everolimus 0.75mg 10 tab
65/71
1015 1476a Tab. Deferasirox- Each tab. to contain: Deferasirox 100mg 6 tab 1016 1476b Tab. Deferasirox- Each tab. to contain: Deferasirox 400mg 6 tab 1017 1485a Tab. Entecavir- Each tab. to contain: Entecavir 0.5mg 10 tab 1018 1485b Tab. Entecavir- Each tab. to contain: Entecavir 1mg 10 tab 1019 1486b Insulin Glargine Inj.- Each vial to contain: Insulin Glargine 100
units/ml 10 Ml. vial
1020 1497a Tab/Cap. Esomeprazole Magnesium Each tab./cap. to contain : Esomeprazole Magnesium IP 20mg
10 Cap/ tab
1021 1497b Tab/Cap. Esomeprazole Magnesium Each tab./cap. to contain : Esomeprazole Magnesium IP 40mg
10 Cap/ tab
1022 1533a Tab. Hydrochlorothiazide Each tab. to contain : Hydrochlorothiazide IP 12.5mg
10 tab
1023 1533b Tab. Hydrochlorothiazide Each tab. to contain : Hydrochlorothiazide IP 25mg
10 tab
1024 1534a Inj. Human Recombinant Coagulation Factor VII- Each vial to contain : Human Recombinant Coagulation Factor VII activated 1mg. (r-DNA origin)1mg
Vial
1025 1534b Inj. Human Recombinant Coagulation Factor VII- Each vial to contain : Human Recombinant Coagulation Factor VII activated 2mg. (r-DNA origin)1mg
Vial
1026 1537a Warfarin sodium Tab Each Tab to contain Warfarin sodium IP 2mg
10 tab
1027 1537b Warfarin sodium Tab. Each Tab. to contain : Warfarin sodium IP 5mg.
10 tab
1028 1539a Tab. Betahistine Dihydrochloride Each tab. to contain : Betahistine Dihydrochloride IP 8mg
10 tab
1029 1539b Tab. Betahistine Dihydrochloride Each tab. to contain : Betahistine Dihydrochloride IP 16mg
10 tab
1030 1540a Tab. Rosuvastatin Each tab. to contain : Rosuvastatin IP 10mg 10 tab 1031 1540b Tab. Rosuvastatin Each tab. to contain : Rosuvastatin IP 20mg 10 tab 1032 1545a Tab. Tolperisone HCl Each tab. to contain : Tolperisone HCl
150mg 10 tab
1033 1545b Tolperisone Hcl Tab. Each Tab. to contain: Tolperisone Hcl JPC. 450 mg
10 tab
1034 1551a Tab. Amoxycillin + Clavulanate + Lactic acid Bacillus- Amoxycillin Trihydrate Eqv. to Amoxycillin 500 + Clavulanate Potassium eqv. To Clavulanic Acid 125 + Lactic acid Bacillus 60 million spores
10 tab
1035 1551b Tab. Amoxycillin + Clavulanate + Lactic acid Bacillus- Amoxycillin Trihydrate Eqv. to Amoxycillin 250 + Clavulanate Potassium eqv. To Clavulanic Acid 125 + Lactic acid Bacillus 60 million spores
10 tab
1036 1552b Cefuroxime Axetil +Clavulanate Potassium Each Tab. to contain: Cefuroxime Axetil IP 250 mg Clavulanate Potassium IP 62.50 mg
4/10 tab
1037 1552c Tab. Cefuroxime + Clavulanic Potassium- Each tab. to contain : Cefuroxime axetil 500mg, Clavulanic Potassium 125mg
4/10 tab
1038 1553a Inj. Doripenem Each vial to contain: Inj. Doripenem 250 mg 1 vial 1039 1553b Inj. Doripenem Each vial to contain: Inj. Doripenem 500 mg 1 vial 1040 1557a Ceftriaxone+Tazobactum Inj. Each vial to contain: Inj.Ceftriaxone
IP 250 mg , Tazobactum Sodium 31.25 mg 1 vial
1041 1557b Ceftriaxone+Tazobactum Inj. Each vial to contain: Inj.Ceftriaxone IP 500 mg , Tazobactum Sodium 62 mg
1 vial
66/71
1042 1557c Inj. Ceftriaxone + Tazobactam Sod.- Each vial to contain : Ceftriaxone 1gm, Tazobactam Sod. 125mg per vial
1 vial
1043 1558a Inj. Cefuroxime Each vial to contain : Cefuroxime 750mg IP 1 vial 1044 1558b Inj.Cefuroxime Each vial to contain: Inj.Cefuroxime IP 1.5 gm 1 vial 1045 157b Roxythromycin Tab., Each tab. to contain: Roxythromycin IP
150mg 10 Tabs
1046 1590a Triamcinolone Tab. Each ml to contain: Triamcinolone IP 10 mg 1ml vial 1047 15a Hyoscine Butyl Bromide Tab., Each Tab. to contain: Hyoscine
Butyl Bromide 10mg. 10 Tabs
1048 15b Inj. Hyoscine Butyl Bromide Each Disp tab. to contain : Hyoscine Butyl Bromide IP 20mg
1ml. Amp
1049 160a Ampicillin Cap., Each cap. to contain: Ampicillin Trihydrate eqv. to Ampicillin, IP 250mg
10 Caps
1050 160b Ampicillin Cap., Each cap. to contain: Ampicillin Trihydrate eqv. to Ampicillin, IP 500mg
10 Caps
1051 1625b Glutaraldehyde Each 100gm contain: Glutaraldehyde IP 10 gms, Quaternary Ammonium Compounds 12 gms
5Ltr.
1052 1626a Collagen Conatin: Collagen Membrane in Dry Form 5X5CM 1pc. 1053 1626b Collagen Conatin: Collagen Membrane in Dry Form 10x10 CM 1pc. 1054 1626c Collagen Conatin: Collagen Membrane in Dry Form 10x20 CM 1pc. 1055 1626d Collagen Conatin: Collagen Membrane in Dry Form 15x30 CM 1pc. 1056 1627a Collagen Conatin: Collagen Absorbant Dressing 10 X 10CM 1pc. 1057 1627b Collagen Conatin: Collagen Absorbant Dressing 10 X 20CM 1pc. 1058 1627c Collagen Conatin: Collagen Absorbant Dressing 15X30 CM 1pc. 1059 162a Ampicillin Inj., Each vial to contain: Ampicillin Sod. IP 250mg 1 Vial 1060 162b Ampicillin Inj., Each vial to contain: Ampicillin Sod. IP 250mg 1 Vial 1061 1650a Fligrastim Inj. Each PFS/vial to contain: Filgrastim 150 mcg 1 pfs/vial 1062 1650b Inj. Filgrastim Each PFS / vial to contain : Filgrastim 300mcg 1 pfs/vial 1063 1652a Hepatitis B Immunoglobulin Inj. Each 0.5ml to contain: Inj.
Hepatitis B Immunoglobulin BP 100 IU 0.5ml vial
1064 169a Cephalexin Cap., Each cap. to contain: Cephalexin Monohydrate eqv. to Cephalexin IP 250mg
10 Caps
1065 169b Cephalexin Cap., Each cap. to contain: Cephalexin Monohydrate eqv. to Cephalexin IP 500mg
10 Caps
1066 170a Gentamycin Inj., Each ml to contain: Gentamycin IP 40mg 2ml Amp 1067 1717b Oint. Hydrocortisone Acetate- Each tube to contain:
Hydrocortisone Acetate 1% 20gm tube
1068 171a Erythromycin Tab., Each tab. to contain: Erythromycin Stearate eq. to Erythromycin IP 500mg
10 Tabs
1069 174a Cotrimoxazole Paed. Tab., Each tab. to contain: IP Trimethoprim 20 mg. Sulphamethoxazole 100 mg.
10 Tabs
1070 174b Cotrimoxazole Paed. Tab., Each tab. to contain: IP Trimethoprim 160 mg. Sulphamethoxazole 800 mg.
10 Tabs
1071 175a Tetracycline Cap. Each tab. to contain Tetracycline IP 500mg 10 Caps 1072 177a Ciprofloxacin Tab., Each tab. to contain: Ciprofloxacin
Monohydrate eqv. to Ciprofloxacin 250mg IP 10 Tabs
1073 177b Ciprofloxacin Tab., Each tab. to contain: Ciprofloxacin Monohydrate eqv. to Ciprofloxacin 500mg IP
10 Tabs
1074 180a Cefotaxime Inj., Each vial to contain : Cefotaxime Sod. Eqv. to Cefotaxime IP 250mg
1 Vial
67/71
1075 180b Cefotaxime Inj., Each vial to contain : Cefotaxime Sod. Eqv. to Cefotaxime IP 1gm
1 Vial
1076 180c Cefotaxime Inj., Each vial to contain : Cefotaxime Sod. Eqv. to Cefotaxime IP 500mg
1 Vial
1077 184a Tab. Ethambutol Each tab. to contain: Ethambutol IP 200mg 10 Tab. 1078 184b Tab. Ethambutol Each tab. to contain: Ethambutol IP 400mg 10 Tab. 1079 185a Tab. Pyrazinamide Each tab. to contain: Pyrazinamide IP 500mg 10 Tab. 1080 185b Tab. Pyrazinamide Each tab. to contain: Pyrazinamide IP 750mg 10 Tab. 1081 186a Tab. Isoniazide- Each tab. to contain: Isoniazide IP 100mg 10 tab 1082 186b Tab. Isoniazide- Each tab. to contain: Isoniazide IP 300mg 10 tab 1083 187a Cap. Rifampicin Each cap. to contain : RifampicinIP 150mg 10 cap 1084 187b Cap. Rifampicin Each cap. to contain : RifampicinIP 450mg 10 cap 1085 2006a Cefoperazone & Sulbactum, Each vial to contain: Cefoperazone
1gm+Sulbactum 1gm Inj. 1 Vial
1086 203a Tinidazole Tab., Each tab. to contain: Tinidazole 300mg IP 10 Tab 1087 203b Tinidazole Tab., Each tab. to contain: Tinidazole 500mg IP 10 Tab 1088 23a Metronidazole Tab., Each tab. to contain: Metronidazole 200mg
IP 10 Tabs
1089 23b Metronidazole Tab., Each tab. to contain: Metronidazole 400mg IP
10 Tabs
1090 245b Inj. Succinyl Choline Each ml. to contain : Succinyl Choline Chloride IP 50mg- 50mg
10ml vial
1091 249a Bupivacaine Inj. IP Containing: Bupivacaine Hcl IP 0.25% 20ml vial 1092 249c Inj. Bupivacaine Heavy containing : Bupivacaine HCl IP 0.5%-
4ml 4ml Amp
1093 278A Dextrose inj.IP (for I.V infusion) Contaning : Dextrose Anhydrous i.p. 5% w/v
500ml
1094 278b Dextrose Inj. IP (for I.V. infusion) Containing: Dextrose Anhydrous 10% w/v
500ml
1095 284a Hepatitis B VACCINE (R-DNA) - Each Vial to contain : 20mcg. Of Hepatitis B Surface Antigen
1 vial
1096 284b Hepatitis B VACCINE (R-DNA) - Each Vial to contain : 10mcg. Of Hepatitis B Surface Antigen
1 vial
1097 284c Hepatitis B VACCINE (R-DNA) - Each Vial to contain : 20mcg. Of Hepatitis B Surface Antigen
10ml vial
1098 302a Levofloxacin Tab., Each tab. to contain: Levofloxacin 250mg IP 10 Tabs 1099 304a Sparfloxacin Tab., Each tab. to contain: Sparfloxacin 100mg 10 X 3 Tab 1100 304b Sparfloxacin Tab., Each tab. to contain: Sparfloxacin 200mg 10 X 3 Tab 1101 30a Tab. Salbutamol Each tab. to contain: Salbutamol IP 2mg 10 Tab 1102 30b Tab. Salbutamol- Each tab. to contain: Salbutamol IP 4mg 10 tab 1103 319a Cap. Ribavirin Each cap. to contain : Ribavirin IP 100mg 4 cap 1104 319b Cap. Ribavirin- Each cap. to contain: Ribavirin IP 200mg 4 cap 1105 324a Tab. Clobazam- Each tab. to contain: Clobazam IP 5mg 10 Tab. 1106 324b Tab. Clobazam- Each tab. to contain: Clobazam I.P. 10mg 10 tab 1107 328b Inj. UrokinaseEach vial to contain : Urokinase 5 lakhs IU 1 vial 1108 329a Glimepiride Tab. Each tab. to contain: Glimepiride 1mg IP 10 Tabs 1109 329b Glimepiride Tab. Each tab. to contain: Glimepiride 2mg IP 10 Tabs 1110 32a SALBUTAMOL RESP. SOLN - Each 2.5ml. to contain :
Salbutamol sulphate eqv. to Salbutamol 2.5mg in normal saline soln
2.5ml resp
68/71
1111 32b Resp. Soln. Salbutamol - Each ml to contain:Salbutamol Sulphate eqv. to sulbutamol 5mg is normal saline soln.
15ml bottle
1112 333a Zidovudine cap. Each cap. to contain: Zidovudine IP 100mg. 10 cap 1113 333b Cap./ Tab. Zidovudine Each Cap. /Tab. to contain : Zidovudine
IP 300mg 10 tab/cap
1114 335a Tab. Acyclovir Each Tab. to contain : Acyclovir IP 200mg 10 tab 1115 335b Tab. Acyclovir- Each tab. to contain: Acyclovir IP 400mg 5 Tab. 1116 336a Carvedilol tab. Each Tab. to contain : Carvedilol IP 3.125mg. 10 tab 1117 336b Tab. Carvedilol Each tab. to contain : Carvedilol IP 6.25mg 10 tab 1118 336c Carvedilol tab. Each Tab. to contain : Carvedilol IP 12.5mg. 10 tab 1119 341a Tab. Iso-Sorbide Mononitrate SR- Each SR to contain : Iso-
Sorbide Mononitrate 30mg 10 tab
1120 341b Tab. Iso-Sorbide Mononitrate SR- Each SR to contain : Iso-Sorbide Mononitrate 60mg
10 tab
1121 346a Cough Expectorant, Each 5ml to contain: Diphenhydramine HCL 14mg., Ammonium chloride 135mg., Sodium citrate 57mg., Menthol 0.9mg.
110ml Bott.
1122 347a CPM Cough Expectorant, Each 5ml to contain: Chlorpheniramine maleate 3.0 mg Ammonium chloride 110 mg, Sodium citrate 46mg. Menthol 0.9 mg.
110ml Bott.
1123 364a Losartan tab.Each Tab. to contain : Losartan potassium IP 25 mg.
7 tab
1124 364b Losartan tab Each Tab. to contain : Losartan potassium IP 50 mg.
7 tab
1125 366a Inj. Enoxaprin- Each PFS to contain : Enoxaprin : Sodium IP 20mg/0.2ml
1 PFS
1126 366c Inj. Enoxaprin 60mg/0.6ml- Each PFS to contain : Enoxaprin IP 60mg/0.6ml
PFS
1127 368a Atorvastatin tab. Each Tab. to contain : Atorvastatin IP 10mg. 10 tab 1128 368b Atorvastatin tab. Each Tab. to contain : Atorvastatin IP 20mg. 10 tab 1129 372a Tab. Dothiepin Each tab. to contain : Dothiepin HCl 25mg 10 tab 1130 372b Dothiepin Tab. Each Tab. to contain: Dothiepin Hcl IP 75mg 10 tab 1131 373a Cap. Doxepin Each cap. to contain : Doxepin HCl IP 25mg 10 cap 1132 373b Cap. Doxepin- Each cap. to contain: Doxepin HCl IP 75mg 10 cap 1133 374a Sertraline tab. Each Tab. to contain: Sertraline IP 25 mg 10 cap 1134 374b Tab. Sertraline- Each tab. to contain: Sertraline IP 50mg 10 tab 1135 376a Cefuroxime tab. Each Tab. to contain: Cefuroxime IP 125mg 4 tab 1136 376b Cefuroxome tab. Each Tab. to contain: Cefuroxime IP 250mg 4 tab 1137 376c Cefuroxime tab. Each Tab. to contain: Cefuroxime IP 500mg 4 tab 1138 400a Inj. Propofol- Each vial to contain: Propofol IP 1%- 10ml vial 1139 408a Inj. Erythropoietin- Each PFS to contain: Erythropoietin 2000
units PFS 1 PFS
1140 408d Inj. Erythropoietin- Each PFS to contain: Recombinant Human Erythropoietin 3000Units
1 PFS
1141 413a Inj. Teicoplanin Each vial to contain : Teicoplanin 200mg per vial 1 vial 1142 413b Inj. Teicoplanin Each vial to contain: Teicoplanin 400mg 1 Vial 1143 420a FLUTICASONE +SALMETEROL INHALER-Each metered dose
to contain : IP SALMETEROL 25mcg. Fluticasone 50mcg. 120 doses
1144 420b FLUTICASONE +SALMETEROL INHALER-Each metered dose to contain : IP SALMETEROL 25mcg. Fluticasone 250mcg.
120 doses
69/71
1145 423a Tab. Nicorandil- Each tab. to contain: Nicorandil IP 5mg 20 Tab 1146 423b Tab. Nicorandil- Each tab. to contain: NicorandilIP 10mg 20 Tab 1147 428a Tab. Acetyl Salicylic Acid- Each enteric coated tab. to contain:
Acetyl Salicylic Acid IP 75mg 14 Tab
1148 428b Tab. Acetyl Salicylic Acid Each enteric coated tab. to contain : Acetyl Salicylic Acid IP 150mg
14 tab
1149 428c Tab. Acetyl Salicylic Acid I.P. 325mg (Tab. Ecosprin 325mg) 14 tab 1150 433a Tab. Sodium Valproate+Valproic Acid CR Each CR tab. to
contain : (Sodium Valproate+Valproic Acid) eqv. to Sodium Valproate 200mg
10 tab
1151 433b Tab. Sodium Valproate + Valproic Acid CR- Each CR tab. to contain: (Sodium Valproate + Valproic Acid) eqv. To Sodium Valproate 500mg.
10 Tab.
1152 434a Tab. Pioglitazone Each tab. to contain : Pioglitazone IP 15mg 10 tab 1153 434b Tab. Pioglitazone Each tab. to contain : Pioglitazone IP 30mg 10 tab 1154 43a Atenolol Tab. Each tab. to contain: IP Atenolol 25mg 10 Tabs 1155 43b Atenolol Tab. Each tab. to contain: IP Atenolol 50mg 10 Tabs 1156 448a Permethrin 1% Lotion Containing: Permethrin 1% 60ml bottle 1157 44b Tab. Propranolol- Each tab. to contain: Propranolol IP 40mg
(Tab. PONOL 40) 10 Tab
1158 452a Adhesive Tape, Adhesive Tape BP/ USP 5cmx5m, Hypoallergenic extra porous
one spoll
1159 452b Adhesive Tape, Adhesive Tape BP/USP 7.5cmx5m, Hypolallergenic extra porous
one spoll
1160 452c Adhesive Tape, Adhesive Tape BP/USP 10cmx5m, Hypolallergenic extra porous
one spoll
1161 459a Inj. Gemcitabine- Each vial to contain: Gemcitabine 200mg 1 vial 1162 459b Inj. Gemcitabine- Each tab. to contain: Gemcitabine USP 1gm 1 Vial 1163 463a Zolpidem Tab. Each tab to contain : Zolpidem 5 mg 10 tab 1164 463b Tab. Zolpidem- Each tab. to contain: Zolpidem IP10mg 10 tab 1165 465b Human Anti-D Immunoglobulin Inj. Each inj. Containing : Human
Anti-D Immunoglobulin 300 mcg (Ultrafiltered) 1 pfs/vial
1166 466a Methylprednisolone Tab. Each tab. to contain:Methylprednisolone 4mg.
10 tab
1167 466b Methylprednisolone tab.Each Tab. to contain: Methylprednisolone IP 16mg
14 tab
1168 470a Perindopril tab. Each Tab. to contain : Perindopril 2mg. 10 tab 1169 470a Tab. Perindopril- Each tab. to contain: Perindopril 2mg 10 tab 1170 470b Tab. Perindopril- Each tab. to contain: Perindopril 4mg 10 tab 1171 470c Tab. Perindopril- Each tab. to contain: Perindopril Erbumine 8mg 10 tab. 1172 472a Tab. Clonazepam- Each tab. to contain: Clonazepam IP 0.5mg 10 tab 1173 472b Tab. Clonazepam- Each tab. to contain: Clonazepam IP 1mg 10 tab 1174 473a Tab. Resperidone Each tab. to contain : Resperidone USP 1mg 10 tab 1175 473b Tab. Resperidone Each tab. to contain : Resperidone USP 2mg 10 tab 1176 474a Tab. Olanzapine Each tab. to contain : OlanzapineIP 2.5mg 10 tab 1177 474b Tab. Olanzapine- Each tab. to contain: Olanzapine IP 5mg 10 Tab. 1178 475a Haloperidol tab. Each Tab. to contain: Haloperidol IP 1.5mg 10 Tab. 1179 475b Tab. Haloperidol Each Tab. to contain : Haloperidol IP 5mg 10 tab 1180 477a Tab. Amitriptyline, Each tab. to contain: IP Amitriptyline 10mg 10 tab
70/71
1181 477b Tab. Amitriptyline Each tab. to contain : Amitriptyline IP 25mg 10 tab 1182 486a Tab. Paroxetine Each tab. to contain : Paroxetine IP 10mg 10 tab 1183 486b Tab. Paroxetine Each tab. to contain : Paroxetine IP 20mg 10 tab 1184 487a Inj. Paclitaxel- Each vial to contain: Paclitaxel IP 100mg 1 Vial 1185 487b Inj. Paclitaxel Each vial to contain: Paclitaxel IP 200mg 1 vial 1186 488a Inj. Carboplatin Each vial to contain: Carboplatin IP 150mg 1 vial 1187 488b Inj. Carboplatin Each vial to contain: Carboplatin IP 450mg 1 vial 1188 49a Tab. Diltiazem Each tab. to contain: Diltiazem IP 30mg 10 tab 1189 49b Tab. Diltiazem Each tab. to contain: Diltiazem IP 60mg 10 tab 1190 4a Ranitidine Tab. IP Each tab. to contain: Ranitidine Hcl eqv. to
Ranitidine 150 mg 10 Tabs
1191 4b Ranitidine Tab. IP Each tab. to contain: Ranitidine HCl eqv. to Ranitidine 300 mg
10 Tabs
1192 509a Human Growth Hormone-Each Cartridge containing: Somatropin 16 IU (R-DNA origin)
1 Cartridge
1193 509b Human Growth Hormone-Each Cartridge containing: Somatropin 18 IU
1 Cartridge
1194 509e Human Growth Hormone Cartridge containing: Somatropin 4 IU 1 Vial 1195 509e Human Growth Hormone Containing: Somatropin 4 IU (R-DNA
origin) 1 Vial
1196 50a Diltiazem SR tab. Each S.R. Tab. to contain : Diltiazem 90mg 10 Tab 1197 525a Tab. Metoprolol ER 50 - Each ER tab. to contain: Metoprolol
Succinate USP 47.5mg. Equivalent to Metoprolol Tartrate 50 mg. 10 Tab
1198 527a Tab. Gabapentin Each tab. to contain : Gabapentin IP 300mg 10 tab 1199 527b Gabapentin tab.Each Tab. to contain: Gabapentin IP/BP/USP
400mg. 10 tab
1200 529a Azithromycin Cap/Tab., IP Each cap./tab. to contain: Azithromycin 250mg
10 Cap/Tab
1201 529b Azithromycin Cap/Tab., IP Each cap./tab. to contain: Azithromycin 500mg
10 Cap/Tab
1202 52b Tab./Cap. Nifedipine SR Each SR Tab./Cap. to contain : Nifedipine SR IP 20mg
10 tab/cap
1203 546a Paper Adhesive Tape - Paper Adhesive Tape Hypoallergehnic with Acrylate Adhesive 2.5cm x 9.14m
1 roll
1204 546b Paper Adhesive Tape - Paper Adhesive Tape Hypoallergehnic with Acrylate Adhesive 5cm x 9.14m
1 roll
1205 547b Fluticasone Rotacap Each Rotacap to contain: Fluticasone IP 100mcg
30 cap
1206 548b Beclomethasone Rotacap- Each Rotacap to contain : Beclomethasone 200mg.
30 cap
1207 554b Tab. Bromocriptin Each tab. to contain: Bromocriptin IP 2.5mg 10 Tab. 1208 555a Tab. Clozapine Each tab. to contain : Clozapine IP 25mg 10 tab 1209 555b Tab. Clozapine Each tab. to contain : Clozapine IP 100mg 10 tab 1210 556a Tab. Escitalopram Each tab. to contain: Escitalopram IP 10mg 10 Tab. 1211 556b Tab. Escitalopram- Each tab to contain: Escitalopram IP 20mg 10 tab 1212 557a Inj. Dalteparin Sodium Each PFS to contain: Dalteparin Sodium
2500 IU 1 PFS
1213 557b Inj. Dalteparin Sodium 5000 IU 1 PFS 1214 558a Finaestride tab. Each Tab. to contain : Finaestride IP 1mg 10 Tab. 1215 558b Tab. Finasteride Each tab. to contain: Finasteride IP 5mg 10 Tab.
71/71
1216 563a Misoprostol Tab. Each tab. to contain: Misoprostol 100mcg 4 tab. 1217 563b Tab. Misoprostol- Each tab. to contain: Misoprostol 200mcg 4 tab. 1218 567b Tab. Rabeprazole Each tab. to contain : Rabeprazole IP 20mg 10 tab 1219 56a Tab. Enalapril Maleate Each tab. to contain : Enalapril Maleate
IP 2.5mg 10 tab
1220 56b Tab. Enalapril Maleate Each tab. to contain : Enalapril Maleate IP 5mg
10 Tab
1221 56c Tab. Enalapril Maleate Each tab. to contain : Enalapril Maleate IP 10mg
10 tab
1222 571b Tab. Simvastatin Each tab. to contain : Simvastatin IP 10mg 10 tab 1223 575b Cefixime Tab., IP Each tab. to contain: Cefixime 100mg 10 Tabs 1224 575c Cefixime Tab., IP Each tab. to contain: Cefixime 200mg 3X10 Tab 1225 576a Tab. Gliclazide MR Each MR tab. to contain : Gliclazide 30mg 10 tab 1226 576b Tab. Gliclazide MR Each MR tab. to contain : Gliclazide 60mg 10 tab 1227 578a Tab. Alendronate Each tab. To contain : Alendronate 35mg 4 tab 1228 578b Tab. Alendronate- Each tab. to contain: Alendronate IP 70mg 4 tab. 1229 585a Cotton Crepe Bandage Cotton Crepe Bandage (Stretched,
BPC/ISI marked) Roll of 8 cm. x 4 m. one roll
1230 585b Cotton Crepe Bandage Cotton Crepe Bandage (Stretched, BPC/ISI marked) Roll of 10 cm. x 4 m.
one roll
1231 585c Cotton Crepe Bandage Cotton Crepe Bandage (Stretched, BPC/ISI marked) Roll of 15 cm. x 4 m.
one roll
1232 587b Sevoflurane- Each 250ml. to contain: Sevoflurane USP 250ml 250ml bottle 1233 603a Intravenous Lipid Soln. 10% Each 100ml. to contain: Fat
emulsion containing Fractionated Soyabean Oil 10gm., Fractionated Egg Phospholipids 1.2gm. Glycerol 2.2gm.
100ml
1234 603b Intravenous Lipid Solution 20%- Each 100ml. To contain : Fat emulsion containing fractionated soyabean Oil 20gm, fractionated Egg Phospholipds 1.2 gm glycerol 2.2mg.
250ml
1235 61a Tab. Spironolactone Each tab. to contain : Spironolactone IP 25mg
10 tab
1236 61b Spironolactone tab., IP Each tab. to contain: Spironolactone 100mg.
10 tab
1237 68a Ethamsylate tab. Each Tab. to contain Ethamsylate 250mg. 10 tab 1238 68b Tab. Ethamsylate Each tab. to contain : Ethamsylate 500mg 10 tab 1239 72a Tab. Acenocoumarol Each tab. to contain : Acenocoumarol IP
1mg 10 Tab
1240 74a Inj. Streptokinase Each vial to contain : Streptokinase I.P. 7.5 lac IU
1 vial
1241 74b Streptokinase Injection Each Vial to Contain:Streptokinase 15lac IU
1 vial
1242 82a Paracetamol Syp. Each 5ml. to contain: Paracetamol 125 mg. IP 60 ml. 1243 83a Ibuprofen Tab IP Each tab. to contain: Ibuprofen 200mg 10 Tabs 1244 83b Ibuprofen Tab IP Each tab. to contain: Ibuprofen 400mg 10 Tabs 1245 94a Tab. Alprazolam Each tab. to contain : Alprazolam IP 0.25mg 10 tab 1246 94b Tab. Alprazolam Each tab. to contain : Alprazolam IP 0.5mg 10 tab 1247 0 Sterlity Testing for alone -